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The role of the infinitely small in nature is infinitely great.  
- Louis Pasteur 
Abstract  
Being the most diverse and abundant domain of life, bacteria exemplify the remarkable ability of 
evolution to fit organisms into almost any imaginable niche on the planet. Although the capacity of 
bacteria to diversify and adapt is fundamental to natural ecosystems and modern biotechnology, the 
same adaptive mechanisms constantly threaten human health. Less than a century ago, infectious 
disease was among the most common causes of mortality, but luckily this situation was drastically 
improved with the introduction of vaccination and effective antimicrobial drugs. Unfortunately, this 
situation is changing with the rapid emergence of multidrug resistant bacteria that do not respond to 
our current treatments. This process is to a large extent driven by gene exchange that allows bacteria to 
rapidly acquire ready-made adaptive features. The aim of this thesis has been to understand the 
adaptive mechanisms governing the dynamics of bacterial gene-sharing. Specifically, the focus has been 
on antibiotic resistance genes and their genetic vectors due to the profound implications of these 
genetic elements in human health.   
To observe the extend and impact of gene transfer events in a highly relevant natural environment, we 
looked into the genomes of Escherichia coli longitudinally sampled from the infant gut over the first year 
of life. Sequence analysis revealed a high degree of genomic plasticity, with frequent gene acquisition 
and loss events. While the acquisition of new genetic material is often deleterious, we show that 
plasmids encoding resistance and virulence factors may indeed be stably maintained in the gut despite 
imposing a measurable fitness cost to their bacterial hosts in vitro.   
In two studies investigating the stability of genetic elements, we zoom in on the molecular mechanisms 
enabling conflict resolution between incoming genetic elements and naïve recipient genomes. In both 
studies, the burden of initially costly genetic elements is ameliorated via adaptive evolution over time. In 
the case of a large multi-drug resistance plasmid, adaptation happens through IS26 mediated deletions 
of costly genes that (collaterally) sacrifice the transfer proficiency of the plasmid. For the industrially 
relevant mevalonate production pathway, we observe similar population-level loss dynamics. Using 
ultra-deep sequencing we show that the cost-attenuated pathway variants are interrupted by different 
IS-element insertions that enrich over time due to the fitness benefit of production loss. For both 
studies, the compensatory activity depends on the host background, and we suggest measures that can 
harness evolution to increase genetic stability of the costly production pathway.   
The final study of this thesis investigates the phenotypic effects of expressing 200 antibiotic resistance 
genes in E. coli. As the currency of evolution, genes are subject to selection at different levels that may 
promote or limit their success when transferred to a new host. Through sequence analysis and 
experimental interrogations, we suggest that functional constrains, rather than sequence composition, 
is the main challenge that acquired genes encounter when transferred across phylogeny.    
The work conducted in this thesis provides novel insight into the persistence and evolution of highly 
relevant genetic elements in vitro, In vivo and in situ. The conclusions shed light on fundamental 
evolutionary questions of genome dynamics and bacterial adaptation, which may ultimately improve 
our ability to predict and prevent the spread of antibiotic resistance and guide the engineering of robust 
biological systems. 
 
Dansk sammenfatning 
Trods deres beskedne størrelse repræsenterer bakterier den største mangfoldighed af liv på jordkloden. 
Bakteriernes enorme diversitet skyldes deres evne til hurtigt at tilpasse sig nye omstændigheder. Denne 
evolutionære kapacitet er vigtig for jordens økosystemer og udnyttes til produktion af billige, og mere 
miljørigtige, kemikalier af den bioteknologiske of farmaceutiske industri. Ligesom tilpasning til andre 
miljøer, har nogle bakterier udviklet evnen til at forårsage infektioner hos mennesker, og før opfindelsen 
af antibiotika var infektionssygdomme blandt den hyppigste dødsårsag. Desværre oplever vi en udvikling 
der igen øger truslen fra bakterielle infektioner, fordi mange bakterier er blevet resistente overfor de 
antibiotika som før blev brugt til at bekæmpe dem. Dette skyldes tilpasningen af bakterier til vores 
forbrug af antibiotika, og en stor del af svaret på deres hurtige tilpasning skal findes i deres evne til at 
dele mobile DNA-elementer med hinanden.  
I denne afhandling har jeg undersøgt de molekylære faktorer, som er med til at afgøre spredningen og 
tilpasningen af mobile DNA-elementer involveret i antibiotikaresistens hos sygdomsfremkaldende 
bakterier.   
I de første to studier har vi undersøgt omfanget og indflydelsen af mobile genetiske elementer i 
tilpasningen af Escherichia coli bakterier isoleret fra spædbørns tarmflora i løbet af det første leveår. Via 
genomiske DNA-analyser detekterede vi hyppig overførsel, samt tab, af plasmider og bakteriofag-
elementer. Dette var tilfældet ligegyldigt om barnet modtog antibiotika eller ej. Hvor nogle plasmider, 
som bidrager til virulens eller antibiotikaresistens kan overleve over længere tidsperioder i et tarmmiljø 
uden direkte nytteværdi for værtsbakterien, observerede vi at et plasmid involveret i 
antibiotikaresistens tilmed kunne øge værtsbakteriens overlevelse i tarmen selv uden tilstedeværelsen 
af antibiotika.  
I de næste to studier zoomer vi ind på plasmider som evolutionære enheder og belyser nogle af de 
mekanismer, som afgør deres tilpasning til nye værtsbakterier. I det første studie har vi undersøgt, 
hvordan et multiresistens plasmid tilpasser sig til kliniske Klebsiella pneumoniae og Escherichia coli 
isolater. Her ser vi at plasmidet kan opnå højere stabilitet ved, via rekombination af IS-elementer, at 
fjerne plasmidregioner involveret i dets horisontale overførsel. I det andet studie viser vi at IS-
medierede adaptive mekanismer også har betydning for et syntetisk plasmid involveret i bioteknologisk 
produktion af mevalonat. Her omgås cellernes dannelse af toksiske produkter ved at indsætte IS-
elementer fra kromosomet i produktionsgenerne. I begge studier, observerede vi en væsentlig 
sammenhæng mellem stammebaggrund og omfanget af kompenserende begivenheder.  
Formålet med det sidste studie var at belyse de faktorer, som gør at nogle gener har sværere ved at 
sprede sig end andre. Til dette formål benyttede vi 200 af de mest hyppige antibiotikaresistensgener 
fundet i offentlige resistensgen-databaser. Vi viser eksperimentelt at sekvenssammensætningen har lille 
betydning, men at funktion af det protein som genet koder for, spiller en større rolle for 
resistensfunktion of biologisk fitness. Vi ser at specielt proteiner, som er afhængige af cellulære 
komponenter, kan være begrænsede når de overføres imellem fjernt beslægtede bakterier.  
Arbejdet i denne afhandling er primært udført på bakterier og gener med relevans for 
antibiotikaresistens, men de samme basale mekanismer bidrager også generelt til livets udvikling på det 
molekylære plan. Det er min forhåbning at resultaterne vil bidrage til en dybere forståelse af bakteries 
tilpasning, som på sigt kan give os et forspring i kampen mod antibiotikaresistente bakterier, samt 
bidrage til en mere rationel konstruktion af produktionsorganismer. Bidrag til disse områder er hårdt 
tiltrængte, hvis vi ønsker at skabe et samfund som er både medicinsk og miljømæssigt bæredygtigt. 
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 Introduction  1 
Introduction  
 ͞For the first half of geological time our ancestors were bacteria.  
 Most Đreatures still are ďaĐteria...” – Richard Dawkins (1996) 
Evolution is the process through which present-day organisms arose and are constantly changing. 
Since the first self-replication entities arose on our planet, a myriad of life forms have emerged. 
While human existence represents only a minute fraction in the history of life, the majority of life 
forms are single-celled organisms that have inhabited the earth for billions of years.  
Being the most diverse and abundant domain of life, bacteria exemplify the remarkable ability of 
evolution to fit organisms into almost any imaginable ecological niche. Although the capacity of 
bacteria to undertake a wide range of metabolic functions is fundamental to natural ecosystems 
modern biotechnology, the same adaptive mechanisms strongly influence human health. While 
many bacteria support a healthy life, the pathogenic minority that cause disease has received most 
of the attention in modern medicine
1
. Less than a century ago, infectious disease was the most 
common cause of mortality, but luckily this situation was drastically improved with the introduction 
of vaccination and effective antimicrobial drugs. Unfortunately, this was just another bump on the 
evolutionary road of our microbial enemies, and we are currently witnessing the full capability of 
bacterial evolution to overcome our most critical medical inventions
2
.   
Interbacterial transfer of antibiotic resistance genes is among the main events driving the 
emergence of multidrug resistant pathogens
3
. Therefore, in order to predict, and prevent, the 
further emergence of so-Đalled ͞supeƌďugs͟, ǁe Ŷeed uŶdeƌstaŶd the ŵoleĐulaƌ foƌĐes dƌiǀiŶg the 
dissemination of mobile genetic elements and their genetic content.   
The aim of this thesis work has been to obtain knowledge on the adaptive mechanisms and 
evolutionary dynamics of bacteria at the molecular level. Specifically, the focus has been on plasmids 
implicated in the dissemination of antibiotic resistance and virulence within Enterobacteria. I have 
used high-throughput sequencing and diverse laboratory techniques to follow, reproduce, and 
measure the effect of adaptive trajectories followed by bacteria in situ and in vitro. In addition, I 
employed gene synthesis technology to better understand the selective constrains experienced by 
transferable antibiotic resistance genes upon entering a naïve host. While most results have been 
obtained at different genetic levels in the laboratory, I have strived to couple in vitro insights to in 
vivo observations for a broader picture of the complex reality experienced by bacterial strains and 
plasmids residing in the human gut.  
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Chapter 1  
͞Never underestimate an adversary that has a three-point-five-billion-year head start.͟  
- Abigail Salyers (2002) 
1 Antibiotic resistance  
The discovery and development of effective antibacterial compounds is one of our greatest medical 
innovations. By curing and preventing bacterial infections, that were previously untreatable, 
antibiotics have saved countless lives and allowed for invasive surgical procedures
4
. Unfortunately, 
we are now witnessing the power of microbial evolution, and HGT in particular, as a response to our 
extensive antibiotic use
5
.  
The first widely used antibiotic was the synthetic arsenic based compound Salvarsan developed to 
treat syphilis (Treponema pallidium) in 1909
6
. The same systematic screening approach led to the 
discovery of the sulphonamide family of antibiotics in 1935, which is still in use today
7
. Nevertheless, 
the iŶtƌoduĐtioŶ of peŶiĐilliŶ iŶ ϭ9ϰϬ͛es ŵaƌked the iŶtƌoduĐtioŶ of β-lactam antibiotics, which 
quickly became the most widely used class of antibiotics due to their high potency and low toxicity
8
. 
As a natural product, the discovery of penicillin inspired efforts into screening bacteria and fungi for 
their ability to produce antibiotic compounds. Indeed, important drugs such as streptomycin, 
tetracycline and chloramphenicol were discovered within a decade after penicillin by systematic 
screening and isolation approaches
9
. While a few classes of synthetic antibiotics were developed, 
most of the compounds in use today are (derivatives of) natural compounds
9
.  
The production of antibiotic drugs by natural organisms has led to numerous speculations on the 
functions of these compounds in nature
10
. It is tempting to believe that antibiotics have always been 
agents of chemical warfare produced by organisms to avoid or prey upon bacteria. However, many 
natural environments do not reach the high concentrations of antibiotics required for significant 
growth inhibition of competitors, and some studies suggest a more complex regulatory role of 
antibiotics as signalling molecules not directly involved in the killing of competitors
10
.    
For many years, antibiotics were considered wonder drugs that would free us from the burden of 
bacterial infections. Nevertheless, soon after the introduction of the first antibiotics, it was realized 
that bacteria would suddenly become resistant to previously effective treatments. Today, important 
pathogens such as Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli are highly 
resistant to the first generation of penicillin and many of its derivatives (Figure 1). Although resistant 
pathogens emerged soon after the introduction of peŶiĐilliŶ, the fiƌst β-lactamase enzyme, able to 
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hydrolyse penicillin, was discovered even earlier; prior to peŶiĐilliŶ͛s clinical use11. Similarly, more 
recent phylogenetic analysis, and investigations of metagenomic DNA, has revealed that most 
antibiotic resistance genes are ancient and ubiquitously present in natural environments; including 
those of no previous human contact
12–18
. It has been hypothesised that these resistance genes 
mainly evolved in, or as a response to, antibiotic producing organism and subsequently mobilised 
and spread to human pathogens facilitated by anthropogenic selection
4,19
. While the enrichment of 
antibiotic resistance genes by humans is clear, the connection from the clinic to environmental 
reservoirs is still not fully understood
12–17
.  
β-lactamases - an evolving threat to our most important antibiotics  
HistoƌiĐallǇ, the β-lactams is the most widely used antibiotic drug class20,21. Unfortunately, β-
lactamase enzymes aďle to hǇdƌolǇse all kŶoǁ β-lactam drugs are now widely disseminated and pose 
a growing challenge in clinical antibiotic resistance. While β-lactamases have mobilised and spread 
extensively throughout the 19
th
 century, they are also widely present in environmental isolates and 
have likely been around for millions of years
16,22
. The first β-lactamases to emerge among clinical 
isolates belonged to the TEM and SHV families that would confer resistance to the first generations 
of penicillins. By the 1970s these enzymes would be highly disseminated among especially E. coli and 
K. pneumoniae isolates that were still sensitive to the cephalosporin class of β-lactams introduced in 
the 1980s
20
. However, already in 1983 plasmid-borne mutants of the original SHV and TEM enzymes, 
able to hydrolyse cephalosporins, arose
20. These iŵpƌoǀed β-laĐtaŵases ǁeƌe teƌŵed ͞EǆteŶded 
SpeĐtƌuŵ Beta LaĐtaŵases͟ ;ESBLͿ aŶd the SHV aŶd TEM ǀaƌiaŶts ǁeƌe the doŵiŶaŶt ESBLs iŶ 
enterobacteria up until the 1990s. However, by the end of the 1990s, other β-lactamases had 
emerged, including the novel CTX-M class that were not directly related to the TEM and SHV β-
lactamases. This CTX-M class quickly arose to become the most prevalent ESBL class carried by E. coli 
and K. pneumoniae clinical isolates, and no particular reason for their success has been proposed
23
. 
 
Because the ESBL prevalence has reached critical levels in most countries (Figure 1) the 
carbapenems is a critical Đlass of β-lactam drugs used as last resort therapy against ESBL positive 
infections
24
. However, the selection imposed by carbapenems have encouraged the rapid 
emergence and spread of carbapenemases, with some European countries experiencing resistance 
rates of > 50% among invasive Gram-negative isolates
25
. In these isolates, carbapenemases are most 
often encoded from plasmids by enzymes such as the Klebsiella Pneumonia Carbapenemase (KPC) 
and New Delhi Metallo-β-lactamase-1 (NDM-1) that, along with VIM and OXA types, demonstrate 
how the emergence and spread of certain resistance genes, as a response to increased drug usage, 
can rapidly compromise medical treatments
26
. 
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Figure 1. The prevalence of invasive (blood and cerebrospinal fluid) K. pneumoniae (A) and E. coli (B) isolates 
resistant to third-generation cephalosporins in Europe (2015). Figures adapted from the ECDC surveillance 
report 2015
25
.  
 
Mechanisms of antibiotic resistance 
Genetic innovations leading to antibiotic resistance is caused by either modification (e.g. mutation or 
amplification) of endogenous genes or, more commonly, the acquisition of pre-evolved resistance 
genes. Mutational resistance is most often caused by alterations of conserved antibiotic targets, up-
regulation of chromosomally encoded efflux pumps or down-regulation of uptake mechanisms, and 
will not be detailed further due to the focus of this thesis on transferable resistance
27
.  
Biochemical research into the mechanistic basis of transferable (primarily plasmid-borne) resistance 
has revealed numerous mechanisms of resistance
4
. The mechanisms by which resistance genes 
confer resistance are diverse and can be classified into five major categories (Figure 2) detailed in 
the following.  
 
Drug modification  
An important class of diverse resistance mediators are those interacting directly with the drug to 
chemically inactivate it by cleavage or modification. Drug hydrolysis is the ŵost ĐoŵŵoŶ Đause of β-
lactam resistance and is ŵediated ďǇ Ŷuŵeƌous β-lactamase variants of different spectrum28. Drug 
modification is another widespread strategy resistance employed by especially aminoglycoside and 
chloramphenicol resistance enzymes (acetyl-, phosphor-, and adenyltransferases); but are also 
common for macrolides (e.g. ereA) and have, more recently, emerged for tetracycline (tetX)
29
.   
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Efflux 
Because most drugs work inside the cell, preventing the drug from reaching its target by decreased 
permeability or increased efflux, serves as a widespread resistance strategy
27,30
. Whereas decreased 
permeability is intrinsic to some bacteria, and can be achieved via mutational down-regulation of 
membrane porins, active efflux of antibiotic compounds is also a common mechanism for 
transferred resistance genes
29,31
. Efflux pumps are membrane spanning structures that vary in their 
complexity and substrate specificity
30
. While some efflux pumps e.g. the tetA tetracycline/proton 
antiporter are fairly specific, others e.g. the chromosomal AcrAB-TolC and MexAB-OprM are more 
promiscuous efflux systems intrinsic to E. coli and P. aeruginosa conferring low-level resistance to 
multiple drug-classes when up-regulated. Efflux-mediated resistance has been reported for most 
drug classes, but are less frequently involved in resistance towards drugs acting on cell envelope 
structures (outside the cell) compared to those acting inside the cell e.g. ribosome targeting 
antibiotics
30
.  
Target modification  
As for mutational resistance, drug-targets can be modified to avoid binding of the drug. There are 
several ways by which enzymatic modifications or physical protection can, similar to amino acid 
changes, prevent the drug from binding to its target site
27
. Ribosome modifying enzymes are often 
found on plasmids in both Gram-positive and Gram-negative bacteria and a prevalent class is 
encoded by the erm (erythromycin ribosomal methylation) genes
29
. These enzymes confer macrolide 
resistance via methylation of the adenine 2058 residue of the 23S rRNA in the 50S ribosomal 
subunit, which also affect the binding of lincosamides and streptogramin B
29
. The vancomycin 
resistance (van) gene-clusters encode cell wall restructuring enzymes that modify the cell wall of 
Gram-positives to allow peptidoglycan cross-linking despite the presence of vancomycin
32
. Other 
proteins do not chemically modify the drug target, but may displace (e.g. TetO and TetM) or stabilize 
the drug-bound structure (gyrase binding Qnr peptides) to avoid lethal effects via close interaction 
with the target
29
.  
Resistant target (target replacement)  
Another way to circumvent (recessive) lethal effects of drug inhibition, is to supply a resistant target 
replacement that retains its native functionality
29
. An important example is the mecA-encoded 
peŶiĐilliŶ ďiŶdiŶg pƌoteiŶs ǁith loǁeƌ affiŶitǇ foƌ β-lactams widely present in S. aureus (MRSA)33. 
Trimethoprim and sulfamethoxazole drugs target two essential enzymes in the folate synthesis 
pathway: the dihydrofolate reductase and dihydropteroic acid synthase respectively
29,34
. Resistance 
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to these drugs can be accomplished by acquisition of resistant variants, or mutations in, these genes, 
but might also be achieved via overexpression of the native enzymes to titrate the drugs
29
.      
Regulatory mechanism  
Bacteria have evolved systems, which in reaction to external stimuli elicits a response, to 
environmental stimuli e.g. xenogenic compounds, high temperature or nutrient starvation. These 
phenotypic adaptations happen through rewiring of cellular networks that increases resistance via 
existing features of the genome
29
. For example, the CpxA sensor kinase of E. coli is activated upon 
envelope stress and activates a kinase cascade to up-regulate efflux pumps that excrete toxic 
chemicals
35
. Although plasmid-encoded global regulators e.g. H-NS homologs may influence 
endogenous or acquired resistance mechanisms
36
, regulatory changes leading to resistance are 
mostly achieved via mutations e.g. of efflux repressors or porin expression
27
. The lack of trans-acting 
regulators on plasmids is likely a result of the complex contexts in which they have to function, as 
well as the generally low level of resistance conferred by these resistance mechanisms in most 
species (manuscript V)
27,35
.  
 
Figure 2. Molecular mechanisms of transferable antibiotic resistance. Genetic vectors may carry genes that 
confer resistance through five major categories: 1) Modification or degradation of the drug. 2) Elimination of 
the drug through active efflux. 3) Modifications of cellular structures to avoid inhibition or lethal effects of 
antibiotic binding. 4) Replacement of the drug target by a resistant variant. 5) Regulatory interference to 
activate endogenous resistance mechanisms.        
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Chapter 2  
2 Horizontal gene transfer and bacterial evolution  
The beauty of evolution is that simple principles, acting on genetic entities, allow us to understand 
complex biological phenomena such as disease dynamics and antibiotic resistance. Neo-Darwinistic 
theory rests on the notion that new traits arise by gradual change and selection imposed by the 
environment
37
. The molecular basis for this theory is the generation of de novo mutations in existing 
genetic material caused by factors such as uncorrected DNA-replication errors, intra-genomic 
recombination or exposure to mutagens. Such mutations can either be deleterious, neutral or 
ďeŶefiĐial to the ƌepƌoduĐtiǀe suĐĐess, oƌ ͞fitŶess͟, of the oƌgaŶisŵ iŶ a giǀeŶ eŶǀiƌoŶŵeŶt. This 
paradigm is limited by the assumption that two diverging phylogenetic groups always share 
(variations of) the genetic material found in their common ancestor. However, these principles of 
͞gƌadual ĐhaŶge͟ do not explain the large iŶŶoǀatiǀe ͞juŵps͟ sometimes observed in nature38.    
 
in the late 1940s Tatum and Lederberg challenged the assumption of strictly vertical evolution in 
bacteria ďǇ deŵoŶstƌatiŶg the ͞seǆual͟ ƌeĐoŵďiŶatioŶ of geŶetiĐ tƌaits, lateƌ ideŶtified as plasŵid 
transfer, between two variants of E. coli
39
. However, the extent to which genetic transfer played a 
role in evolution was not known until several decades later
40
.  
From initial sequencing efforts applied in molecular phylogeny, it became clear that different genetic 
markers would yield conflicting phylogenetic relationships between organisms
41
. This realization, 
along with the numerous observations of multiple antibiotic resistance plasmid-transfers, lead to the 
increasing recognition of HGT as an important driver of evolution
40,42,43
. When bacterial whole 
genome sequences became available around the turn of the millennium, the horizontal aspect of 
evolution was further supported, and a surprising variation in genomic content within species was 
revealed
38,44–47
. One of the first comparative genomics papers compared three E. coli genomes 
available at that time (2002) and suggested that these three strains shared less than 40% of their 
genomic content, despite their common species affiliation
48
. Transferred genes are typically 
identified from their divergent sequence composition, from homology networks or incongruent 
phylogenetic gene-signals compared to established, e.g. ribosomal, phylogenetic markers
49–51
. 
Although such techniques have their limitations, and only successful transfer event can be detected, 
it has been inferred that at least 81 ± 15% of all bacterial gene families have undergone horizontal 
transfer at some point in their evolutionary history
52
.   
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Of these transfer events, several examples of cross-domain gene transfers exist e.g. between 
archaea and bacteria as well as between eukaryotes and prokaryotes and vice versa
53–55
. Discovering 
such cross-clade transfer events challenged the idea of a unidirectional tree of life and offered the 
͞Ŷetǁoƌk of life͟ as a ŵoƌe meaningful metaphor describing the pervasive gene sharing across 
phylogeny
56
.  
Bacteria often reside in communities where HGT can readily take place, and many genes are 
associated more with a particular environment than a specific host
57,58
. The massive genetic flux 
experienced by prokaryotic organisms has blurred the species definition, and even closely related 
species can vary substantially in their genomic content
59
. This realisation has encouraged the use of 
terms such as ͞accessory genes͟ aŶd the ͞paŶ-geŶoŵe͟. Wheƌeas the ͞Đoƌe-geŶoŵe͟ ƌefeƌs to the 
genes shared between all members of a species, the pan-genome refers to all genes within a species; 
including those harboured by only a subset of strains. For example, while the core-genome of 
sequenced E. coli isolates is made up from around 3188 genes, the current pan-genome of this 
species exceeds 60.000 gene families
60
. These ͞eǆtƌa͟ aĐĐessoƌǇ geŶes ƌepƌeseŶt a pool of 
transferable genetic material, which bacteria can potentially draw for their adaptation
61
.   
 
Gene acquisition and genomic rearrangement/deletion events are thought to occur more frequently, 
and have a higher selective impact, compared to single nucleotide substitutions in most bacterial 
species, and have likely played a major role in evolution (Figure 3)
62
. However, it has been 
challenging to understand how prokaryotic genomes can be so highly energetically optimized, and 
functionally dense, while still tolerating the constant flux and potential disruptive effects of 
horizontally acquired genes
62,63
. While isolated populations of e.g. intracellular pathogens, usually 
haǀe sŵall ͞Đlosed͟ paŶ-genomes, species that experience fluctuating environmental conditions 
tend to haǀe laƌge ͞opeŶ͟ paŶ-genomes, and this might reflect the benefit of flexible adaptation that 
HGT provides
64,65
. While stress, e.g. induced by antibiotic exposure, may modulate recombination 
and HGT frequencies, to what extent the rates of HGT is subject to selection is not clear
66,67
. 
Although high rates of gene acquisition increases the chance of acquiring rare beneficial genes, it is 
often deleterious to receive novel genetic material, and the pervasive rates of HGT in nature could 
also indicate that (selfish) mobile genetic elements are simply overwhelming their unwilling hosts
62
. 
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Figure 3. Microbial genomes are subject to constant genetic flux facilitated by multiple genomic events. 
Deletions, amplifications, single nucleotide mutations (SNPs), recombination and the acquisition of numerous 
mobile entities through HGT allow for adaptive innovations. Adapted from Mira et al. 2001
68
.  
 
2.1. Modes and elements of gene transfer 
A first crucial step in the transfer of genetic material is the physical delocalisation of DNA from one 
cell to another. For this purpose, the most well studied mechanisms are: Transformation, phage 
transduction and conjugation
69
.   
Transformation 
Transformation is the direct uptake of DNA from the surroundings
70
. The term was originally coined 
by the British microbiologist Frederick Griffith following his famous experiment with Streptococcus 
pneumoniae in 1928. He infected mice with a live, but avirulent, strain along with a heat inactivated 
virulent strain of S. pneumoniae. While he did not expect the establishment of an infection, a 
ŵoƌphologiĐal ͞tƌaŶsfoƌŵatioŶ͟ of the aǀiƌuleŶt stƌaiŶ iŶto the ǀiƌuleŶt stƌaiŶ was observed71. He 
attributed this phenomenon to a ͞tƌaŶsfoƌŵatioŶ faĐtoƌ͟, which was later recognized as DNA72. 
Transformation requires several competence factors to be expressed by the host, and the efficiency 
of DNA uptake relies exclusively on the recipient bacterium
73
. The competence machinery facilitate 
the uptake, stabilization and processing of the exogenous DNA
70
. Although their expression 
conditions vary substantially, competence factors have been identified in more than 82 bacterial 
species
73
. For these species, few of which are pathogenic, natural transformation can be the major 
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source of HGT and genome evolution, however, our knowledge on the contribution of natural 
transformation to antibiotic resistance dissemination is still limited
74
.  
Phage transduction 
Transduction is bacteriophages-mediated transfer of DNA
69
. Phages are believed to be the most 
abundant biological entities on the planet; estimated to outnumber their bacterial prey by 10:1 
75
. 
The successful infection of a temperate phage leads to either cell lysis, resulting in host killing and 
immediate propagation of the phage, or chromosomal integration (lysogeny). The latter manifests as 
so called ͞prophages͟, ǁhiĐh are highly abundant in bacterial genomes75. While the natural life cycle 
of phages does not normally involve the packaging and transfer of bacterial DNA, accidental uptake 
of host DNA by phages can happen by either generalized or specialised transduction
5
. Specialised 
transduction involves the inclusion of flanking chromosomal DNA in the excised prophage; 
restricting transfer to genes in close proximity of the integrated phage. Generalized transduction is 
the accidental packaging of random host DNA during the lytic cycle, which potentially allows for all 
genes in the genome to be transferred
76
.   
While transducing phages generally also encode protein components of the phage particle itself, 
certain prophage-like genomic regions almost exclusively encapsulate random genomic DNA to form 
tƌaŶsduĐiŶg paƌtiĐles teƌŵed ͞GeŶe TƌaŶsfeƌ AgeŶts͟77.  Phage mediated HGT is widely documented 
and important examples of genes disseminated through phages include the photosynthesis genes in 
cyanobacteria as well as virulence factors of E. coli, Vibrio cholerae and Staphylococcus aureus
78–81
. 
Being encapsulated, phage-mediated transfer is believed to have a long reach in terms of time and 
distance compared to other transfer mechanisms, however, phages are often very host specific and 
tend to mediate transfer within a narrow host-range
82
. Although broad host-range phages do exist, 
recent findings suggest that transduction may also take place without strict host (replication) 
compatibility
83,84
. 
Conjugation 
In contrast to transformation and transduction, the process of conjugation requires cell-to-cell 
contact, because a junction, through which DNA is transferred into recipient cells, needs to be 
formed
69
. In Gram-negative bacteria, this happens via a single stranded DNA intermediate that is 
channelled through a type-IV secretion system (T4SS). By virtue of its dedicated role in DNA transfer, 
conjugation is perhaps the most sophisticated and relevant mechanism mediating the transfer of 
adaptive factors, such as antibiotic resistance, virulence and metabolic genes, in nature
85–87
. Many 
large plasmids encode full conjugational transfer systems mediating their own transfer, but these 
might also aid the transfer of, often smaller, mobilizable plasmids in trans
88
. Conjugation is widely 
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involved in the transfer of genetic elements ranging from small mobilizable plasmids to large 
chromosomally located integrative conjugative elements (ICEs) as well as entire bacterial 
chromosomes
89
. In contrast to the other mechanisms of transfer, some conjugation systems are 
extremely broad in their transfer range and allow for cross kingdom transfer of plasmid DNA e.g. 
from bacteria to plants and other eukaryotes
89,90
.   
Due to the biological cost of expressing and integrating the large structures involved in conjugation, 
they are often subjected to tight regulation that allow expression only temporarily such as 
immediately following arrival in the recipient cell or in certain growth stages in response to optimal 
cell densities
91
. These (transient) costs can be afforded by a mobile element if the horizontal 
propagation outweighs the negative effects on vertical inheritance
92
. However, the structural 
components of conjugation systems may also provide a direct selective benefit for the host cell due 
to its role in adhesion and biofilm formation
93
.  
2.2. Plasmids and their genetic content 
The work of this thesis has focused largely on the transfer and evolution of plasmids, and these 
important genetic elements will be described in detail below.   
Soŵe Ǉeaƌs afteƌ theiƌ disĐoǀeƌǇ the teƌŵ ͞plasŵid͟ ǁas defiŶed ďǇ Joshua Ledeƌďeƌg iŶ 1952 as ͞a 
generic term for any extrachromosomal heredity determinant͟94. This term is still valid today where 
thousands of plasmid sequences have been deposited in public databases. Apart from being 
abundant natural vectors of gene transfer, plasmids have also played a detrimental role in the 
development of recombinant DNA technology and their usefulness for heterologous gene expression 
makes them fundamental to modern biotechnology
43
. Because of their highly mosaic structure and 
self-sustaining genetic features, plasmids are perhaps the most important vehicles of HGT and are 
highly implicated in the dissemination of traits such as virulence or antibiotic resistance
85,95,96
. 
Plasmids are often modular with conserved regions involved in stability and replication, and other, 
ŵoƌe ǀaƌiaďle, ͞adaptiǀe͟ regions are susceptible to rearrangements or insertions of mobile genetic 
elements carrying accessory features (Figure 4). Many plasmids harbour transposable elements, 
some of which have carried genes or integron structures, able to capture novel genetic entities, into 
the plasmid backbone
61
.  
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Figure 4. A) Plasmid gene-functions can be categorized into four groups contributing to different aspects of 
plasmid survival; each of which are described in the main text. B) Plasmids are themselves host replicons for 
lesser mobile genetic elements that are acquired in a hierarchical fashion. The structure of plasmids often 
shows a pattern of sequentially acquired mobile genetic elements; sometimes collected in ͞hot-spot͟ regions 
with a high genetic turnover. Figures from Norman et al. 2009
61
.  
 
Transposable elements  
The simplest mobile genetic elements are insertion sequences (IS)
97
. They employ transposase 
enzymes to copy (replicative transposition) or cut (conservative transposition) themselves from one 
place in the genome to another
98
. For some transposase families, the recombination mechanism 
recognises specific target site motifs, whereas others seem to jump more or less randomly
98
. Even 
though ISs do not confer any direct adaptive benefits, transposase genes are the most ubiquitous 
and abundant genetic elements in nature, where they play an important role in genome 
reorganisation
99
. IS elements provide genome plasticity by catalysing insertions, deletions and 
rearrangements at much higher frequencies than the genetic innovations achievable by DNA 
replication errors alone (manuscript IV)
100,101
. Their importance in HGT rely on the ability of proximal 
IS elements to transfer genetic cargo as transposons, and the wide presence of transposons on 
plasmids reveals their essential role in plasmid genesis and (re-)organization
61
. Although the 
adaptive content of transposons has supported their wide dissemination, they can also aid in 
adaptation via disruptive insertions or recombination events to delete costly regions as is 
exemplified by in the work of this thesis (manuscript III and IV)
101
.  
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Integrons 
Another important class of genetic structures promoting gene mobility and expression are integrons. 
Although integrons are often found in transposons, the controlled integration and expression of 
gene cassettes by integrons has many benefits compared to the potentially disruptive nature of 
transposon insertions
102
. Genetic material is recognised by the presence of an attC-site and inserted 
into the integron structure via site-specific recombination with the integron attl site; a reaction that 
is catalysed by the integron encoded Int1 integrase of the tyrosine integrase family
102
. Apart from 
acquiring genes, a key feature of integrons lie in their ability to express the acquired genetic material 
from a strong integron-associated promoter located upstream of the attl recombination site. While 
integron structures found in environmental isolates are highly diverse, the integrons of pathogenic 
bacteria typically belong to the class 1 type embedded in IS-flanked genetic contexts on 
plasmids
102,103
. Class 1 integrons are believed to originate from environmental variants that were 
transferred to, and highly enriched in, pathogens upon resistance gene acquisition as a response to 
increasing antibiotic exposure
103
.    
Replication, copy-number and host-range 
Plasmids need to carefully control their replication in order to maintain sufficient copy numbers for 
stable inheritance, but at the same time avoiding negative selection from excessive burdening of the 
host
104
. Therefore, replication is often coordinated with the replication of the host chromosome and 
takes place by the strand displacement, rolling circle or theta mechanism. All replicons examined in 
this thesis replicate by the theta replication mechanism, which progress in a similar manner to 
chromosomal replication. Theta replicating plasmids may depend entirely on host initiation proteins 
;e.g. ColEϭͿ ďut ŵoƌe ofteŶ ĐaƌƌǇ theiƌ oǁŶ ƌepliĐatioŶ ͞Rep͟ iŶitiatoƌ pƌoteiŶ that ďiŶds to directly 
repeated ͞iteron͟ ƌeĐogŶitioŶ sites. The binding of the rep protein to these sites serves to melt the 
DNA duplex and recruit host replication factors, but protein-protein interactions between Rep 
proteins, on different plasmids within the cell, may inhibit this initiation if the copy number (and 
thus amount of Rep protein) is already high enough
105
. The overlap of dosage-dependent regulation 
is also the reason for incompatibility between similar replicons; a feature widely used for plasmid 
classification. The host-range of plasmids is determined primarily by the compatibility of host-factors 
with the plasmid replicon
106
. Therefore, some plasmids encode more replicons or additional 
replication factors to broaden their host compatibility. However, because replication does not equal 
stable inheritance, plasmids have evolved distinct ways to avoid loss upon cell division.  
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Plasmid stability systems 
There seems to be a trade-off between plasmid copy number and size for natural plasmids, and large 
plasmids are often maintained in very few copies per cell. Low copy numbers, however, comes with 
a higher risk of plasmid segregational loss because the chance of random dispersal of plasmids to 
both daughter cells upon cell-division decreases with decreasing plasmid copies. Therefore, 
partitioning systems are of vital importance to ensure stable inheritance of low-copy plasmids. These 
systems employ two trans-acting proteins and a (centromere-like) binding site to actively bring 
plasmids into each daughter cell upon cell-division. An example of such a system consist of the 
͞ParA͟ filaŵeŶt pƌoteiŶ that ĐoŶŶeĐts to the plasŵids ͞parS” site via the ͞ParB͟ aŶĐhoƌiŶg 
protein
107
. If these first-line segregation systems fail, many plasmids employ second-line rescue 
systems that limit the competitive effects of plasmid-free cells on the plasmid-bearing population. 
These ͞addiction systems͟ were discovered due to their effect on plasmid stability and are 
widespread on mobile elements as well as chromosomes. They encode a stable toxin along with a 
less stable anti-toxin that, under normal conditions, neutralizes the effect of the toxin. If a plasmid 
encoded toxin-antitoxin (TA) system is lost, the relatively stable toxin will inhibit the growth of the 
plasmid-free cell due to the quicker turnover of the antitoxin. TA systems are diverse and work 
through many different mechanisms. While the toxic component is generally a protein that targets 
essential processes of the cell, the anti-toxin can also be inhibitory RNAs. For example, type I and III 
TA systems encode protein toxins that are inhibited by RNA anti-toxins binding directly to the toxin 
protein or its encoding mRNA. Interestingly, plasmid-borne restriction/modification systems may 
also act as TA systems with the added benefit of restricting incoming plasmid competitors
108
.  
The continuum of plasmid-host compatibility  
When is a plasmid compatible? Rather than being a deterministic quality, the host compatibility of 
plasmids is determined more fluently by transfer, replication and stability mechanisms, which may 
be somewhat dynamic features
109,110,106
. Whereas some plasmids are only associated with a very 
limited set of hosts, others can seemingly propagate in a broad range of species
109,111
. It is evident 
that even closely related plasmids can co-exist to some degree, despite overlap in replication 
features that traditionally categorized theŵ as ͞iŶĐoŵpatiďle͟106. Importantly, many plasmids can 
replicate in a number of hosts, but the degree to which they are stably maintained over time can 
vary substantially
101,110
, and  instability is a plastic feature, which may be modulated through 
adaptive evolution to expand or shift effective host compatibility
101,112
. The notion of host-range is 
complicated further because many plasmids can transfer much beyond the hosts that allows for 
their replication
89,90,101,110,113
. The implications of such transfer events are not well understood, but 
delivery of bacterial DNA to eukaryotes does play a role in bacterial virulence
113
.  
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This plasticity calls for an updated definition of host-range to consider not only replication-proficient 
hosts, but to also include the hosts in which a plasmid is (and has the evolutionary potential to be) 
stably maintained (Figure 5). For example, initially very unstable plasmid-host pairs may be 
maintained under sufficient positive selection for plasmid-borne traits to encourage the evolution of 
a more stable association in the absence of selection
101,114
.  
 
 
Figure 5. Plasmid-host compatibility can be nuanced across replication, stability and transfer proficiency. 
Ratheƌ thaŶ ďeiŶg eƋuallǇ ͞Đoŵpatiďle͟ ǁith all poteŶtial plasŵid ƌeĐipieŶts, a plasŵid ŵaǇ eǆpeƌieŶĐe ǀaƌǇiŶg 
degrees of stability due to differences in replication proficiency, costs or segregational efficiency. Plasmids 
typically resides within a domestic group of hosts, representing the most stable plasmid-host combinations 
(green area), but may occasionally transfer to, and reside in, less optimal hosts (yellow and red areas). While 
transfer proficiency can be high, naïve plasmid-host combinations are often unstable due to suboptimal, or 
costly, interactions with new hosts. Given enough time, i.e. via positive selection of plasmid-borne traits, a 
plasmid may evolve to shift its stable host range. The transfer range of conjugation systems is often broader 
than the replication range of the plasmids encoding them; allowing for plasmid delivery to hosts where 
immediate loss is likely unless recombination with endogenous replicons or rapid adaptation takes place. 
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2.3. The role of plasmids in host adaptation  
Despite being unstable, a plasmid can be maintained in a population if it carries beneficial traits, and 
the most variable and interesting feature of plasmids is perhaps the genetic cargo that they 
carry
61,115,116
. These adaptive genes are not directly involved in plasmids maintenance, but provide an 
indirect benefit to the plasmid by improving the survival of the host. Accessory elements are often 
found in defined regions of the plasmid backbone that are separated from those involved in stability, 
replication and transfer
61,115
. Depending on the selective benefit of inserted traits in a given 
environment, variants of the plasmid backbone created by continuous recombination, insertion, 
deletion and mutational events will continuously be selected (manuscript III and IV)
101,115
. Although 
the role of many plasmid-carried genes has yet to be elucidated, some adaptive traits can lead to 
massive innovative jumps exemplified by plasmid-borne metabolic pathways or multidrug 
resistance
101,117
. There are important examples of adaptive plasmid traits that influence the ecology 
of their hosts to an extent where the presence of the plasmid largely defines the species. Such 
plasmid-driven instant speciation events have played a tremendous role in the evolution of 
important pathogens including Yersenia pestis, Bacillus antrhacis and Shigella spp.
118–121
. These 
species all encode their virulence/colonization factors from large stable plasmids and there is 
evidence of sequential acquisition of adaptive virulence genes e.g. by the pMT1 plasmid of Y. pestis, 
that support sudden ecological jumps
120
. In theory, most genes can be carried on plasmids and 
quasi-essential plasmids carrying ribosomal operons exist in certain species
122
. While most genes 
have probably been associated with plasmids throughout history, some genes are more likely to be 
selected in a plasmid context
123
. For example, genes involved in local adaptation and social traits are 
believed to benefit from the mobility, and perhaps the copy-number plasticity, of plasmids that 
might help explain the somewhat puzzling existence of non-transmissible plasmids
124
.   
Plasmids and antibiotic resistance 
Historically, plasmids probably owe their fame to their involvement in antibiotic resistance and most 
of our serious resistance problems can be attributed to plasmids
125–127
. Whereas the treatment of 
persistent infections, such as tuberculosis or Pseudomonas aeruginosa implicated in cystic fibrosis, is 
mainly compromised by in-host evolution of mutational resistance, HGT of plasmid carried antibiotic 
resistance genes is largely responsible for the current pandemic of multidrug resistant pathogens
126
. 
When plasmid-borne resistance was first reported some 60 years ago, transferable multidrug 
resistance was not anticipated by the research community, and it came as a big surprise that pre-
made resistance packages could be transferred between pathogens
127
. The first observations of 
transferable resistance were made by Japanese researches in the mid-1950s following an outbreak 
of Shigella dysenteria resisting treatment of up to four antibiotics
127
. The demonstration that these 
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so-Đalled ͞R-faĐtoƌs͟ ǁeƌe tƌaŶsfeƌƌaďle to otheƌ Enterobacteriaceae, and curable using acridine 
orange, made the connection to concurrent research on the F-plasmid that defined R-factors as 
plasmids
128
. These studies were published in Japanese journals and received little attention in the 
west. Eventually, the Japanese work on R-plasmids was published in western journals but were met 
with scepticism
127
. It was not until the early 1960s that the British geneticist Naomi Datta discovered 
similar phenomena of transferable multi-drug resistance in Salmonella typhimurium during an 
outbreak in London
129
. Subsequent studies showed that plasmids were common across bacterial 
species, and their presence and resistance profiles would often reflect antibiotic usage rather than 
specific host strains
127
. Such observations led to the worrisome realisation that antibiotic resistance 
was not easily confined, and that the problem was likely amplified by the massive use of antibiotics 
outside the clinic. Today, plasmid-borne multidrug resistance is widespread and highly problematic 
for clinical outcomes
96,130
. Important Gram-negative pathogens approaching a pan-resistant level 
due to plasmid acquisition are: Acinetobacter baumanii, P. aeruginosa, K. pneumonia and E. coli. 
Especially nosocomial E. coli and K. pneumoniae infections are prevalent and are becoming 
increasingly resistant due to plasmid carriage, which places them among the most urgent bacterial 
threats in our health care system today
2,3
.    
Important bacterial clones implicated in plasmid-borne antibiotic resistance  
While any pathogenic strain can in principle acquire a multidrug resistance plasmid and become a 
clinical problem, there seems to be a bias towards specific clone-types in the dissemination of 
multidrug resistance plasmids
3
. Two important high-risk clones that seem to be especially good at 
disseminating and acquiring resistance plasmids are E. coli ST131 and K. pneumonia ST258
131,132
. 
Within the last 20 years, E. coli ST131 has become the dominant extraintestinal pathogenic E. coli 
sequence type in the world
133
. Its evolutionary history suggest a role of early mutational 
fluoroquinolone resistance and CTX-M-ϭϱ β-lactamase encoding plasmid acquisition as important 
adaptive steps, however, high virulence and increased host-to-host transmission are also hallmarks 
of the ST131 clone
3
. K. pneumonia ST258 is often implicated in nosocomial bloodstream and lung 
infections, and its tendency to carry plasmid encoded carbapenemases renders this clone-type 
especially problematic. The ST258 clone is believed to be a hybrid of K. pneumonia ST11 and ST442 
with an added genomic island (ICEp258.2) that encode type IV pili and restriction systems
3
. 
Compared to the ST11 ancestor, lacking this genomic island, ICEp258.2 seems to facilitate the 
carriage of carbapenemase encoding IncF plasmids to a higher degree
132
.   
Although the reason for the success of these clone-types is still not fully understood, stable plasmid 
carriage seems to play an important role in their adaptation. Interestingly, recent comparative 
genomics analysis of ST131 genomes suggest that adaptation of regulatory regions in the core 
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genome, as a response to plasmid acquisition, have increased the plasmid hosting qualities of this 
clone
134
. However, we still need to figure out if other factors, e.g. high virulence, colonization or 
transmissibility, have associated these clones more frequently with clinical environments, and 
therefore increased plasmid exposure and subsequent adaptation, or whether it is the other way 
around (improved plasmid carriage has led to clinical success).   
2.4. Why do plasmids exist?  
While there can be obvious benefits for pathogenic hosts in carrying plasmids encoding virulence or 
antibiotic resistance genes, we know fairly little about how selfish genetic elements persist when 
they do not confer an advantage to their hosts. This long standing question in plasmid biology, more 
recently referred to as the ͞plasŵid paƌadoǆ͟, has been subject to much attention in recent years, 
but was originally taken on by researches in the 1970s
135
. Plasmids encode inherently selfish features 
(conjugation, partitioning and TA-systems etc.) that promote plasmid survival at the expense of host 
fitness
136
. Therefore it was proposed that, because plasmid-loss will always occur at some frequency, 
long-term plasmid survival requires either positive selection for plasmid-borne traits or high rates of 
conjugational transfer
116
.  
Initial efforts employed mathematical modelling of plasmid invasion experimental setups to explore 
the population dynamics and existence conditions of bacterial plasmids
135,137
. These pioneering 
studies were carried out on constitutively conjugating F-plasmids in the absence of selection and 
predicted a wide range of conditions under which these plasmids could be maintained as infectious 
parasites through conjugative transfer alone
135,137
. However, most initial studies were carried out on 
very few plasmids, which had been maintained in the laboratory for years, and these studies did not 
explain the existence of non-conjugative plasmids in nature
138
. As more plasmids, iŶĐludiŶg ͞fƌeshlǇ 
isolated͟ Ŷatuƌal plasŵids were subjected to similar investigations in the following years, it became 
clear that most natural plasmids encode strictly controlled transfer machinery and were not always 
capable of parasitic maintenance; even under optimal conditions
138
.  
Because only some, very infectious, plasmids could survive as purely parasitic entities, and only 
under the favourable conditions of e.g. high population densities used in laboratory experiments, 
the view on plasmids as purely selfish entities was relaxed
139
. Due to the high cost of de-repressed 
conjugative plasmids compared to regulated ones, it seemed that the excessive cost of constitutive 
transfer would seldom pay off in nature
138–141
. Instead, it was suggested that plasmids must have 
evolved towards mutualism with their hosts to lessen their burden at expense of their horizontal 
propagation
139
. The idea that some degree of mutualism was required for plasmid survival could also 
explain why costly or non-conjugative plasmids would often encode beneficial features such as 
antibiotic resistance
139,142
. While most conjugative plasmids are probably maintained by a 
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combination of conjugative transfer and positive selection for plasmid-borne traits, the role of 
infectious transfer, including the influence of host background and external environments, in 
parasitic plasmid maintenance is still debated
116,143–146
.  
Due to the tendency of bacterial genomes to expel unnecessary genetic elements over time
63
, it has 
been puzzling why highly selected e.g. antibiotic resistance genes do not jump from the plasmid into 
the chromosome more often to get rid of the (costly) plasmid
116
. Plasmid specific qualities have been 
proposed to argue for the selection of plasmid located over chromosomally located genes, and 
underline the importance of plasmid transfer in answering this dilemma (Figure 6)
116,147–149
. One idea 
is that plasmid-borne traits are often only locally beneficial, i.e. in a local niche or in a limited time-
span, and would be able to invade faster than chromosomal genes during sporadic selection
149
. Such 
reasoning can also help explain why universally beneficial (i.e. essential) genes are almost exclusively 
encoded from the chromosome. A similar hypothesis was put forward by Bergstrom et al. suggesting 
that the long-term survival of plasmids is faĐilitated ďǇ theiƌ aďilitǇ to ͞saŵple͟ poteŶtiallǇ supeƌioƌ 
hosts immigrating into a local plasmid bearing population; a scenario where stationary chromosomal 
genes would be outcompeted. This reasoning is in line with the conventional argument for sexual 
reproduction, stating that the higher diversity created by genetic recombination is beneficial 
because it increases the chance of creating novel superior gene combinations
150
.      
 Another appealing aspect of transferable plasmids is their ability to promote social traits
116,148
. It has 
been argued that genes, such as those involved in iron acquisition, virulence or bacteriocin 
production, are carried on plasmids because it allows for re-infection of cheaters to strengthen 
cooperation within bacterial populations
147–149,151
. Another important cooperative characteristic that 
plasmids are known to promote is biofilm formation; a life style that may also allow for higher rates 
of conjugation
93,152,153
. While the selective advantages of biofilms are manifold, they have also been 
suggested to promote plasmid-survival due to their spatiotemporal properties
145
. The idea is that 
plasmids are retained in the lower, nutrient depleted, levels of a biofilm structure where cells are 
not (or very slowly) dividing, and that this ͞ƌeseƌǀoiƌ͟ may rescue the population under sporadic 
plasmid selective conditions (Figure 6)
145
.   
While the biofilm-reasoning would also support the persistence of non-mobile plasmids, the 
remaining models for plasmid survival rely on the ability of plasmids to spread by conjugation. 
Therefore, it has been challenging to explain the high number of plasmids without known transfer 
systems found in natural bacterial isolates
88
. These plasmids are often small (< 10kb) and replicate 
by RNA-controlled mechanisms, e.g. colE1-type replicons, that are kept in relatively high copy 
numbers
105
. San Millan et al. showed that genes can benefit from a location on multi-copy plasmids, 
due to the increased dosage and evolvability experienced by plasmid-borne genes compared to 
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single-copy chromosomal genes
124
. The same study also demonstrate an important trade-off 
between copy number and fitness cost of plasmids, which highlights the necessity of positive 
selection in the maintenance of these plasmids
124
. In another study, San Millan et al. demonstrate 
that the fitness landscapes experienced by plasmids can be more complex than previously thought, 
with some plasmids modulating the costs of co-residing plasmids to increase their combined 
fitness
154
.     
Plasmids tend to be costly upon arrival in a new host and with no transfer mechanisms to 
compensate their cost, non-transferable plasmids require positive selection for their long-term 
maintenance
114,124
. However, a pivotal study by Bouma and Lenski published in 1988 showed that 
initially costly plasmids can co-evolve with their host to become cost-free, and even beneficial, in the 
absence of selection
155
. These observations have since been repeated for many different 
plasmids
101,114,156–160
 and imply that plasmids can in principle persist with minimal transfer or 
selection (Figure 6)
161
. It is not known to what extend these cost ameliorations happen in nature, 
and whether they entail tradeoffs in other (natural) environments that we are not aware of. 
Therefore, much work is still needed if we want to understand the (long-term) role of these 
mechanisms on the survival of natural plasmids in their native habitats.   
 
Figure 6. Plasmid-located genes may be selected over chromosomal genes in spite of the (initial) fitness 
burden imposed by plasmid-carriage. Plasmid-survival has been attributed to several qualities of plasmids and 
natural phenomena that increase their benefit compared to chromosomal genes. 1) Mobile plasmids may 
transfer to incoming superior genetic backgrounds to improve their survival
116
. 2) Sporadic selection for 
plasmid-borne traits allows plasmid-enrichment e.g. from stable reservoirs such as metabolically inactive 
layers of a biofilm (3)
145,149
. 4) Social traits are more easily maintained on mobile plasmids due to their re-
infective properties
147
. 5) Multi-copy plasmids allow for higher gene-dosage and evolvability, which may 
benefit certain genotypes
124
. 6) Plasmid-host adaptations can occur (even for very costly plasmids if they are 
temporarily kept by selection) to increase plasmid persistence
101,114,155,162
.    
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Chapter 3   
3 Barriers to horizontal gene transfer  
A fundamental aim of evolutionary biology has been to understand why some genes are more 
widely disseminated compared to others. Because extensive genetic transfer has shaped many 
modern life forms and occurs readily across the tree of life, by transfer of small genetic segments to 
whole chromosomes, it has been proposed that no insurmountable barriers to HGT exist
163
. 
However, from laboratory experiments we know that some genes can be fully resistant to transfer 
between certain hosts due to their toxic effects
164
. Other studies, on environmental antibiotic 
resistance genes, show that the total functional gene pool of resistance genes far exceeds those 
found in human pathogens; even though functional-selection studies show that these genes can 
confer resistance in a relevant species
14,165–167
. While these studies are often experimentally biased 
in terms of unnaturally high expression levels, they indicate that lateral gene flow is restricted by 
more than absolute functionality. In the following, I will discuss what is currently believed to be the 
most important factors implicated in the successful transfer and persistence of genetic elements. 
 
Mobilisation   
If a gene is never mobilised from its original host genome, it is unlikely to experience transfer. As 
summarized earlier in this chapter, there are several modes and elements of transfer that can carry a 
gene from one cell to another (Figure 4B)
69
. Although some of the mechanisms (transformation and 
generalized transduction) do not depend on a mobile genetic context, the remaining transfer 
mechanisms are highly dependent on the association with elements that are able to mobilise a gene 
from its stationary position on the host chromosome. Intracellular mobilisation can happen via 
transposable elements or integrons that may move genes between the chromosome and e.g. a 
plasmid vector able to mediate intercellular transfer between genomes. Studies comparing genes of 
the environmental resistome to that of human pathogens, suggest the main difference between 
these two groups to be the increased frequency of mobility elements near resistance genes in 
human pathogens
14,168,169
. Looking into the genomic context of the genes used in manuscript V we 
classified every gene as either mobile or non-mobile depending on the presence or absence of 
flanking genes associated with mobility e.g. transposase, integron, conjugation or phage related 
genes. This classification was a strong predictor of dissemination (Mann-Whitney U-test, P < 0.001); 
supporting the idea that initial mobilisation is a crucial step in gene dissemination (Figure 7).  
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Figure 7. The association of antibiotic resistance genes with mobile elements is a strong predictor of 
dissemination across bacterial genera (Mann-Whitney U-test, P < 0.001). Resistance genes from manuscript V. 
 
DNA entry and genomic defence mechanisms   
The next step towards successful gene dissemination is the association of a gene with a transfer 
mechanism able to carry the gene between cells. Due to the trade-offs between evolvability and 
genetic integrity, most prokaryotes have evolved strategies to prevent excessive genetic flux from 
polluting their genomes
69
. As only a minority of species are able to take up naked DNA from the 
environment, successful gene transfer relies largely on recipient compatibility with the vectors 
implicated in HGT
69
. The likelihood of transfer by these vectors depend on e.g. the presence of 
phage receptors, replication (stability) and conjugation proficiency of a plasmid or DNA homology 
supporting recombination if the vector is not autonomously replicating
69,170
.  
Enzymatic restriction is a classical example of a more active defence mechanism present in many 
bacterial species that functions to protect the recipient genome against incoming DNA
108
. These 
systems are encoded on chromosomes as well as on plasmids, and come in pairs of restriction and 
modification enzymes that ensure, via specific DNA methylation patterns, that only foreign DNA is 
recognized and cut by the restriction nuclease
108
. Consequently, although restriction enzymes do not 
impose an absolute barrier
171
, some phage and plasmid genomes encode anti-restriction proteins 
that mimic certain DNA-motifs to decoy restriction enzymes and improve infection rates
172
. Many 
plasmids also encode restriction-antirestriction systems themselves, presumably to fight off 
competing mobile elements and increase their stability
173
.  
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Another way that plasmids can avoid competition from similar plasmids in the same cell, is via 
surface exclusion mechanisms
174
. These mechanisms are encoded within the conjugation operon 
and act on the cell envelope to reduce pilus binding and DNA entry
69
.  
More recently, the sequence specific and highly adaptable properties of CRISPR-Cas systems have 
been recognized for their usefulness as a tool in genetic engineering
175
. The CRISPR-Cas system 
functions as an adaptive immune system that protects bacterial and archaeal hosts against phages 
and plasmid intruders
176
. While the CRISPR-Cas family is diverse, all members rely on the same 
principles of iŶĐoƌpoƌatiŶg DNA ͞spaĐeƌs͟ into chromosomal CRISPR-arrays that are subsequently 
transcribed to precisely target foreign DNA
176
. Tight CRISPR-based immunity can be highly 
advantageous in the presence of lytic phages, but might also hinder the entry of beneficial genetic 
elements
177
. However, this trade-off seems balanced via the frequent escapers emerging from the 
recombination prone repetitive nature of CRISPR arrays; creating the flexibility in population 
immunity that allows the occasional sampling of beneficial genetic elements
177
. An interesting 
example of this plasticity of CRISPR-Cas defence was demonstrated by sequencing of CRISPR loci in 
enterococci isolated before and after the common use of antibiotics
178
. In this study, Palmer and 
Gilmore find a strong inverse correlation between the presence of CRISPR-Cas loci and acquired 
antibiotic resistance genes; suggesting that the advantage of resistance outweighed the benefit of 
CRIPSR-Cas defence in this case
178
.        
 
3.1. The biological cost of gene acquisition 
When a gene has successfully entered a new host, it will either be retained or lost through purifying 
selection or genetic drift. The probability of a genetic element to persist in a population is partly 
determined by its contribution to the fitness of the cell, and the potential cost of resistance genes 
and their plasmids is believed to play a key role in the persistence of antibiotic resistance
179,180
.    
The biological fitness of an organism is defined as its reproductive success in a certain 
environment
180
. Strictly, fitness is defined by the number of extra individuals peƌ geŶeƌatioŶ:|Ѡ| = 
Naftet/ Nbefore, where N is the number of individuals (carrying a certain trait) before and after one 
generation
181
. Fitness can be manifested through many different phenotypes and includes the ability 
to reproduce (grow), survive and transmit. From a gene-centric point of view, fitness is determined 
by the success of the replicative unit, e.g. genome, plasmid or transposon, in which the gene is 
located
149
.   
A gene can contribute to its own reproductive success by encoding a beneficial phenotype that 
increases survival of its reproductive locus. A metabolic gene that allows more efficient utilization of 
resources or an antibiotic resistance gene mediating detoxification will enable faster growth of their 
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host when nutrients are limited or xenogenic compounds are present. Some genes may increase 
overall survival while not directly affecting growth e.g. by allowing efficient adhesion in a dynamic 
bladder or gut environment where rapid elimination from a preferred niche would otherwise reduce 
the population size
182,183
. In contrast, horizontal transmission of genetic elements e.g. plasmids or 
phages often comes at the expense of reduced vertical transmission, but might still pay off because 
overall vector propagation can still be supported through decupling from vertical inheritance
92,138
.  
It has long been known that the introduction of foreign genetic elements, such as cloning vectors, 
inflict changes to host homeostasis that affects measures of fitness
184–186
. Such effects have been 
suggested to steŵ fƌoŵ the ͞ŵetaďoliĐ ďuƌdeŶ͟ iŵposed ďǇ plasŵid ƌepliĐatioŶ aŶd geŶe eǆpƌessioŶ 
that draws on cellular resources, but might also stem from competition with, or disruption of, 
essential processes in a broader sense
187–190
.  
 
DNA maintenance is cheap but gene expression is costly 
While there is some correlation between the number of resistance genes on plasmids and their cost, 
there is no strong correlation between host fitness and plasmid size
191
. It is also intriguing that a 
whole (1.66 Mb) bacterial chromosome can be transplanted into yeast cells without noticeable 
growth defects
192
. Although DNA replication does require cellular energy, and drains on carbon 
metabolism, the cost of DNA replication itself is most often negligible compared to downstream 
processes; especially in nutrient rich environments
193–195
.   
Because the informational content in DNA is expressed via an amplification cascade of transcription 
and translation, the cost of these processes is inevitably higher than the cost of replication. 
Furthermore, their individual contribution to the total cost of protein expression depends on the 
nutrient availability; indicating that limited metabolic resources play a role in the cost of these 
processes
196
. While mRNA synthesis does spend cellular resources, a more pronounced cost of 
transcribing incoming gens lies in the sequestering of RNA polymerases that might be limiting for the 
transcription of vital processes
197
. This was supported by Lamberte et al. showing that the 
introduction of AT-rich DNA is especially costly due to the higher probability of intragenic promoter 
motifs, and by Yona et al. demonstrating that the E. coli genome has evolved to avoid (expression 
from) intragenic promoters
197,198
.   
Similarly, the cost of translation has been attributed to titration of ribosomes and tRNAs form more 
vital cellular processes
195
. Theoretical work suggests that the material cost of amino acids can be 
subject to selection, and that inefficient translation, caused by suboptimal codon usage, can 
decrease fitness
199,200
. Suboptimal codon usage may also cause translational problems due to, for 
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example, tRNA depletion and ribosomal stalling. From the idea that codons employing the most 
aďuŶdaŶt tRNAs alloǁ foƌ a higheƌ eǆpƌessioŶ, the teƌŵ ͞ĐodoŶ adaptatioŶ iŶdeǆ͟ ;CAIͿ has been 
established to reflect the codon preferences of highly expressed gens within a genome
201
. However, 
while selection for optimal codon usage in highly expressed genes of fast growing bacteria is well 
established, it has been challenging to identify a universal selective force acting on codon bias across 
organisms and life styles
202–204
. This lack of a clear selective signal is likely due to selection for other 
qualities such as optimal protein folding, reduced mRNA interactions or improved stability (Figure 
8)
199,205
. 
  
 
Figure 8. Molecular factors affecting the establishment and persistence of horizontally transferred genes. 
Apart from initial mobilisation and vector compatibility, the selection of transferred genes is determined at 
multiple functional levels by the effects on host fitness and external (selective) forces.     
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Costs originating from disruptive protein behaviour  
Although the costs associated with replication, transcription or translation are of evolutionary 
importance (e.g. as evident from codon selection
203
), these costs are often low compared to the 
potentially deleterious effects inflicted by the encoded proteins of incoming DNA (Figure 8)
190,206–208
. 
From protein production efforts, it is well known that too highly expressed proteins tend to misfold 
aŶd ŵight lead to the foƌŵatioŶ of iŶsoluďle ͞iŶĐlusioŶ ďodies͟ that ĐaŶ ďe toǆiĐ to the Đell206,209. 
These effects seem to impose evolutionary constrains on highly expressed proteins to optimize their 
folding properties
209
. This is in line with the observations of Tomala and Korona who used an 
expression library of Saccharomyces cerevisiae native proteins to show that the cost of proteins did 
not rely on translational features such as mRNA-folding or CAI but rather on structural features of 
the expressed proteins
207
. The authors show that especially transmembrane and unstructured 
protein regions, together with protein length, were the main predictors of fitness cost related to 
native protein expression in S. cerevisiae 
207
.   
Numerous proteins have been shown to incur a cost when heterologously expressed for production 
purposes, due to the direct or indirect (e.g. product) toxicity of their function
190,210–213
. The costs of 
disruptive protein functions are also evident from mobile elements
189,214–217
. For example, plasmids 
costs can arise from the interaction between chromosomal and plasmid proteins. For example, the 
TrfA1 plasmid replication initiation protein reduces fitness of the Shewanella oneidensis host by 
antagonistic interactions with the DNA helicase DnaB
189
, and similar costly interactions between 
chromosomal and plasmid encoded proteins have been observed for other host-plasmid 
combinations
92,101,214,218
.   
   
The cost of transferable resistance genes 
It is commonly assumed that acquiring (mutational or horizontal) antibiotic resistance entails a 
burden on the host
179,191,219
. However, in contrast to mutational resistance, little effort has been 
made to quantify and study the fitness effects of transferable resistance genes (Table 1 and 
manuscript V)
179,180,219
. Although the costs of resistance are offset by the strong selection of 
antibiotics and occasional tight regulation, they likely play a key role in the long term persistence 
and dissemination of resistance
166,220,221
. While few reports assessing the cost of transferable 
resistance exist, these reveal a span of fitness effects where some genes are associated with high 
costs (> 20% fitness reduction) and others have no measureable cost, and may even be beneficial, in 
the absence of antibiotics (Table 1 and manuscript V). To compensate for a potentially high cost of 
resistance, the expression of some resistance genes is regulated to ensure a low cost of carriage 
when antibiotics are absent
222
.  
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While there are examples of regulated drug-modifying genes e.g. chromosomal ampC β-lactamase 
regulated by the ampR repressor, tight regulation is more often seen for genes within the efflux or 
target-modifying mechanistic classes
222
. Important examples are the vancomycin resistance 
conferring Van-clusters, the tetracycline efflux encoding tetA gene and many enzymes involved in 
ribosomal methylation
29,222,223
.   
 
Table 1. Fitness effects of heterologously expressed resistance genes reported in the literature. All fitness cost 
estimates were acquired by in vitro measurements (growth rate or competition assays). 
Antibiotic class Gene Fitness cost Expression 
level 
Implicated 
mechanism 
Host 
bacterium 
References 
Tetracycline tetA Medium High 
(unregulated) 
Potassium 
metabolism 
E. coli 
215,224
 
Vancomycin VanA and 
VanB 
clusters 
High High 
(unregulated) 
Cell wall synthesis S. aureus,  
E. faecalis,  
E. faecium 
217,223
 
Linezolid,  
Macrolides 
cfr + ermB High Medium Ribosomal 
methylation 
S. aureus 
225
 
Linezolid cfr Low Medium Ribosomal 
methylation 
S. aureus 
225
 
β-lactams SME-1 High Very high 
(pUC) 
Signal peptide E. coli 
226
 
β-lactams OXA10, 
OXA24 
High Very high 
(pUC) 
Cell wall  E. coli 
227
 
β-lactams SFO1 High Very high 
(pUC) 
Cell wall  E. coli 
227
 
β-lactams AmpC Medium High 
(unregulated) 
Unknown S. enterica 
228
 
β-lactams AmpC Low/none High 
(unregulated) 
Unknown E. coli,  
E. cloacae,  
P. 
aeruginosa 
228,229
 
Aminoglycosides rmtC Low/none Low Ribosomal 
methylation 
E. coli 
230
 
Quinolones qnr genes Low/beneficial High (pBR322) Gyrase 
interactions 
E. coli 
224,231
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3.2. The context matters  
͞Everything is everywhere, but the environment selects͟   
   - Lourens Gerhard Marinus Baas Becking (1934)
232
  
It was recently suggested that universally fit resistance-conferring mutants exist
233
, however, such 
notions are likely an artefact of unexplored fitness trade-offs in known or unknown environmental 
conditions
234
. Disseminated antibiotic resistance genes are often found in variety of different 
genetic, genomic and environmental contexts; and have likely experienced many more on the way to 
their present location. Therefore, the cost of a gene can only be viewed in relation to its context, and 
there are numerous examples of variability in fitness effects of mutations and gene acquisition 
between hosts and growth media (Table 1)
101,126,191,228,235,126
. Apart from the modulation of fitness 
effects, the genetic and extracellular environmental context may also affect evolutionary trajectories 
that compensate the costs of resistance
101,126,236
.  
The external environment 
Antibiotic resistance genes are most beneficial in the presence of antibiotics, but their fitness effects 
in the absence of antibiotics may depend on the external as well as the internal (host) environment 
(Table 1). This is especially important when considering co-selection by adjacent genes on multi-
gene units such as plasmids, were the combined selective effects are hard to predict
126
. For example, 
many pathogen-carried antibiotic resistance plasmids often contain genes annotated to have 
metabolic or virulence functions (manuscript I)
115
. Such features may be beneficial during infection 
or when certain nutrients (e.g. iron) are limited, but may also provide broader benefits of e.g. 
adhesion and biofilm formation, which does not depend on antibiotic selection
93
.  
Fitness is often measured as growth rates or head-to-head competitions in the laboratory
191,237
. 
While these measures may overlap well with more complex in vivo environments
115,191
, as the reader 
will see in manuscript II of this thesis, there are exceptions. Ideally, fitness should be measured in 
exactly the situation we wish to know more about such as the human body for pathogenic bacteria. 
By continuous sampling from natural environments, we obtain a direct measure of fitness through 
e.g. clone abundance, but isolating the factors responsible for selection is complicated and require 
simplified experimental setups
115,238
. However, there are obvious ethical complications if we want to 
carry out controlled experiments in humans, and it is still challenging to account for differences 
between individuals, e.g. in their microbiota or immune factors
239
. In addition, most natural bacterial 
isolates studied in the context of antibiotic resistance are likely to experience environmental 
fluctuations, e.g. those of a human digestive tract or immune response, that makes it hard to obtain 
oŶe ͞tƌue ŵeasuƌe͟ of fitŶess iŶ simplified experimental setups.  
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The human gut environment 
͞It has been shown that (gene) transfer in the intestinal tracts of animals and humans occurs ad 
liďituŵ; it’s a ďordello dowŶ there!͟ – Davies and Davies 20104 
The human gut exemplifies an especially important microbial environment that facilitates HGT, and 
it has been suggested as a significant reservoir through which pathogens acquire resistance and 
virulence traits
58,115,169,238
. Being in close contact with our body, pathogens may cause infection in the 
gut or be transmitted from the gut to infection-prone areas such surgery wounds or the urinary tract 
115,240,241
.  
The colonization of the gut by bacteria takes place within a few days after birth, where facultative 
anaerobic bacteria, mainly E. coli and enterococci, are the first to colonize followed by anaerobic 
genera of Bifidobacterium, Clostridium and Bacteroides in response to lower oxygen levels and the 
nutrients from breast milk
242
. The speed and diversity with which the gut is colonized depends on 
the route of delivery and the general hygiene of the environment, and 45% of Swedish infants are 
colonized by a mean of 2.1 distinct E. coli lineages three days after birth
243
. As a result of lower 
hygiene, these numbers are much higher in developing countries, where a similar group of infants 
carried 8.5 E. coli lineages on average
244
. E. coli is highly adapted to the gut environment and readily 
reaches numbers of >10
10
 CFU/g faeces in the infant gut after which it declines to 10
6
-10
8
 CFU/g in 
most adult carriers
242
. Other members of the Enterobacteriaceae family e.g. Klebsiella and 
Enterobacter species are common in the infant gut, but lack the competitive fitness to persist in high 
numbers into adulthood
242,245
. As solid foods are introduced, the infant microbiota shifts towards the 
adult composition with increased abundance of Bacteroides, Ruminococcus, Lachnospiraceae, 
Prevotellaceae and Clostridium, accompanied with a decrease in Enterobacteriaceae, 
Bifidobacterium and Lactobacillales
245
.  
The human gut is a complex environment, far from that of a Petri-dish, and its microbial inhabitants 
are subjected to fluctuations in oxygen levels, pH, nutrients, physical forces, suppression from the 
host immune system and competition from other microbial inhabitants
242,246
. In response to these 
harsh conditions, gut inhabiting bacteria have evolved numerous strategies to optimize their 
colonization
246
. Such strategies may provide unambiguous benefits (e.g. gut-specific nutrient 
utilisation) that would not be detected in most laboratory setups.    
The physical turnover of intestinal content promoted by peristaltic movements expels bacteria from 
the intestines unless they are able to attach physically to the intestinal surface. Therefore, outer 
membrane adhesion structures such as pili or lectins that attach to epithelial cells or mucus layers 
are important colonization factors
247
. Due to their accessibility and role in pathogenesis, these 
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surface structures are also preferred recognition sites and antibody targets for the immune system. 
Although similar mechanisms are widely used by harmless commensals, many colonization factors 
may therefore also be Đategoƌised as ͞ǀiƌuleŶĐe͟ faĐtoƌs or vice versa246. Due to the co-localisation of 
colonization factors and antibiotic resistance genes, on the same mobile elements within the gut 
microbiota, co-selection may play a role in their persistence
248
.    
A general strategy employed by epithelial immune cells to regulate the microbiota is the secretion of 
antimicrobial peptides (AMPs)
249
. While these peptides targets broadly by interacting with conserved 
cell envelope structures, some strains have developed increased tolerance to AMPs e.g. by reducing 
negatively charged residues of the outer membrane
246
. In addition to modulation by the immune 
system, direct competition also takes place between gut inhabiting strains. Many bacteria produce 
their own antimicrobial peptides (bacteriocins) to directly inhibit competitors and these are often 
encoded on plasmids; likely due to their social nature and role in plasmid stability
250
.   
Apart from physical niche competition and immune evasion, a major competitive factor of gut 
microbes is the ability to utilize limited nutrients. For example, some successful species of the infant 
gut are able to utilize oligosaccharides from breast milk or digest intestinal mucus layers, and such 
differential feeding strategies are important host strategies in the establishment of a healthy 
microbiota
245
. Such strategies are especially important in response to infection, where the immune 
systems can actively remove nutrients such as iron, zink, and manganese by secretion of 
sequestering proteins to limit the growth of pathogens
246
. Increased secretion of reactive oxygen 
species (ROS) by the infected host tissue also serves to limit pathogen colonization and many 
superior colonisers express enzymes (e.g. catalase) to reduce oxidative damage
246
. Interestingly, 
some enteropathogens take advantage of this mechanism to outcompete the normal gut microbiota 
by anaerobic respiration of products formed from ROS oxidised enterocyte metabolites upon 
inflammation
251
.  
The environment as a barrier to HGT 
Even if a gene is successfully mobilised and is able to contribute to the shared gene pool of an 
isolated community, physical distance between donor and recipient is an obvious barrier to HGT
252
. 
Whereas conjugation requires direct cell-to-cell contact, the distance reached by transformation and 
transduction depends on the stability of the free DNA or phage particles
253
. Nonetheless, with the 
broad transfer ability of some HGT mechanisms it is not unlikely that a chain of transfer events may 
connect ecologically different gene pools to overcome geographical distances
166
. However, if 
organisms occupy a narrow environmental niches, they are less likely to encounter potential donor 
organisms, which is evident from the reduced and uniform genomes of most endosymbionts
65
.    
Gene exchange network analysis have shown ecological preferences for most transfer events 
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happening within the human microbiome, soil habitats and other environments (Figure 9)
13,254,255
; 
however genes conferring broadly beneficial traits such as antibiotic resistance are disseminated 
widely across ecological niches. These observations suggest that the barrier posed by ecological 
differences may largely be a question of functional displacement, rather than ineffective transfer, 
where genes conferring niche specific or universal benefits are less likely to be lost in a given 
environment
58,254
. As such, the external environment becomes critical to the propagation of 
transferable genes, but the selective effects, and thus overall stability of transferred elements, can 
also be highly dependent on the internal, genomic environment, in which they arrive
101,110
.   
 
Figure 9. Gene exchange networks colored by phylogenetic and ecological associations. Networks adapted 
from Popa and Dagan 2011
252
.   
 
3.3. Phylogenetic factors affecting HGT  
Although antibiotic resistance genes are present in many environments, the do not move 
unhindered across ecological niches
13
, and more recent studies suggest phylogeny as a stronger 
barrier for genes of the human, animal and soil resistomes
12,168
. In addition, gene exchange network 
analysis across gene categories suggests that HGT primarily happens between closely related 
genomes (Figure 9)
82,168,252,255,256
. Reasons for this phylogenetic confinement have been discussed at 
different levels: from vector entry to compatibility of expression and propagation machinery, to 
selection at different levels
252
.  
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All transfer mechanisms show some restrictions in their host-range due to, for example, receptor 
availability or recombination proficiency
69
. While narrow host-range plasmids can only replicate in a 
few species with similar hosts replication proteins, many broad host-range e.g. IncP plasmid vectors 
are able to transfer much beyond the observed gene-exchange networks of most transferred 
genes
110,111,255,257
. DNA similarity is important for transformation events, where homologous 
recombination is needed for stable genomic integration
51,255
. Whereas other ways to integrate DNA 
e.g. transposons, integrons, site-specific or illegitimate recombination exist, plasmid vectors and 
certain phages are not dependent on stable integration events for their propagation
255,258
.  
Sequence level features as barriers to HGT 
The sequence similarity of donor and recipient genomes is a strong predictor of transfer frequency, 
suggesting that fundamental genetic barriers exist
82,255,259–261
. Apart from the effects of sequence 
homology on recombination efficiency, more general features such as the GC-content and codon 
usage have been suggested to influence compatibility of transferred genes with the recipient 
genome
255,259,260,262
.  
GC-content 
An interesting observation is that the majority (86%) of predicted recent transfers have taken place 
between genomes differing less than 5% in their GC-content, which suggests a role of sequence 
composition in the establishment of foreign genetic elements
255
. One relatively well studied 
mechanism used by proteobacteria to control the expression of incoming genes, is the binding of 
foreign DNA by nucleoid structuring proteins; including H-NS and its homologs
263
. These proteins 
recognize sequences of lower GC-content, compared to the genome average to bind and silence 
potentially costly heterologous genes
264
. This cost can be partly attributed to the intra- or extragenic 
sequestering of RNA polymerase by AT-rich DNA in the acquired DNA
197
. Apart from its physical 
binding of transferred DNA, the role of H-NS in HGT is further supported by the existence of plasmid 
encoded homologs and the, seemingly co-evolved, role of H-NS in the regulation of conjugative 
transfer genes
265,266
. Furthermore, transferred genes tend to have slightly lower GC-content 
compared to their host genomes; suggesting a selection for some degree of H-NS silencing
267
.  
A study by Raghavan et al. suggests a direct effect of the GC-content on the fitness of E. coli
268
. In 
this study, the growth rate of highly expressed synonymous gfp constructs, spanning a GC-range 
from 40.4–53.7%, was measured to be significantly increased for the high-GC variants268. While GC-
dependent fitness effects are interesting, they have only been demonstrated for (unnaturally) high 
expression setups in E. coli and a mechanistic basis is still lacking
269
.   
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Codon usage   
There seems to be a connection between codon usage and the transferability of genes within 
microbial communities
259,260,270
. Computational studies suggest that high codon similarity between 
donor and recipient genomes is crucial for HGT
260,270
. However, other studies propose that this is 
only true to a certain point, because excessive expression may be deleterious (in agreement with the 
H-NS model) to gene retention
259
.   
Functional studies performed on synonymous libraries of highly expressed gfp variants have 
revealed that an elevated CAI of the entire ORF was beneficial for growth, but the CAI did not predict 
expression very well
200
. In contrast, the codons determining mRNA-folding energy of the N-terminal 
(–4 to +37 positions) strongly predicted the expression of codon shuffled gfp200,271. A strong folding 
i.e. secondary structure of the mRNA close to the translation initiation site is thought to slow 
ribosome progression with a much more profound effect than that of e.g. suboptimal tRNA 
accessibility experienced by low CAI genes
272
. Therefore the influence of mRNA-folding could also be 
a valuable predictor to include when investigating barriers of HGT (manuscript V). 
A general problem arising when correlating the influence of sequence composition to transferability 
predictions is that causality is hard to establish. Because the sequence composition is similar within 
closely related organisms, there could be several other explanations for why sequence similarity 
between donor and recipient genomes is frequent. A common evolutionary and/or ecological history 
might entail overlapping physiology, niche occupancy, transfer vector compatibility and selective 
conditions, which likely have a much more profound influence on HGT than that of the sequence 
composition itself (manuscript V)
252
. Another explanation could be that organisms more engaged in 
HGT with each other, may have co-evolved their translational machinery to support a common gene-
pool of e.g. certain functional qualities
262,270
.   
Functional barriers to HGT    
The integration of genetic innovations that have (co-)evolved with distantly related genomes can 
pose a functional challenge
252
. Phylogenetic barriers might be formed by incompatibility with 
functional elements, other than the open reading frame itself, which may hinder proper functional 
integration of transferred genetic elements. For example, the expression of a newly acquired gene 
might be compromised if the native expression platform is incompatible with recipient machinery
252
. 
However, recent findings show that mutations readily occur to achieve de novo promoter function or 
to compensate the influence of suboptimal sequence composition on expression levels
198,273
. Such 
observations along with the broad host-range of certain plasmids, imply that the compatibility of 
transcriptional machinery might not be a major barrier to HGT
257
.  
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A repeated observation in HGT literature is a strong bias in the biological functions of transferred 
genes
274
. This bias was proposed already in the early genome sequencing days, following the 
oďseƌǀatioŶ that so Đalled ͞iŶfoƌŵatioŶal͟ geŶes ǁeƌe uŶdeƌƌepƌeseŶted among recently transferred 
geŶes Đoŵpaƌed to ͞opeƌatioŶal͟ geŶes275. Whereas the first of these gene categories covers the 
genomic core genes involved in information processing tasks such as translation, transcription and 
ƌepliĐatioŶ, the latteƌ ͞opeƌatioŶal͟ Đlass include more peripheral biosynthetic, metabolic and 
regulatory functions
275
. There are, however, important exceptions of e.g. polymerases and DNA 
repair genes widely present on plasmids, and the original hypothesis was later refined by Jain et al. 
in 1999
276–279
. In this paper, they detail their original hypothesis by arguing that the distinction 
between informational and operational genes could be attributed to differences in the complexity of 
the contexts in which they operate
277. This ͞ĐoŵpleǆitǇ hǇpothesis͟ states that geŶe pƌoduĐts highlǇ 
dependent on (co-evolved) interaction partners were less likely to be transferred alone, because 
their functional integration in a foreign genomic context would require compatibility with all 
interaction partners in the recipient genome to be successful
280
. That is, the more interactions a 
protein require for correct functionality, the more interactions can go wrong to damage existing, 
potentially vital, interactions resulting in lower host fitness
281
. These constraints are also evident 
from the limited adaptive freedom of highly connected genes
282
. Several years later, the notion was 
further supported by the availability of protein-protein interaction data that showed a strong signal 
for connectivity and the propensity of a gene to undergo HGT
274,280
.   
 
Whereas the complexity hypothesis has received substantial support in silico
255,276,277,280,282–284
, few 
studies have subjected its claims to experimental testing and have yielded somewhat conflicting 
results
164,281,285–287
. These studies investigate the functional compatibility and fitness effects of 
supplying, or replacing, informational genes with distant homologs. Sorek et al. find that ribosomal 
genes were significantly underrepresented in the cloneable fraction of whole genome sequencing 
libraries from multiple Sanger-sequenced organisms when expressed in E. coli; suggesting that these 
genes are toxic, at least when supplied in a multi-copy vector
164
. A recent study by Kacar and 
Garmendia et al. shows an increased fitness cost of replacing elongation factor Tu with its distant 
homologs in E. coli, and similar results have been obtained by Lind et al. when replacing ribosomal 
subunits in Salmonella typhimurium
281,287
. In contrast, the supplementation of distant homologs of 
acetyl-CoA carboxylase or RNA polymerase b subunits did not impose significant costs in E. coli
285,286
. 
Furthermore, both Lind et al. and Kacar and Garmendia et al. demonstrate that increased gene 
dosage can ameliorate the initial costs of foreign gene replacement
281,288
. Hence, it seems likely that 
  
Chapter 3 – Barriers to horizontal gene transfer  35 
highly connected genes are generally, but not always, costly and that this barrier may be more 
flexible than previously thought. 
 
Given the preceding discussions, it is evident that gene dissemination is restricted in numerous 
ways. However, considering the time of prokaryotic existence and the speed with which antibiotic 
resistance genes have spread in response to antibiotic pressure
289
, it seems likely that most genes 
can be mobilized and disseminate to some extent. Even if these genes, or their mobile elements, are 
subject to strong selective or functional barriers, compensatory adaptive strategies may enhance 
fitness to encourage proper integration into new genomic contexts
136,162,198,223,273,290
. Finally, second-
order selection and sheer chance (founder effects) may also play a substantial role in the transfer 
patterns observed. For example, some genes might be disseminated due to co-selection by other 
beneficial or addictive (TA-systems) genes and some may, by chance, be frequent in an environment 
just because they arrived first
166
.   
Hitherto, most studies have been largely observational and leave room for a more holistic 
understanding of the factors governing successful HGT. To encourage this progress, the work 
conducted in this PhD thesis sought to map HGT in situ and experimentally address the barriers 
proposed by in silico observations using a large-scale and diverse synthetic library of naturally 
occurring genes.  
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Concluding remarks and future directions 
Life evolves from a set of common principles dictated by molecular mechanisms, environmental 
selection and a fierce competition for survival. Research into these principles has allowed us to 
predict, and even control, the evolutionary trajectories of life forms and that knowledge has 
advanced our existence in many areas including agricultural breeding, modern biotechnology and 
disease control
291–293
. However, for the fast growing microbes, evolution takes place at a rate that 
sometimes leaves us as vacant spectators to the fascinatingly threatening plasticity of these ever-
adapting life forms.   
Imposing a strong selection pressure on bacteria will eventually lead to their adaptation. While 
controlled adaptive evolution experiments are exploited in the engineering of strains for more 
sustainable bio-based production of chemicals, unharnessed evolution can also be detrimental to 
large-scale production scenarios (manuscript IV). In medicine, unintended evolution is exemplified 
by the important lesson of antibiotic resistance that is increasingly compromising the treatment of 
critical pathogens
2
. This medical crisis is largely caused by the overuse of antibiotics, and therefore 
(global) regulatory policies, encouraging more rational use of antibiotics along with accelerated drug 
development, are the main efforts necessary to halt resistance development
21
.   
 
At the genetic level, evolutionary principles are shaping the way bacteria become resistant, and 
understanding the limitations of evolutionary processes involved in mutational and acquired 
antibiotic resistance is critical if we want to predict and prevent future resistance spread and de 
novo evolution of pathogenic traits. For instance, the assessment of the propensity of relevant 
genes, and their mobile elements, to engage successfully in HGT should be an integral part of 
developing new antibiotics
294
.   
Being widely implicated in HGT, the role of plasmids in our current pandemic of antibiotic resistant 
pathogens should not be underestimated. I invite the reader to consider a broader view of plasmids 
as plastic entities navigating dynamic fitness landscapes that continuously shape, and still are being 
shaped by, different genomic and environmental contexts. Therefore, steps towards elucidating the 
evolution and interaction of endemic clones and plasmids, in their natural habitats, is needed to fully 
comprehend the relevance of different environmental reservoirs and selective factors in the 
dissemination of antibiotic resistance among critical bacterial clones. Such insight will not only 
improve our understanding of antibiotic resistance, and bacterial evolution in general, but the 
harnessing of unwanted evolution will also aid in our ability to engineer more robust biological 
systems for industrial and medical applications (manuscript IV)
292
. 
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Present investigations  
The research conducted for this thesis couples molecular insight to the behaviour and evolution of 
genetic elements, at different environmental and genetic levels, and is presented in three themes: 
 
Evolution of E. coli in the infant gut  
Manuscript I and II investigate the evolution of co-existing E. coli lineages residing in the infant gut. 
The gut microbiota has received much attention for its role in health and disease, and the included 
studies underline its role as a hot-spot for HGT. While the gut is a complex selective environment, 
we sought to explain several genomic events by controlled in vitro and in vivo interrogations. 
Although some genomic events could be explained by beneficial effects on fitness, others did not 
show a selective benefit in our model-setups. These studies exemplify the high genetic turnover of 
gut-residing E. coli isolates and underline the ability of virulence and antibiotic resistance genes to 
persist for extended periods of time in spite of no direct selection.   
 
Host-plasmid adaptation in the clinic and industry  
In the two studies of manuscript III and IV, focusing on the adaptive events leading to increased 
stability of initially costly plasmids, we demonstrate how transposable elements constitute an 
efficient adaptive resource able to target expensive plasmid regions. In a large multidrug resistance 
plasmid, originating from a clinical Klebsiella pneumoniae strain, this cost amelioration happened 
through intramolecular recombination events that compromise the ability of plasmid transfer. 
Similarly, we observed that transposon mediated loss of function dynamics severely compromises 
production capacity in the industrially relevant case of mevalonate biosynthesis. For both studies, 
we emphasize the importance of the host background and show that these events, although 
universally beneficial, occur at much lower frequencies in certain hosts.  
 
Molecular factors governing the success of transferable resistance genes  
In manuscript V we explore the functional integration and biological costs of HGT. To do this, we 
employed a synthetic library of 200 antibiotic resistance genes representatively sampled from public 
databases. Though experimental interrogations, we find that the sequence composition of a 
resistance gene is of minor importance compared to the mechanistic constrains imposed by the 
encoded protein product. We demonstrate that drug-modifying proteins are less restricted by 
previous host affiliations in their functionality and costs. In contrast, proteins employing mechanisms 
with a high degree of metabolic or physiological interactions were less likely to work, and imposed a 
cost that scaled with the phylogenetic distance of their customary hosts when tested in E. coli. 
Evolution of E. coli in the infant gut 
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Elucidating the adaptive strategies and plasticity of bacterial genomes in situ is crucial for
understanding the epidemiology and evolution of pathogens threatening human health.
While much is known about the evolution of Escherichia coli in controlled laboratory
environments, less effort has been made to elucidate the genome dynamics of E. coli in
its native settings. Here, we follow the genome dynamics of co-existing E. coli lineages
in situ of the infant gut during the first year of life. One E. coli lineage causes a urinary
tract infection (UTI) and experiences several alterations of its genomic content during
subsequent antibiotic treatment. Interestingly, all isolates of this uropathogenic E. coli
strain carried a highly stable plasmid implicated in virulence of diverse pathogenic strains
from all over the world. While virulence elements are certainly beneficial during infection
scenarios, their role in gut colonization and pathogen persistence is poorly understood.
We performed in vivo competitive fitness experiments to assess the role of this highly
disseminated virulence plasmid in gut colonization, but found no evidence for a direct
benefit of plasmid carriage. Through plasmid stability assays, we demonstrate that this
plasmid is maintained in a parasitic manner, by strong first-line inheritance mechanisms,
acting on the single-cell level, rather than providing a direct survival advantage in the gut.
Investigating the ecology of endemic accessory genetic elements, in their pathogenic
hosts and native environment, is of vital importance if wewant to understand the evolution
and persistence of highly virulent and drug resistant bacterial isolates.
Keywords: Escherichia coli, genome evolution, virulence plasmid dynamics, plasmid persistence, horizontal gene
transfer, antibiotic treatment, urinary tract infections, infant gut
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INTRODUCTION
The human gut is home to a dense microbial ecosystem, the
human gut microbiota, playing an important role in human
health and physiology (Marchesi et al., 2015). As a commensal
constituent of the gut microbiota in warm-blooded animals,
Escherichia coli is highly adapted to the gut and colonizes the
gastrointestinal tract within the first hours of life (Drasar and
Hill, 1974). However, some environmental and commensal E.
coli isolates have acquired genetic factors that allow them to
cause disease within the digestive tract or when transferred to
other body sites such as the blood, brain, and urinary tract
(Smith et al., 2007). While diarrheagenic E. coli are a common
cause of gastro intestinal infections in third world countries
and travelers, extraintestinal pathogenic E. coli (ExPEC) are
facultative pathogens that reside in the human gut microbiota but
occasionally establish in extra-intestinal body sites (Köhler and
Dobrindt, 2011). Here, urinary tract infections casued by ExPEC
are among the most common bacterial infections in developed
countries, were patients are often infected via transmission of
strains from their own intestinal flora to their urinary tract
(Foxman, 2010).
The broad adaptation of E. coli to the gut environment
and extraintestinal body sites is reflected in the remarkable
genetic diversity within the species. This genetic flexibility is
largely facilitated by horizontal gene transfer (HGT) of accessory
genetic elements including plasmids and phages (Brzuszkiewicz
et al., 2009). These elements are widely present within the
gut microbiota and can provide their bacterial hosts with
antibiotic resistance or virulence factors (Salyers et al., 2004;
Sommer et al., 2010). Acquiring virulence genes might not
only influence the risk and severity of infections caused by the
pathogen, but has also been suggested to assist in the general
persistence of commensal bacterial strains of the gut (Diard
et al., 2010; Chen et al., 2013). Indeed, virulence determinants
such as those involved in adhesion, biofilm formation and
iron acquisition correlate with prolonged colonization in the
digestive tract (Adlerberth et al., 1998; Nowrouzian et al.,
2003).
Recent studies into the dynamics of clinical bacterial genomes
at genomic resolution have been carried out with time-series
sampling and underlines the high plasticity of plasmids and their
host associations in situ (Conlan et al., 2014, 2016). Conjugative
plasmids are of particular interest, as they are the main vehicles
of HGT in E. coli, playing an essential role in the adaptation
toward antibiotics or specific host niches (Johnson and Nolan,
2009; Norman et al., 2009).
Whereas, much effort has been devoted to study the survival
conditions of plasmids in vitro (Slater et al., 2008) our knowledge
on the behavior of plasmids in situ of their native hosts and
natural environment is limited (Karami et al., 2007; Conlan et al.,
2014, 2016). In order for a plasmid to persist in the long term,
it needs to either be stably segregated upon cell division, confer
a fitness advantage to its host, or transfer at high enough rates
to compensate the lack of the latter two (Simonsen, 1991; Slater
et al., 2008). As most plasmids do not exhibit sufficient rates
of transfer to survive without selection, stable inheritance, and
adaptive traits are key to their long term survival (Simonsen,
1991).
To elucidate the genome dynamics of E. coli in its native
environment of the gut, we genome sequenced individual E. coli
isolates over the first year of an infant’s life. We conduct in vitro
and in vivo competition assays to elucidate the selective drivers
of the observed dynamics, and gain a deeper understanding of
the endemic mobile elements contributing to the dissemination
of virulence and antibiotic resistance factors.
MATERIALS AND METHODS
Genome Sequencing of E. coli Lineages
The strains were isolated and typed as part of a previous study
by Karami et al. (2007). These were cultured in LB broth and
genomic DNA was isolated using an UltraClean© Microbial
DNA Isolation Kit (MoBio Laboratories, Inc., California).
Sequencing libraries were prepared using the TruSeq andNextera
XT (Illumina, California) protocols. Illumina HiSeq sequencing
was performed by Partners HealthCare Center for Personalized
Genetic Medicine (Cambridge, Massachusetts).
Sequence Analysis
Genomes for each sequenced isolate were assembled using Velvet
(v1.2.10; Zerbino and Birney, 2008) and annotated via RAST
(Aziz et al., 2008). Reads from the isolates were mapped onto
the reference, e.g., earliest isolated, genome via Bowtie2 (2.1.0;
Langmead et al., 2009), and single nucleotide polymorphisms
(SNPs) were enumerated via SAMTools (0.1.19; Li et al., 2009).
The SNP threshold was set to include SNPs with a phred score
of above 30 and at least 90% of the high-quality reads at
the site as the variant. Additionally, to ensure that all isolates
within a lineage consisted of the same genomic content as
the representative isolates, genomic areas lacking mapped read
coverage were identified using BEDTools (2.18.2; Quinlan and
Hall, 2010).
The pNK29 plasmid was assembled into a circular plasmid
with aid from plasmid alignments produced using MUMer
(Kurtz et al., 2004). Contigs belonging to the pNK29 antibiotic
resistance plasmid were first identified in lineage B as the new
genetic material of the isolate at 32 days, and then used to identify
the corresponding contigs in the lineage A genome. The RAST
annotations for this plasmid were refined based on homologous
genes in pOLA52 (NC_010378.1) that were either missing or
incorrect in pNK29.
Plasmid Identification and Comparison
Other plasmids were identified by first separating contigs based
coverage to infer copy-number relative to genomic contigs and
then by grouping contigs together with similar abundances.
The average coverage of each contig was determined using
BEDTools (Quinlan and Hall, 2010). Plasmid incompatibility
grouping was done using the PlasmidFinder tool (Carattoli
et al., 2014). Homologous previously sequenced plasmids were
identified using BLAST and the NCBI nt database (Altschul et al.,
1990). Circular plasmid diagrams were created using the BLAST
ring image generator (BRIG; Alikhan et al., 2011).
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For pNK29-2, blastn searches of the plasmid contigs revealed
14 plasmids with very high identity (99%) and hits with a pNK29-
2 coverage of >97% where selected (Figure 3 and Table S4).
As an exception, pECO-bc6 was also included despite its lower
coverage (88%) to illustrate deletion of plasmid accessory genes
flanked by inverted repeats. The EasyFigure software was used
for linear comparison of plasmid sequences displayed in Figure 4
(Sullivan et al., 2011).
The core genome of the E. coli hosts listed in Figure 3
was estimated using ROARY via annotations from PROKKA
(Seemann, 2014; Page et al., 2015). The aligned, ungapped
core genome was used to construct a maximum likelihood
phylogenetic tree using the RAxML software (Stamatakis, 2014).
MLST types were assigned usingMLSTfinder (Larsen et al., 2012),
and fimH types were assigned using the sequences referred to by
Dias et al. (2010).
Strain Tagging and pNK29-2 Plasmid
Curing
Lineage A and B strains isolated at the first time point were tagged
with antibiotic resistance markers to allow quantification during
competitive fitness experiments, plasmid loss experiments,
assessment of conjugation ability, and plasmid curing. Resistance
cassettes conferring resistance to Chloramphenicol and
Kanamycin respectively were amplified from cloning vectors
of the pZ system (Lutz and Bujard, 1997) and inserted into the
chromosomal araB gene of the Lineage A and B strains using the
Lambda Red recombineering system of pTKRED (Kuhlman and
Cox, 2010). The following regions of homology were used for
insertions into araB: 5′-GTAGCGAGGTTAAGATCGGTAATC
ACCCCTTTCAGGCGTTGGTTAGCGTT-3′ and 5′-GCCTAA
CGCACTGGTAAAAGTTATCGGTACTTCCACCTGCGACA
TTCTGA-3′.
The pNK29-2 plasmid was tagged with the Sh ble Zeocin
resistance gene in a transposase gene located at 61 kb using the
following homology ends: 5′-CTTCGGGAACGCTGTAACGAT
TACCACCAACCTCGATATAGCTGTCCCGG-3′ and 5′-TAA
CAACGGGAAAGTCGTGTTCAACTCCGGATTCCTGTTGC
TGGCCGACC-3′.
To cure pNK29-2 we disrupted the stbA gene of the stbAB
stability operon with a Kanamycin resistance marker using
the following homology ends: 5′-CATAAATGTGATGTGT
GAAGTATGATGATATTTTGACACGGTAACCTGAGTA
GGGATAACAGGGTAAT-3′ and 5′-TTCATTTTAAGAC
GCACATCATTCATTGCCTCCTGCACCGAATCAGTAG
CTAGGGATAACAGGGTAAT-3′. These contain the 18 bp
I-SceI endonuclease site enabling in situ double digestion
of the recombinant plasmid to enhance plasmid loss via
induction of the I-SceI endonuclease from pTKRED. Following
recombineering, recombinants were selected on Kanamycin
containing plates incubated at 30◦C to retain the pTKRED
plasmid. These were verified with PCR to confirm insertion
into the stbA gene. Verified colonies were inoculated directly
into LB medium containing 0.5% w/v L-arabinose and grown
at 30◦C for 2 h to induce expression of the pTKRED encoded
I-SceI endonuclease and subsequently switched to 42◦C for
3 h to allow curing of the temperature sensitive pTKRED
vector. The culture was diluted and plated on LB to obtain
single colonies that were confirmed for plasmid curing by the
absence of growth on Kanamycin (pNK29-2) and Spectinomycin
(pTKRED). The curing of pNK29-2 was validated by PCR using
primers targeting two distinct loci of the pNK29-2 backbone:
Upstream stb: 5′-CTCAACAAGGGTTATTGC-3′, downstream
stb: 5′-GAATGGCAAATGAAACG-3′ and Upstream 61 kb
transposase: 5′-GAATGGCAAATGAAACG-3′, downstream 61
kb transposase: 5′-AGAAGGCTGCGGTGCTGAAG-3′. The
plasmid-cured variant of the lineage A strain was re-transformed
with the Zeocin tagged pNK29-2 plasmid to control for potential
effects of the curing process.
Conjugative Transfer Assessment
In order to test the ability of pNK29-2 to conjugate, outgrown
over-night (O/N) cultures as well as exponentially growing
cultures of the lineage A strain and E. coli MG1655::tetA was
mixed equally and incubated O/N. Incubations were done at
37◦C and 30◦C on a solid agar surface as well as in liquid cultures
without shaking. Additional tagging at the 32 and 26 kb positions
were carried out to ensure that the initial insertion at the 61
kb position of pNK29-2 was not the cause of the dysfunctional
conjugation ability.
In vitro Competition, Growth Rate, and
Plasmid Loss Assays
Two O/N cultures were diluted to the same OD and mixed
1:1 in LB medium. The competition was carried out in 1.5
ml cultures and a volume of 1.5 µl was transferred to a
fresh well every 20 h. From OD measurements the number of
generations was estimated to∼10 generations/transfer. The ratio
of the competitors was determined as the fraction of colonies
on Chloramphenicol agar plates compared to plates containing
Kanamycin. Plasmid loss was assessed by comparing plate-counts
of at least 100 colonies on LB and Zeocin agar plates. In addition,
colonies from LB plates were streaked on Zeocin containing
plates and PCR (using the primers listed in the plasmid curing
section) was performed on a subset of colonies to verify plasmid
presence. Competitions in iron-limited medium was carried out
as for the LB competitions described above, except that M9
medium [M9 minimal medium (standard), 2010] with 5 µM
FeCl3 was used instead or LB. OD measurements of growth
rates in M9 5 µM FeCl3 were conducted in 96-well plates
containing 150 µl medium/well using a ELx808 plate reader
(BioTek, USA). Breathe-Easy (Sigma-Aldrich) film was applied
to minimize evaporation during measurements. OD at 600 nms
was measured with 5-min intervals for 24 h and incubated with
shaking at 37◦C between measurements.
In vivo Competition Experiments
Female BALB/c mice (5–6 weeks old) were used in all in vivo
studies (Charles River Laboratories, distributed by Scanbur).
All mice were pre-treated orally with streptomycin as described
previously (Lasaro et al., 2014). Briefly, streptomycin sulfate salt
(Sigma-Aldrich) was added to the drinking water at 5 g/L, along
with 5 g/L of glucose, to enhance taste, for 72 h followed by 24
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h of fresh water (no drug or glucose) to allow the streptomycin
to clear the animal’s system prior to infection. A single colony of
each E. coli strain was grown in LB shaking overnight at 37◦C.
Cells were pelleted, washed once in PBS and re-suspended in
PBS (13 mM phosphate with 137 mM NaCl at pH 7.4), and then
mixed in a 1:1 ratio of E. coli lineage A isolate with pNK29-
2 to the cured variant. Fifteen mice that were pre-treated with
streptomycin followed by 24 h without drug were administered
100 µL containing 2× 108 CFU of this 1:1 E. colimixture by oral
gavage. Feces was collected at days 2, 4, 7, and 12 post-infection.
Additionally, on day 12 following termination of the experiment,
a segment of the small intestine was removed. The feces and
small intestine segment were homogenized in PBS, serially
diluted, and equal amounts were plated on LA-Cam (25 µg/ml
chloramphenicol, selecting for the pNK29-2 containing strain)
and LA-Kan (50µg/ml kanamycin, selecting for the cured strain).
Following overnight incubation at 37◦C, CFUs were enumerated
and subsequently replica plated from both LA-Cam and LA-
Kan to LA-Zeo (40 ug/ml zeocin) to screen for the presence and
transfer of the pNK29-2 plasmid containing a Zeocin-resistance
marker. CFU values were normalized per gram of tissue (CFU/g).
The competitive index was calculated by dividing the OUTPUT
on days 2, 4, 7, and 12 (CamR CFU/g divided by KanR CFU/g)
by the INPUT on day 0 (CamR CFU/g divided by KanR CFU/g).
The input value was 1.04 indicating a 1:1.04 initial ratio of E.
coli lineage A isolate with pNK29-2 relative to the cured E.
coli lineage A isolate. The non-parametric Mann-Whitney U-
Test was used to compare the sample populations. The P-values
indicate the probability of falsely rejecting the null-hypothesis of
equal population means.
Ethics Statement
Animal experiments were performed in accordance with national
(regulation SJVFS 2012:26) and institutional guidelines. The
Uppsala Animal Experiments Ethics Review Board in Uppsala,
Sweden approved all mouse protocols undertaken in this study
under reference no. 154/14. Animal experiments were performed
at the Swedish National Veterinary Institute (SVA) in Uppsala,
Sweden.
RESULTS
The current study material was obtained from an infant enrolled
in the ALLERGYFLORA study with the original purpose of
correlating the composition of the gut microbiota to the
development of allergies later in life (Adlerberth et al., 2006).
This infant was subjected to long-term antibiotic treatment as
a consequence of a urinary tract infection, and was selected for
this study due to an observed change in the resistance profile of
E. coli strains isolated from this infant (Karami et al., 2007).
Fecal samples were obtained from the infant at 2, 9, 16, and
32 days, and 2, 6, and 12 months after birth (Figure 1). E.
coli lineages were identified by morphological and biochemical
characteristics as well as subsequent confirmation by PFGE and
random amplified polymorphic DNA (RAPD) typing. The two
main lineages were designated “A” and “B.” E. coli lineage A was
recovered at all the sampling time points and lineage B was only
transiently present in the samples collected from day 9 to 32
days of age (Karami et al., 2007; Figure 1). At 11 days of age,
a UTI infection was diagnosed and trimethoprim administered
intravenously (i.v.) for 5 days. However, due to the subsequent
presence of enterococci in addition to E. coli, the antibiotic
treatment was changed to i.v. ampicillin for 5 days followed by
oral amoxicillin treatment for an additional 8 days. Lastly, the
infant was administered trimethoprim prophylactically for the
following 7 months (Figure 1).
Transfer of an Antibiotic Resistance
Plasmid between Two Distinct E. coli
Lineages Co-Colonizing the Infant Gut
We sequenced the genomes of the E. coli isolates, obtained
from the fecal and urine samples of the infant, which
confirmed the lineages previously identified via RAPD and
PFGE typing. Comparing the genomic similarity of the two
lineages revealed that the lineages did indeed originate from
two different strains; with the initial isolate of lineage A
(4.91Mb) sharing only 77% of lineage B’s (5.45Mb) genomic
content.
To assess the genomic divergence of the individual lineage A
isolates, during the sampling period, a SNP-based phylogenetic
tree was constructed (Figure 2, Table S1). Only one SNP was
found when comparing the genomes of lineage A isolates
collected at 2, 9, and 16 days to the UTI isolate (Figure 2). Given
the very high sequence similarities between these isolates, lineage
A colonizing the gut microbiota was assumed to be the cause of
the UTI.
From the annotated genomes of lineage A and lineage B
isolates, we identified several factors that could contribute
to the pathogenicity of these strains. The genome of the
uropathogenic lineage A encoded the type 1 fimbriae FimH
among other adhesion factors (AidA-I and yqi encoded
adhesions), siderophore (enterobactin and yersiniabactin)
transporters and hemin receptors (TonB-system) as well as
enterotoxins (senB and vat) and Hemolysin E. Although the
lineage B isolates did not cause infection, its genomic content
reveals similar virulence factors such as the type 1 fimbriae
(fimH), serum survival factors (iss) and iron acquisition
(aerobactin synthesis and transport), but no enterotoxins.
While no SNPs were detected in the three isolates from lineage
B, we report the sequence of pNK29, a 42.2 kb TEM-1b encoding
conjugative IncX plasmid, that transferred from lineage A to
lineage B in situ of the gut (Karami et al., 2007; Figure S1,
Table S2). This plasmid was first detected in lineage B at 32 days,
and coincided with high resistance toward ampicillin compared
to earlier isolates (Figure 1). Similar conjugative plasmids of the
IncX family are prevalent in pathogenic E. coli, as well as other
Enterobacteriaceae isolated from humans and animals, playing
an important role in the dissemination of antibiotic resistance
genes (Norman et al., 2008; Toro et al., 2014).
Karami et al. reported an increase in lineage A counts from
106.4 CFU/g fecal matter to a density of 1011 CFU/g as the infant
was switched from trimethoprim to ampicillin and amoxicillin
treatment during the UTI infection from day 16 to 32 (Karami
et al., 2007). Such events can increase population size, and thus
the probability of plasmid transfer and enrichment of pNK29
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FIGURE 1 | Resistance profiles of co-existing E. coli lineages during the course of a urinary tract infection and antibiotic treatment. E. coli isolates were
obtained during the first 12 months of an infant’s life. At 8 days of age, the infant was admitted to the hospital due to a urinary tract infection from which the lineage A
clone was isolated at day 11. After 5 days of i.v. trimethoprim the treatment was switched to 5 days of i.v. ampicillin followed by an additional 8 days of oral (p.o.)
amoxicillin. Trimethoprim was administered to prevent reoccurring infections for the following 7 months. Along the course of treatment, lineage B acquired a TEM-1b
encoding IncX plasmid from lineage A; rendering both lineages resistant to the β-lactam treatment at day 32.
bearing cells. A similar increase in population counts from 103.9
to 1010.3 CFU/g was observed for lineage B as a result of pNK29
acquisition and antibiotic selection (Figure 1).
Interestingly, pNK29-bearing lineage B isolates were no longer
detected in the subsequent samples collected after cessation
of amoxicillin treatment (Figure 1). Plasmids often impose a
fitness cost upon first encounter with new host backgrounds
which could render lineage B less fit in the absence of selection
(Porse et al., 2016). Measuring the in vitro competitive fitness of
the initial plasmid-carrying lineage B isolate revealed a burden
of carriage (−4.9%, sd ± 4.1%, P = 0.046); indicating that a
counterselection of linage B, due to plasmid invasion, might have
taken place after discontinuation of amoxicillin treatment.
Major Genomic Events of Lineage a during
Gut Colonization
Apart from the pNK29 plasmid, all isolates of lineage A carried
a large virulence plasmid, designated pNK29-2, which was
detected throughout the year of sampling. In addition to these
two large plasmids, a novel plasmid-element was detected in
the 6 m2 and 12m isolates (Figure 2). This small (2,545 bp)
cryptic plasmid was termed pNK29-3 and had a low GC content
of 33.4%. Two open reading frames were identified on the
plasmid, which encode putative mobilization and replication
proteins (Figure S2). By comparing the coverage depth of the
plasmid to the average coverage depth of the genome, we
estimate the copy number to be around nine plasmids per cell.
BLAST-analysis revealed a high resemblance to the pIGMS31
previously isolated from Klebsiella pneumoniae as well as pEA1
(DQ659147.1) isolated from a Brazilian Pantoea agglomerans
strain (Figure S2; Smorawinska et al., 2012; Carattoli et al.,
2014). It was shown that while pIGMS31 can be mobilized to
Alpha- and Gamma-proteobacteria, it replicates via a rolling
circle mechanism that functions in Gammaproteobacteria only
(Smorawinska et al., 2012). Therefore, pNK29-3 likely originates
from other Gammaproteobacteria constituents of the gut flora.
Coinciding with the acquisition of pNK29-3 by lineage A,
the 6 m2 and 12m isolates of lineage A were also missing
∼54 kb of their chromosome compared to the previous isolates.
Annotations and flanking attR and attL sites of this region
suggested that it was an integrated phage. Using the PHAST
server and BLAST searches against NCBI GenBank, we detected
a high similarity to the Siphoviridae prophage of E. coli strains
FH199 and UMNK88 (Zhou et al., 2011). Losing this prophage
did not alter the resistance profile of the strain, but might
have been a result of negative selection imposed by increased
excision activity as a consequence of the cellular stress imposed
by antibiotic exposure (Beaber et al., 2004).
Lineage a Harbored a Highly Disseminated
and Stable Virulence Plasmid
The pNK29-2 plasmids of lineage A displayed very high sequence
identity to several widely disseminated plasmids deposited in
NCBI’s Genbank (Figure 3). Interestingly, 12 highly similar
plasmids were previously isolated from various pathogenic E.
coli strains and one originated from Klebsiella pneumoniae. In
particular, the endemic pUTI89 plasmid was found to have only
7 SNP differences to the pNK29-2 plasmid, and aligning the
contigs from this plasmid showed that there were no additional
insertions (Chen et al., 2006). Only two of the SNPs lead to
non-synonymous changes. These are located in the rsvB gene, a
resolvase, and in the traE gene, a conjugal transfer protein for F
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FIGURE 2 | SNP tree and genomic events of lineage A. Branch-numbers
show the amount of SNPs separating the isolates obtained from 2 days to 12
months after birth. The majority of samples were isolated during hospitalization
and prophylactic treatment. No SNPs were detected between the isolates
collected at days 2, 9, and 16, and only one SNP (in the blaTEM1b promoter)
was detected between these isolates and the isolate collected at 32 days. Two
isolates were included at the 2 months sampling point (2 m1 and 2 m2) and
these shared 5 SNPs in common compared to the 32 days isolate. Two 6
month isolates were also included. The infant was subjected to antibiotic
treatment from day 11 to 8 months after birth. Apart from SNP differences one
sub-lineage had undergone major genomic changes by means of
chromosomal deletions and acquisition of new plasmid DNA.
pilus assembly (Table S3). We tested the ability of pNK29-2 to
conjugate to E. coli MG1655, in liquid and on solid media, and
we did not detect any transconjugants; implying that the mutated
traE transfer gene is dysfunctional in pNK29-2.
pNK29-2 Resembles Virulence Plasmids
Found in a Diverse Set of Pathogenic E.
coli
The E. coli strain UTI89, harboring the pUTI89 plasmid, is an
archetypical uropathogenic E. coli (UPEC) strain isolated from a
patient with an acute bladder infection (Mulvey et al., 2001). The
pUTI89 plasmid belongs to the IncFIB/IIA incompatibility group
and shares several characteristics with the F-plasmid including
a full tra operon for conjugative transfer (Chen et al., 2006).
Additionally, its core backbone includes stability mediating genes
such as the ccdA-ccdB toxin-antitoxin system and the stbAB
operon ensuring stable inheritance upon cell division (Cusumano
et al., 2010). Several of the lesser conserved plasmid regions
can be related to virulence and overall adaptation to the human
host. These encode the enterotoxicity (senB), copper tolerance
(scsC/scsD) and iron acquisition factors. The cjrABC operon
encodes proteins involved in iron transport that also cause
sensitivity to colicin and has shown involvement in UTI virulence
(Smajs and Weinstock, 2001; Cusumano et al., 2010).
While a majority of the bacterial hosts carrying these virulence
plasmids is associated with UTIs, extremely similar plasmids
have been isolated across E. coli patho- and sequencetypes
from all over the world (Figure 3). For example, the prototype
neonatal meningitis E. coli strain RS218, isolated in 1974, carries
a virulence plasmid virtually identical to pUTI89 and pNK29-
2, which has been shown to play an important role in its
pathogenicity (Wijetunge et al., 2014).
Likewise, the genomic backgrounds hosting these plasmids
are diverse (Figure 3) and include strains of the dominating
extraintestinal pathogenic E. coli ST131 of major clinical
importance (Stoesser et al., 2016). The geographical locations
where these strains have been isolated varies, with highly similar
plasmids isolated from different strains in the US, Japan, Canada,
and Sweden, suggesting that these pUTI89-like plasmids are
globally disseminated in a non-clonal fashion (Figure 3).
Plasmids Similar to pNK29-2 Carry
Antibiotic Resistance Genes Obtained from
Independent Insertion Events
Although these plasmids share substantial homology, some show
variation within defined but variable “genetic load” regions of
their plasmid backbone (Figure 4).
Antibiotic use is a strong selection force and some of
the plasmids similar to pNK29-2 encode one or more,
antibiotic resistance genes organized among mobile element
associated cassettes. For instance, the p1ESCUM and pKPN-7c3
plasmids have acquired the tetA gene, conferring tetracycline
resistance, at different positions within their genetic cargo
region, but associated with the same mobile elements (Figure 4;
Johnson et al., 2016). pMVAST0167_1 and pECO-fce encode
multiple antibiotic resistance genes from their genetic load
region and share a TEM-1b gene in the same location and
accommodate a similar integron with genes conferring resistance
toward aminoglycosides (aadA5), sulphonamides (sul1) and
trimethoprim (dfrA17). Compared to pMVAST0167_1, pECO-
fce encodes several additional resistance genes (sul2, tetA, strA,
strB, and tmrB) from a cassette inserted between the TEM-1b
gene and the int1 integron (Figure 4).
pNK29-2 Confers a Fitness Cost to its Host
In vitro
While the pNK29 plasmid, encoding the TEM-1b β-lactamase,
was strongly selected for during the β-lactam treatment
administered here (Karami et al., 2007), it is not obvious how
large virulence plasmids persist in the gut. The lineage A strain
persistently colonized the gut for the entire duration of the study,
from 2 days to 1 year after birth, suggesting that it is well adapted
to the human host. Such long term survival could be supported by
general persistence factors of UPEC strains, suggesting an overlap
between UTI virulence and gut persistence factors (Nowrouzian
et al., 2005; Chen et al., 2013). Only minor selection is required
for a plasmid to survive if it does not impose a significant fitness
cost on its host. We used antibiotic resistance markers to tag
the plasmid and the host chromosome of lineage A in order to
separate the plasmid-bearing variant from the cured variant and
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FIGURE 3 | Overview of plasmids resembling pNK29-2 and their host phylogeny. Thirteen plasmids with high similarity to pNK29-2 were downloaded from
Genbank (see Table S4 for accession numbers and references). Info on host strain, its disease associations and geographical origin was obtained from the literature.
The “Year” column denotes the first mentioning of the host strain in the literature unless the isolation year was clearly stated. In silico MLST typing was performed and
FimH types were added to the ST131 clade highlighting their internal diversity. A core-genome based maximum-likelihood tree was constructed to illustrate the
diversity of the E. coli plasmid hosts. Node numbers are bootstrap confidence values.
FIGURE 4 | Genetic variability and conservation within similar virulence plasmid backbones. six out of the Thirteen virulence plasmids similar to pNK29-2
showed signs of major restructuring events and are illustrated here. While these plasmids show some degree of variation, they also share a conserved core of transfer
(green), stability (blue), and virulence genes (red). Mobile elements constituting inverted repeats (highlighted in orange) allow for instability of the cjrABC-containing
region exemplified in pSaT040 and pECO-bc6. Additional genes involved in antibiotic resistance have been inserted upstream the fully conserved iron acquisition
cluster of the genetic load region in p1ESCUM, pMVAST0167_1, pKPN7c3, and pECO-fce. The TEM-1b and tetA genes are highlighted in cyan and light green
respectively. pECO-fce is significantly larger than the remaining plasmids due to a duplication of its transfer region which has been condensed for simplicity. Colored
shades illustrate BLAST identity of pairwise comparisons and orange shades highlight inverted regions.
detect plasmid loss as well as transfer events. We used markers
previously used for tagging in similar fitness experiments, where
they did not impose a measurable cost (Chen et al., 2013).
Similarly, we also confirmed that the Sh ble Zeocin resistance
gene, used for plasmid tagging, did not impose a significant
cost during 5 days of competitive growth against the non-tagged
variant (two sample t-test, P = 0.11).
The cured and plasmid bearing strains were mixed in equal
proportions and propagated in LB medium for 8 days without
selection. From CFU quantifications on selective agar plates, the
average in vitro fitness cost of the plasmid-carrying strain was
measured to be 0.92 sd ± 0.25% per generation. Although this
cost of plasmid carriage is low, one would expect a steady decline
of the plasmid bearing cells under these growth conditions.
Due to the presence of putative iron acquisition systems on
the pNK29-2 plasmid, we also tested the competitive fitness
as well as absolute growth rates in iron-limited M9 minimal
medium containing 5 µM FeCl3 mimicking the lower range of
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FIGURE 5 | Competitive growth of lineage a strain against a pNK29-2
cured variant within streptomycin treated mice. Mice where inoculated by
oral gavage with equal amounts of plasmid carrying and plasmid-free cells.
The competitive index (top left equation) is the ratio of CFUs obtained from
selective plating. This ratio was also quantified for the small intestine at the
endpoint (day 12) of the experiment to assess the potential role of adhering
cells. Replicates were excluded when the strains were no longer detected.
Significance indicators illustrate pairwise comparisons of means
(Mann-Whitney U-Test: *P = 0.014, **P = 0.0015, ***P = 0.001)
physiological concentrations (Wang, 1996). We were not able
to detect a significant advantage in terms of growth rate (Two
sample t-test, P = 0.43—Figure S3) or competitive fitness of the
plasmid carrying strain when mixed 1:1 in the same medium
(1.07± 2%, one sample t-test, P = 0.45).
The Plasmid Carrying Strain is
Outcompeted In vivo of the Mouse Gut
Because the plasmid encodes a diverse set of factors thought
to be involved in iron acquisition, toxin production as well as
several hypothetical proteins, that might be selected for in more
complex in vivo settings, we set out to test the competitive
fitness in a gut environment of streptomycin treated mice. The
plasmid-cured strain was competed against its plasmid-carrying
ancestor in the mouse gut and we measured the proportion
of plasmid-carrying to plasmid-free cells in the feces over the
course of 12 days (Figure 5). Here, we observed a steady decline
in plasmid-carrying cells compared to plasmid-free cells with
the plasmid-free cells dominating the average population after
7 days of direct competition. Interestingly, the plasmid-carrying
populations avoid complete out-competition by plasmid-free
cells in this time-span (Figure 5).
To investigate whether the measurements obtained from feces
were representative of the intestinal contents, including cells
adhering to the intestinal wall, we measured the proportion of
plasmid-bearing cells sampled directly from the small intestine
of the mice at the end of the 12 days experiment. There was no
significant difference between the direct sampling compared to
fecal counts (Mann-Whitney U-Test, P = 0.27) and >10% of the
cells contained the plasmid in the average replicate population at
this stage (Figure 5).
From the competition experiment we calculated the average
fitness cost per generation of the plasmid in the mouse gut to be
0.83 sd± 0.2%, assuming that the competing E. coli underwent 10
generations per day (Rang et al., 1999; Lee et al., 2010; Myhrvold
et al., 2015). This cost is slightly lower, but not significantly
different, from the plasmid cost measured in vitro (Two sample
t-test: P= 0.61).
pNK29-2 is Stably Inherited Despite its
Cost
Although the plasmid-bearing strain is less fit than the
plasmid-cured variant in vivo, it seems possible that a minor
subpopulation of plasmid-bearing cells can persist for extended
time periods; especially if competition from plasmid-free
daughter cells is postponed via stable inheritancemechanisms. As
for all the virulence plasmids analyzed here (Figure 3), pNK29-
2 carries the highly conserved stbAB stability operon (Figure 4)
that encodes active segregation machinery; ensuring that the
plasmid is stably segregated to both daughter cells during cell
division (Guynet et al., 2011). To test the segregational stability of
pNK29-2 in its native lineage A host (day 0 isolate), we conducted
14 days of serial passaging in LBmedium, corresponding to∼140
generations of growth. In such a setup, plasmid-free segregants
would eventually take over the population due to the cost of
plasmid carriage. However, we did not observe any plasmid-free
cells within this time span with a detection limit of plasmid-free
cells of∼1%. Similarly, no plasmid-free cells were detected in the
in vivo competition assays, during the 12 days of gut colonization.
Taken together, these results imply that virulence plasmids,
such as pNK29-2, have no direct advantage in gut colonization
but are able to persist in spite of a small, but significant, fitness
cost due to efficient plasmid inheritance mechanisms.
DISCUSSION
Culture independent methods based on metagenomic
sequencing have been used to investigate the abundance
profiles of strains colonizing the gut over time (Morowitz et al.,
2011; Brown et al., 2013; Sharon et al., 2013). However, these
methods are limited in their ability to observe genomic events at
high resolution such as horizontal transfer and single nucleotide
variations.
Due to our longitudinal sampling and the high resolution
of single isolate genome sequencing, we were able to observe a
glimpse of the complex genome dynamics of E. coli in its native
settings. We confirm a gut-inhabiting strain as the origin of a
bladder infection; supporting the general belief that UTIs are
caused by gut inhabiting E. coli strains that eventually enters
the urethra (Chen et al., 2013). Furthermore, we report the
sequence of pNK29, a novel 42.2 kb IncX plasmid carrying a
TEM-1b β-lactamase, which was transferred between the two co-
existing E. coli lineages of the gut. Few phenotypic reports exist
documenting plasmid mediated HGT of antibiotic resistance
genes between bacteria in the human gut and our data supports
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that transfer of resistance genes take place in the gut, and
may be enhanced by antibiotic treatment (Bidet et al., 2005;
Karami et al., 2007; Trobos et al., 2009; Goren et al., 2010). The
recipient lineage was only sampled at one time-point after the
termination of β-lactam antibiotic administration (day 32) and
declined to undetectable levels thereafter. This could indicate
a negative selection of pNK29-carrying lineage B isolates in
the absence of antibiotic selection; however, confirming the
role of pNK29 in the counterselection of lineage B in the gut
will require further in vivo competition experiments. Lineage B
showed a large drop in population counts when subjected to
the first round of trimethoprim treatment upon hospitalization
(Figure 1). The prophylactic administration of trimethoprim
coincided with the disappearance of lineage B, and could be
another likely explanation for its absence in the consecutive time
points.
While we did not observe any genomic alterations of lineage
B apart from the acquisition of pNK29, lineage A experienced
chromosomal deletions and acquired a cryptic plasmid as well as
a high number of SNPs during the sampling period (Figure 2).
Genome plasticity is believed to play a crucial role in the
adaptation of pathogens to the selective forces imposed by the
immune system or the remaining microbiota within a human
host (Brzuszkiewicz et al., 2009). The mutation rate observed for
lineage A was high and resemble that of mutator phenotypes that
are often enriched among UPEC isolates (Labat et al., 2005). Such
increased rates of mutation and recombination events might also
be the result of antibiotic treatment of the infant; leading to
induction of the bacterial SOS response, which has been shown
to increase mutation rates (Beaber et al., 2004; Michel, 2005).
Non-synonymous mutations were indeed detected in genes
related to antibiotic tolerance, e.g., those involved in folate
metabolism (folA—targeted by trimethoprim), fusaric acid
resistance (fusB), ABC-transport and membrane permeability
(porins; Table S1). Equivalently, the genomic deletion of the
54 kb region might have resulted from antibiotic mediated stress
known to induce prophage excision and increase horizontal gene
transfer in general (Beaber et al., 2004; Nanda et al., 2015).
Apart from small cryptic plasmids providing no obvious
selective advantage to their bacterial host, gut-inhabiting E. coli
isolates often carry plasmids that allow adaptation toward the
human host by contributing virulence or antibiotic resistance
factors (Johnson and Russo, 2005). In addition to the β-lactamase
carrying pNK29 IncX plasmid, we identified a 114 kb plasmid
(pNK29-2) in lineage A that was strikingly similar to other
previously sequenced virulence plasmids from a diverse set of
pathogenic E. coli strains (Figure 3). These plasmids have been
shown to play a role in the initial stages of UTI infection in a
mouse model in a different genetic host background, and could
have provided lineage A with the necessary virulence factors
leading to the successful UTI infection observed in the studied
infant. Although it is generally believed that specific pathotypes
of E. coli carry different virulence plasmids, plasmid backbones
virtually identical to pNK29-2 have recently been found in K.
pneumoniae as well as several divergent E. coli strains; with
the earliest isolate dating back to 1974 (Figure 3). The high
conservation of these plasmids suggests that they provide a
universal adaptive benefit to their ExPEC hosts regardless of
infection site (Johnson and Nolan, 2009; Cusumano et al., 2010;
Wijetunge et al., 2014).
When comparing the genetic composition of the currently
sequenced virulence plasmids with high similarity to pNK29-2,
it is clear that certain regions tend to preserve genetic features
across host, geography and time (Figures 3, 4). These include
mediators of iron acquisition, toxin production and putative
copper resistance mediators (scsC and scsD; DebRoy et al.,
2010). Carrying genes implicated in virulence, these plasmids
could confer a survival advantage to their bacterial host during
infection. Prior studies have examined the role of pUTI89 and
pRS218 in urinary tract infections and neonatal meningitis,
respectively (Cusumano et al., 2010; Wijetunge et al., 2014).
These studies did not observe any phenotypic differences in vitro
between the plasmid bearing and cured host in terms of growth
rate, type 1 pilus expression or biofilm formation. However,
they did observe a significant difference in infectivity using
rodent infection models (Cusumano et al., 2010; Wijetunge et al.,
2014).
A vital defense mechanism of the human body is to restrict
iron from pathogens, thus acquisition and transport of iron is
an important survival mechanism for ExPEC strains in vivo
(Andrews et al., 2003). Therefore, iron acquisition could be
beneficial for survival in many niches of the human body,
including the densely populated gut microbiota, where access
to iron is limited (Andrews et al., 2003; Nowrouzian et al.,
2003). While Cusumano et al. speculated that the cjr operon of
pUTI89 was beneficial in a UTI infection scenario due to its
putative involvement in iron acquisition, we could not detect
an advantage in neither absolute growth rate nor competitive
fitness of lineage A carrying the pNK29-2 plasmid when grown
in iron-limited conditions (Cusumano et al., 2010). Although
the effect was small or non-existent in our experimental setups,
pNK29-2 might provide an advantage by other means. For
example, the pNK29-2 genes encoding siderophore receptors or
transporters might provide an advantage, only if the available
iron is on a certain form e.g., bound by its respective
siderophore. As other iron acquisition systems are located on
the chromosome of lineage A, the pNK29-2 encoded systems
could be redundant in this strain, but might be selected in
other hosts to encourage plasmid maintenance in a communal
context.
Previous studies have shown that even minor differences
in host genomes can be highly influential in determining
plasmid establishment as well as subsequent adaptation and
long term persistence (Humphrey et al., 2012; Porse et al.,
2016). Thus, it is intriguing that virulence plasmids imposing
a minor, but significant, fitness cost without providing any
strongly selected phenotypes, can persist in a competitive
environment such as the human gut. From our in vivo
competition experiment, it is clear that the pNK29-2 carrying
strain was less fit in the murine gut but does reach stable counts
from day 7 to 12 (Figure 5). This stagnation in competition
could encourage extended plasmid persistence and might be
explained by changes in the growth rate of gut inhabiting
strains over time; indicating a non-constant selection pattern
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(Rang et al., 1999). Such selection patterns are known to
occur in mixed bacterial populations encompassing social iron
acquisition phenotypes and similar dynamics could take place
in the competition between pNK29-2 carrying and plasmid-free
strains in the gut (Stojiljkovic et al., 1993; Ross-gillespie et al.,
2007). However, this does not seem to be the case from our
growth rate measurements in iron-limiting conditions, were the
plasmid carrying strain did not have an advantage on its own
(Figure S3).
The measured fitness cost of the pNK29-2 in the lineage
A strain was surprisingly similar between in vitro and in
vivo setups, and is low compared to previous observations of
plasmid costs (Vogwill and MacLean, 2015). While plasmids
can in theory compensate their loss and fitness cost by re-
infection of plasmid-free hosts (Slater et al., 2008), this is
unlikely to be the case for pNK29-2 as we did not observe any
transconjugants in our in vitro conjugation assays nor during
the in vivo competition experiment. The inability of plasmids
to conjugate might be explained by the fitness constraints a
functional conjugation machinery can impose on certain hosts;
supported by the existence of plasmid variants, such as pCE10A
from Lu et al., lacking the conjugative transfer operon, that are
otherwise identical to pNK29-2 (Lu et al., 2011; Porse et al.,
2016).
Loss of pNK29-2 was not observed, neither in vivo nor in
vitro, suggesting that primary stability mechanisms such as active
segregation and toxin-antitoxin systems are the most important
persistence parameters for these plasmids. This is consistent with
the high degree of conservation of stability systems among all 14
plasmids examined here and further supported by the fact that
we, as well as previous studies, have experienced considerable
trouble curing strains from these plasmids; unless the stbAB
operon is disrupted (Cusumano et al., 2010; Wijetunge et al.,
2014).
By characterizing the genomes of persistent lineages of E.
coli colonizing the gut of an infant, we observed substantial
dynamics, highlighting that strains colonizing the human gut
undergo continuous change. While genomic plasticity can lead
to improved persistence, some elements are surprisingly stable.
Our cost and stability characterizations suggest that a low cost
and a high segregational stability, combined with plasmid-
encoded universal virulence factors, presumed to increase fitness
in a broad range of infection scenarios (Cusumano et al.,
2010; Wijetunge et al., 2014), are likely the main parameters
governing the success of endemic virulence plasmids. Further
understanding of the factors contributing to genomic variation
of gut colonizing pathogens will aid in rational interventions
against the virulence and antibiotic resistance determinants
widely disseminated among these isolates.
DATA AVAILABILITY
All sequenced genomes can be accessed via the Bioproject
PRJNA352659.
AUTHOR CONTRIBUTIONS
NK, IA, and AW provided the E. coli isolates. AP did the
in vitro work and strain tagging. JK performed the in vivo
competition experiment. HG processed the sequencing data. AP,
HG, and MS analyzed the sequencing data results and AP and
HG wrote the manuscript with input from MS, JK, DA, NK,
and IA.
FUNDING
This research was funded by the EU H2020 ERC-20104-STG
LimitMDR (638902) and the Danish Council for Independent
Research Sapere Aude programme DFF -4004-00213, the
Medical Faculty of the University of Göteborg (ALFGBG138401)
and the Swedish Medical Research Council.
ACKNOWLEDGMENTS
We thank Mari Cristina Rodriguez de Evgrafo and Marius
Faza for aid in sequence library preparation. Christian Munck
and Lejla Imamovic are thanked for helpful discussions. MS
acknowledges support from the Novo Nordisk Foundation, and
the Lundbeck Foundation.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://journal.frontiersin.org/article/10.3389/fcimb.
2017.00126/full#supplementary-material
Figure S1 | Plasmid map and BLAST comparison of pNK29. pNK29
compared to IncX1 plasmids pOLA52 (outer ring, green) and
pRPEC180_47(middle ring, blue). Open reading frames are drawn directionally
(inner ring, black). Selected annotations are labeled outside the ring (see Table S2
for full annotation list).
Figure S2 | Plasmid pNK29-3 compared to most similar plasmids in
GeneBank. The two ORFs encode putative replication and mobilization proteins
and open reading frames are drawn directionally (inner ring, black).
Figure S3 | Growth rate of lineage A with and without pNK29-2 under
iron-limited conditions.
Table S1 | SNPs in different isolates of lineage A. Table containing the SNPs
from lineage A, including the annotation and whether the animo acid change was
synonymous or non-synonymous. The isolates from days 2, 9, and 16 are left out
as they did not have any SNP differences from the representative genome for the
lineage (isolate taken at 2d).
Table S2 | Annotations for pNK29. Names in square brackets indicate
homologs in pOLA52.
Table S3 | SNPs in the pNK29-2 plasmid of lineage A compared to pUTI89.
SNPs were identified by comparing the initial linage A isolate (day 2) with pUTI89
(CP000244.1).
Table S4 | Plasmids similar to pNK29-2 and information on their origin.
The table presented in Figure 3, but more detailed information on size,
location, and references. The GenBank ID refers to the plasmid sequence
entry in GenBank and the Pubmed ID (PMID) to the study where the plasmid
was initially described.
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Figure S1. Plasmid map and BLAST comparison of pNK29. pNK29 compared to IncX1 plasmids pOLA52 (outer ring, green) 
and pRPEC180_47(middle ring, blue). Open reading frames are drawn directionally (inner ring, black). Selected annotations 
are labeled outside the ring (see Table S2 for full annotation list). 
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Figure S2. Plasmid pNK29-3 compared to most similar plasmids in GeneBank. The two ORFs encode putative replication 
and mobilization proteins and open reading frames are drawn directionally (inner ring, black). 
 
Figure S3. Growth rate of lineage A with and without pNK29-2 under iron-limited conditions. 
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Contig no. Position Day 2 UTI Day 32 2 m1 2 m2 6 m1 6 m2 12 m Annotation mutation
61 61701 A G  6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)                      nonsynonymous
56 6755 G A A A A A A No coding sequence identified
5 176310 G A A A A A  Dihydrofolate reductase (EC 1.5.1.3)                                                                                     synonymous
93 189 G A A A No coding sequence identified
42 18614 G A A  Primosomal protein I                                                                                                              nonsynonymous
93 95 G A A No coding sequence identified
93 104 G A A No coding sequence identified
93 105 G A A No coding sequence identified
93 171 G A A No coding sequence identified
15 137066 G A  Radical SAM family enzyme, similar to coproporphyrinogen III oxidase synonymous
24 77511 G A Transcriptional activator of maltose regulon, MalT                                                         nonsynonymous
49 14209 G A hypothetical protein                                                                                                       synonymous
4 85958 G A 3-oxoacyl-acyl-carrier protein reductase (EC 1.1.1.100)                                                 synonymous
62 46358 G A No coding sequence identified
5 175792 T C C C C C Dihydrofolate reductase (EC 1.5.1.3)                                                                                      nonsynonymous
20 275987 T C C Glutamate synthase                                                                               nonsynonymous
20 297334 T C FUSARIC ACID RESISTANCE PROTEIN FUSB                                                 nonsynonymous
21 19073 T C IS                                                                                                                           nonsynonymous
24 25690 T C Nitrite reductase NAD(P)H small subunit (EC 1.7.1.4)                                                     nonsynonymous
34 44455 A G LSU ribosomal protein L19p                                                                                                        synonymous
70 8108 A G Putative Ton-B dependent hemine receptor                                                                     nonsynonymous
62 60490 C T T T T T Alpha-2-macroglobulin                                                                                                                synonymous
93 150 C T T No coding sequence identified
10 126386 C T Ferredoxin-type protein NapG (periplasmic nitrate reductase)                                nonsynonymous
14 3707 C T Putative GTP-binding protein                                                                                                   nonsynonymous
20 214976 C T LppC putative lipoprotein                                                                                                           nonsynonymous
23 43422 C T Putative phosphatase YieH                                                                                                        nonsynonymous
16 43695 G A Inner membrane protein YiaA                                                                                                  nonsynonymous
20 74596 G A Hexuronate utilization operon transcriptional repressor ExuR                                  nonsynonymous
42 9944 G A putative tail protein                                                                                                                   nonsynonymous
46 5067 G A Putative stability/partitioning protein encoded within prophage CP-933T          synonymous
5 123037 G A Cell division protein FtsQ                                                                                                           nonsynonymous
17 98463 T C Holliday junction DNA helicase RuvB                                                                                     synonymous
24 60742 T C Transcription elongation factor GreB                                                                                     nonsynonymous
30 120639 G C expressed protein                                                                                                                       nonsynonymous
10 92885 A G Putative membrane protein                                                                                                      nonsynonymous
26 193630 A G Putative inner membrane protein                                                                                          synonymous
26 218585 A G No coding sequence identified
30 97163 A G Glutamate Aspartate transport ATP-binding protein GltL (TC 3.A.1.3.4)                 nonsynonymous
83 6188 A G FIG01045219: hypothetical protein                                                                                         synonymous
26 171451 G A Inner membrane ABC transporter permease protein YcjP                                            stop
3 137385 T C FIG138056: a glutathione-dependent thiol reductase                                                    synonymous
27 15149 C T IncF plasmid conjugative transfer pilus assembly protein TraU                                 nonsynonymous
51 40378 C T Chitinase (EC 3.2.1.14)                                                                                                                 synonymous
10 196403 C A A DedA family inner membrane protein YohD                                                                      nonsynonymous
15 10933 G A A Protease III precursor (EC 3.4.24.55)                                                                                       synonymous
16 34911 G A A Outer membrane protein A precursor                                                                                   nonsynonymous
20 182830 G A A Inner membrane protein                                                                                                            synonymous
23 37891 G A A 6-phospho-beta-glucosidase (EC 3.2.1.86)                                                                           nonsynonymous
25 57550 G A A ATP-dependent hsl protease ATP-binding subunit HslU                                               nonsynonymous
35 4250 G A A O-antigen ligase                                                                                                                        synonymous
39 14389 G A A Ubiquinone biosynthesis monooxygenase UbiB                                                              nonsynonymous
3 26626 G A A Enoyl-CoA hydratase (EC 4.2.1.17) / 3-hydroxyacyl-CoA dehydrogenase (EC 1.1nonsynonymous
4 39270 G A A Arginine/ornithine antiporter ArcD                                                                                        nonsynonymous
4 66817 G A A Uncharacterized protein YtfN                                                                                                    stop
5 5863 G A A Prolyl-tRNA synthetase (EC 6.1.1.15), bacterial type                                                       nonsynonymous
10 145962 G A Putative ABC transporter ATP-binding protein                                                                  nonsynonymous
15 147808 G A Ornithine decarboxylase (EC 4.1.1.17)                                                                                   nonsynonymous
17 309028 T A FIG00638170: hypothetical protein                                                                                         nonsynonymous
18 136370 G A Hydroxylamine reductase (EC 1.7.-.-)                                                                                    synonymous
19 96733 G A Per-activated serine protease autotransporter enterotoxin EspC                            nonsynonymous
1 53133 G A PTS system, sorbose-specific IIC component (EC 2.7.1.69)                                           nonsynonymous
4 95471 G A No coding sequence identified
53 22400 G A Single-stranded DNA-binding protein                                                                                   synonymous
5 191026 G A Carnitine operon protein CaiE                                                                                                  nonsynonymous
147 554 T C C hypothetical protein                                                                                                                    nonsynonymous
20 183063 T C C Inner membrane protein                                                                                                            nonsynonymous
3 70340 T C C No coding sequence identified
3 122654 T C C NADP-dependent malic enzyme (EC 1.1.1.40)                                                                   synonymous
43 100362 T C C Flagellar hook-associated protein FlgK                                                                                 nonsynonymous
49 16016 T C C LysR family transcriptional regulator YafC                                                                           nonsynonymous
5 120353 T C C Cell division protein FtsZ (EC 3.4.24.-)                                                                                   nonsynonymous
5 170421 T C C Outer membrane protein Imp, required for envelope biogenesis / Organic solvnonsynonymous
62 31047 T C C Uncharacterized protein YphG, TPR-domain containing                                                nonsynonymous
94 267 T C C No coding sequence identified
13 17707 T C Phage head-to-tail joining protein                                                                                         nonsynonymous
25 1495 T C Outer membrane vitamin B12 receptor BtuB                                                                     synonymous
53 13735 T C Holin-like protein CidA                                                                                                                synonymous
10 178934 A G G GTP cyclohydrolase I (EC 3.5.4.16) type 1                                                                              nonsynonymous
21 56232 A G G adherence and invasion outermembrane protein (Inv,enhances Peyer's patchenonsynonymous
83 198 A G G No coding sequence identified
35 2808 A G No coding sequence identified
43 106731 A G Ribosomal large subunit pseudouridine synthase C (EC 4.2.1.70)                             nonsynonymous
5 62832 A G glutamyl-Q-tRNA synthetase                                                                                                    synonymous
77 4289 A G hypothetical protein                                                                                                                    nonsynonymous
147 436 C T T No coding sequence identified
17 79481 C T T Flagellar biosynthesis protein FlhA                                                                                        synonymous
17 216927 C T T PTS system, chitobiose-specific IIC component (EC 2.7.1.69)                                      nonsynonymous
17 299242 C T T No coding sequence identified
30 65147 C T T Ribonuclease I precursor (EC 3.1.27.6)                                                                                   nonsynonymous
43 39245 C T T No coding sequence identified
17 232929 C T Threonyl-tRNA synthetase (EC 6.1.1.3)                                                                                 synonymous
26 200370 C T No coding sequence identified
3 94889 C T Sulfate and thiosulfate import ATP-binding protein CysA (EC 3.6.3.25)                  synonymous
43 29182 C T No coding sequence identified
5 225896 C T Aspartokinase (EC 2.7.2.4) / Homoserine dehydrogenase (EC 1.1.1.3)                    synonymous
7 65266 C T ATP-dependent Clp protease proteolytic subunit (EC 3.4.21.92)                               synonymous
10 14792 G A Phosphate acetyltransferase (EC 2.3.1.8)                                                                             synonymous
122 2192 G A Pyruvate formate-lyase (EC 2.3.1.54)                                                                                     nonsynonymous
15 104208 G A Protein involved in stability of MscS mechanosensitive channel                              nonsynonymous
  
Table S1. SNPs in different isolates of lineage A. Table containing the SNPs from lineage A, including the annotation and whether 
the animo acid change was synonymous or non-synonymous. The isolates from days 2, 9, and 16 are left out as they did not have 
any SNP differences from the representative genome of the lineage (isolated at 2d). Table continuous on next page!   
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15 115558 G A PTS system, mannitol-specific IIB component (EC 2.7.1.69) / PTS system, mann onsynonymous
17 296387 G A Purine nucleotide synthesis repressor                                                                                  synonymous
18 176760 G A Dipeptide transport system permease protein DppC (TC 3.A.1.5.2)                         nonsynonymous
18 200735 T A Glutamate transport membrane-spanning protein                                                         nonsynonymous
19 113564 G A Flagellar biosynthesis protein FlhA                                                                                        synonymous
20 29027 G A Malate synthase G (EC 2.3.3.9)                                                                                                  synonymous
21 38804 G A iron aquisition yersiniabactin synthesis enzyme (Irp2)                                                  nonsynonymous
23 7535 G A Ribose ABC transport system, ATP-binding protein RbsA (TC 3.A.1.2.1)                 synonymous
23 14472 G A No coding sequence identified
23 135025 G A 3-deoxy-D-manno-octulosonic-acid transferase (EC 2.-.-.-)                                         nonsynonymous
24 31001 G A FIG006427: Putative transport system permease protein                                             synonymous
25 1435 G A Outer membrane vitamin B12 receptor BtuB                                                                     synonymous
26 254547 T A hypothetical protein                                                                                                                    nonsynonymous
26 254550 T A hypothetical protein                                                                                                                    nonsynonymous
30 39378 G A Enterobactin synthetase component F, serine activating enzyme (EC 2.7.7.-)     nonsynonymous
32 23323 G A No coding sequence identified
32 70369 G A PhnJ protein                                                                                                                            synonymous
42 3849 G A No coding sequence identified nonsynonymous
51 23078 G A LSU ribosomal protein L4p (L1e)                                                                                               synonymous
53 1415 G A Glutamate-aspartate carrier protein                                                                                      synonymous
53 6083 G A NrfC protein                                                                                                                            synonymous
5 25753 G A Intramembrane protease RasP/YluC, implicated in cell division based on FtsL cnonsynonymous
5 103289 G A VgrG protein                                                                                                                            nonsynonymous
5 296526 G A Putative inner membrane protein                                                                                          synonymous
7 15002 G A Glucokinase, ROK family (EC 2.7.1.2)                                                                                      synonymous
7 35837 G A Nucleoside-specific channel-forming protein Tsx precursor                                       synonymous
10 41534 T C FIG00638014: hypothetical protein                                                                                         synonymous
10 155429 T C Putative metal chaperone, involved in Zn homeostasis, GTPase of COG0523 faminonsynonymous
15 25680 T C Lysophospholipid transporter LplT                                                                                         nonsynonymous
15 59616 T C Predicted oxidoreductase, Fe-S subunit                                                                               nonsynonymous
15 91830 T C 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase (EC 1.14.13.-)synonymous
15 102370 T C No coding sequence identified
17 149347 T C FIG00639292: hypothetical protein                                                                                         nonsynonymous
17 257077 T C Acyl-CoA dehydrogenase (EC 1.3.99.3)                                                                                  nonsynonymous
19 125833 T C FIG00641604: hypothetical protein                                                                                         synonymous
20 29055 T C Malate synthase G (EC 2.3.3.9)                                                                                                  nonsynonymous
20 166907 T C Integral membrane protein TerC                                                                                             synonymous
20 260128 T C Uncharacterized ABC transporter, ATP-binding protein YrbF                                       nonsynonymous
21 13870 T C hypothetical protein                                                                                                                    synonymous
24 56129 T C FIG00638818: hypothetical protein                                                                                         nonsynonymous
24 106762 T C Aspartate-semialdehyde dehydrogenase (EC 1.2.1.11)                                                  nonsynonymous
26 131738 T C DNA topoisomerase I (EC 5.99.1.2)                                                                                          nonsynonymous
27 43829 T C No coding sequence identified
30 47089 T C Isochorismate synthase (EC 5.4.4.2) of siderophore biosynthesis                             nonsynonymous
31 39231 T C Branched-chain amino acid ABC transporter, amino acid-binding protein (TC 3.nonsynonymous
32 37751 T C Lysyl-tRNA synthetase (class II) (EC 6.1.1.6)                                                                        synonymous
39 73336 T C Arylsulfatase (EC 3.1.6.1)                                                                                                             nonsynonymous
39 109139 T C Protein yifE                                                                                                                            synonymous
4 23661 T C FIG000988: Predicted permease                                                                                               nonsynonymous
56 21039 T C ATPase provides energy for both assembly of type IV secretion complex and senonsynonymous
5 61314 T C Sugar/maltose fermentation stimulation protein homolog                                         synonymous
5 85250 T C Blue copper oxidase CueO precursor                                                                                     synonymous
5 127065 T C Cell division protein FtsW                                                                                                          nonsynonymous
5 278788 T C TRAP dicarboxylate transporter, DctM subunit, unknown substrate 8                     nonsynonymous
5 324641 T C Phosphoenolpyruvate-dihydroxyacetone phosphotransferase (EC 2.7.1.121), snonsynonymous
61 31544 T C Propanediol dehydratase reactivation factor large subunit                                         nonsynonymous
61 51403 T C No coding sequence identified
7 53127 T C FIG01057005: hypothetical protein                                                                                         nonsynonymous
10 106855 A G Sensory histidine kinase AtoS                                                                                                   nonsynonymous
11 4616 A G Single-stranded DNA-binding protein                                                                                   nonsynonymous
14 17663 A G GTP-binding protein TypA/BipA                                                                                               nonsynonymous
15 15860 A G FIG004819: Prepilin peptidase dependent protein B precursor                                  nonsynonymous
15 34683 A G No coding sequence identified
16 65330 A G L-xylulose/3-keto-L-gulonate kinase (EC 2.7.1.-)                                                              nonsynonymous
17 102945 A G Cell wall endopeptidase, family M23/M37                                                                          nonsynonymous
17 117869 A G Putative amidohydrolase                                                                                                            synonymous
17 143930 A G Rtn protein                                                                                                                             synonymous
17 164143 A G Putative uncharacterized protein YeaK                                                                                 nonsynonymous
17 240500 A G Vitamin B12 ABC transporter, permease component BtuC                                           synonymous
18 227304 A G Putative membrane protein                                                                                                      synonymous
19 74778 A G oxidoreductase, aldo/keto reductase family                                                                     nonsynonymous
20 82805 A G Putative cell division protein precursor                                                                                synonymous
20 161873 A G Putative cytoplasmic protein                                                                                                    synonymous
24 48644 A G Multimodular transpeptidase-transglycosylase (EC 2.4.1.129) (EC 3.4.-.-)             synonymous
26 254549 A G hypothetical protein                                                                                                                    synonymous
28 32170 A G BarA sensory histidine kinase ( VarS  GacS)                                                                         nonsynonymous
28 53920 A G Putative electron transfer flavoprotein subunit YgcQ                                                    synonymous
28 87481 A G Formate hydrogenlyase transcriptional activator                                                             nonsynonymous
30 59369 A G LysR-family transcriptional regulator YbeF                                                                          nonsynonymous
30 134664 A G SeqA protein, negative modulator of initiation of replication                                    nonsynonymous
31 21929 A G Nickel ABC transporter, periplasmic nickel-binding protein NikA (TC 3.A.1.5.3) nonsynonymous
32 75262 A G FIG00638130: hypothetical protein                                                                                         nonsynonymous
37 18162 A G Protein yhjK                                                                                                                            nonsynonymous
39 100861 A G Threonine dehydratase biosynthetic (EC 4.3.1.19)                                                           nonsynonymous
3 158670 A G Exopolyphosphatase (EC 3.6.1.11)                                                                                           nonsynonymous
43 66383 A G Major curlin subunit precursor CsgA                                                                                      synonymous
4 86155 A G 3-oxoacyl-acyl-carrier protein reductase (EC 1.1.1.100)                                                 nonsynonymous
55 5078 A G Respiratory nitrate reductase beta chain (EC 1.7.99.4)                                                   nonsynonymous
5 230361 A G Inner membrane protein CreD                                                                                                 nonsynonymous
62 46866 A G Iron-sulfur cluster regulator IscR                                                                                             synonymous
62 59308 A G Alpha-2-macroglobulin                                                                                                                synonymous
7 2996 A G putative lipoprotein                                                                                                                    nonsynonymous
7 55881 A G Cytochrome O ubiquinol oxidase subunit IV (EC 1.10.3.-)                                             nonsynonymous
9 29805 A G Protein ydgH precursor                                                                                                                synonymous
9 31986 A G NAD(P) transhydrogenase alpha subunit (EC 1.6.1.2)                                                      synonymous
9 37980 C G Permeases of the major facilitator superfamily                                                                nonsynonymous
10 192408 C T tRNA-dihydrouridine synthase C                                                                                       nonsynonymous
10 228596 C T Scaffold protein for 4Fe-4S cluster assembly ApbC, MRP-like                                     synonymous
10 232712 C T Fimbriae usher protein StcC                                                                                                      nonsynonymous
10 300700 C T Mannose-1-phosphate guanylyltransferase (GDP) (EC 2.7.7.22) / Mannose-6-phnonsynonymous
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Table S2. Annotations for pNK29. Names in square brackets denote homologs in pOLA52. 
 
  
ORF No. Start Stop Strand Annotation
1 105 650  +  DNA distortion protein 1 [taxA]                                                                               
2 653 1819  +  IncQ plasmid conjugative transfer DNA nicking endonuclease TraR (pTi VirD2 homolog) [taxC]                    
3 2172 2690  +  actX, homologous to actX on pOLA52                                                                            
4 2620 2832  +  hypothetical protein                                                                                          
5 2865 3512  +  Peptidoglycan hydrolase VirB1, involved in T-DNA transfer  [pilx1]                                                   
6 3490 3786  +  Major pilus subunit of type IV secretion complex, VirB2   [pilx2]                                                    
7 3808 6561  +  ATPase provides energy for both assembly of type IV secretion complex and secretion of T-DNA complex (VirB4) [pilx3-4] 
8 6572 7330  +  Minor pilin of type IV secretion complex (VirB5) [pilx5]                                                             
9 7331 7618  +  IncQ plasmid conjugative transfer protein TraG                                                                
10 7627 8757  +  Integral inner membrane protein of type IV secretion complex (VirB6) [pilx6]                                          
11 8885 9013  +  pilx7, homologous to pilx7 on pOLA52                                                                          
12 9003 9716  +  Inner membrane protein forms channel for type IV secretion of T-DNA complex, VirB8 [pilx8]                          
13 9721 10650  +  Forms the bulk of type IV secretion complex that spans outer membrane and periplasm (VirB9)  [pilx9]                 
14 10647 11852  +  Inner membrane protein of type IV secretion of T-DNA complex, TonB-like, VirB10  [pilx10]                           
15 11854 12885  +  ATPase provides energy for both assembly of type IV secretion complex and secretion of T-DNA complex (VirB11) [pilx11] 
16 12888 14723  +  Type IV secretion system protein VirD4 [taxB]                                                          
17 14720 15133  +  hypothetical lipoprotein, homologous to pOLA52                                                                
18 15130 15432  +  IncN plasmid KikA protein                                                                                     
19 15533 16858  +  Phage tail fiber protein                                                                                      
20 16887 17114  +  hypothetical protein                                                                                          
21 17194 17712  +  putative nuclease                                                                                             
22 17794 19056  +  Cell division protein FtsH (EC 3.4.24.-)
23 19060 19626  +  FIG01045518: hypothetical protein                                                                             
24 19640 21793  +  DNA topoisomerase III (EC 5.99.1.2)
25 21790 21996  +  Haemolysin expression modulating protein                                                                      
26 22012 22473  +  DNA-binding protein H-NS [hns]                                                                                
27 22524 22787  +  hypothetical protein                                                                                          
28 22898 25699  -  Mobile element protein, homologous to tnpA of Tn3 pRPEC180\_47                                                                                        
29 25670 25921  +  hypothetical protein                                                                                          
30 26067 26624  +  Mobile element protein, homologous to tnpR of pRPEC180\_47 (transposon Tn3 resolvase)                                                                                       
31 26807 27667  +  Beta-lactamase (EC 3.5.2.6)
32 27814 27948  -  hypothetical protein                                                                                          
33 28012 28128  +  hypothetical protein                                                                                          
34 28432 30354  -  L. lactis predicted coding region ORF00041                                                                    
35 30398 30754  +  DNA distortion protein 3                                                                                      
36 30751 31728  -  hypothetical protein                                                                                          
37 31753 32034  -  hypothetical protein                                                                                        
38 32132 32794  -  Chromosome partitioning protein ParA [par]                                                                    
39 33175 33819  +  Resolvase [res]                                                                                           
40 33935 34114  -  hypothetical protein                                                                                          
41 34145 34264  +  hypothetical protein                                                                                          
42 34687 34803  -  hypothetical protein                                                                                          
43 35175 35429  +  hypothetical protein                                                                                          
44 36056 36724  +  L. lactis predicted coding region ORF00041                                                                    
45 36758 37204  -  bis, homologous to pOLA52 (FIG01048616: hypothetical protein)                                                 
46 37244 38080  -  pir, homologous to pOLA52                                                                                     
47 37673 38002  -  YagA protein                                                                                                  
48 38095 38310  -  FIG01048886: hypothetical protein                                                                             
49 38300 38545  -  FIG01047979: hypothetical protein                                                                             
50 38590 38913  -  FIG01047054: hypothetical protein                                                                             
51 39059 39340  -  RelE/StbE replicon stabilization toxin                                                                        
52 39330 39581  -  RelB/StbD replicon stabilization protein (antitoxin to RelE/StbE)                                             
53 39578 39751  -  hypothetical protein                                                                                          
54 40368 40499  -  hypothetical protein                                                                                          
55 40816 41652  +  PI protein                                                                                                    
56 41692 42138  +  FIG01047678: hypothetical protein
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Table S3. SNPs in the pNK29-2 plasmid of lineage A compared to pUTI89. SNPs were identified by comparing the initial 
linage A isolate (day 2) with pUTI89 (CP000244.1). 
Position pUTI89 pNK29-2 Original amino acid Amino acid change annotation 
17995 A G G 
 
hypothetical 
protein 
51718 G T D Y rsvB 
53060 C T 
   
68939 G A Q 
 
hypothetical 
protein 
69562 C T Q 
 
hypothetical 
protein 
80619 G A G D traE 
91269 T G L   trbC 
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The microbial ecosystem residing in the human gut is believed to play an important
role in horizontal exchange of virulence and antibiotic resistance genes that threatens
human health. While the diversity of gut-microorganisms and their genetic content has
been studied extensively, high-resolution insight into the plasticity, and selective forces
shaping individual genomes is scarce. In a longitudinal study, we followed the dynamics
of co-existing Escherichia coli lineages in an infant not receiving antibiotics. Using whole
genome sequencing, we observed large genomic deletions, bacteriophage infections,
as well as the loss and acquisition of plasmids in these lineages during their colonization
of the human gut. In particular, we captured the exchange of multidrug resistance
genes, and identified a clinically relevant conjugative plasmid mediating the transfer.
This resistant transconjugant lineage was maintained for months, demonstrating that
antibiotic resistance genes can disseminate and persist in the gut microbiome; even
in absence of antibiotic selection. Furthermore, through in vivo competition assays, we
suggest that the resistant transconjugant can persist through a fitness advantage in the
mouse gut in spite of a fitness cost in vitro. Our findings highlight the dynamic nature of the
human gut microbiota and provide the first genomic description of antibiotic resistance
gene transfer between bacteria in the unperturbed human gut. These results exemplify
that conjugative plasmids, harboring resistance determinants, can transfer and persists
in the gut in the absence of antibiotic treatment.
Keywords: Escherichia coli, horizontal gene transfer, infant gut, genome dynamics, plasmid transfer, in vivo
fitness, mouse models, antibiotic resistance
INTRODUCTION
The evolution of multidrug resistant bacteria through horizontal gene transfer (HGT) is resulting
in human pathogens that are no longer amenable to antibiotic therapy (Davies and Davies, 2010).
It is believed that antibiotic resistance genes are frequently exchanged between bacteria within the
human microbiome, where the intestinal bacterial community in particular is considered a hub
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for HGT (Liu et al., 2012). Transfer of antibiotic resistance genes
within the gut microbiota is believed to happen primarily via
conjugative plasmids and has been demonstrated to occur in
both animals (McConnell et al., 1991; Schjørring et al., 2008),
and humans (Lester et al., 2006; Trobos et al., 2009). Due to the
low transfer frequency, and initial instability of plasmids in the
absence of selection, previous studies have utilized experimental
set-ups where the host was inoculated with a high number of
bacteria, with subsequent monitoring to detect if the antibiotic
resistance genes had been transferred from the donor strain
(McConnell et al., 1991; Lester et al., 2006; Schjørring et al., 2008;
Trobos et al., 2009).
We and others have documented the transfer of antibiotic
resistance genes amongst naturally occurring bacteria in the
human gut microbiota, and these reports describe changes
in the antibiotic resistance profiles of strains collected from
patients undergoing antibiotic treatment (Bidet et al., 2005;
Karami et al., 2007; Conlan et al., 2014, 2016; Porse et al.,
2017). Additionally, a retrospective study examining Bacteroides
isolates, collected over a period of 40 years, demonstrated that
extensive resistance gene exchange occurred between species of
Bacteroides and other genera in the human colon (Shoemaker
et al., 2001). Yet, while the unperturbed gut microbiome has
been the subject of numerousmetagenomic studies (Balzola et al.,
2010; Huttenhower et al., 2012; Forslund et al., 2013), including
the construction of complete genomes of various species and
strains from metagenomic data (Sharon et al., 2013), the use of
metagenomics is not well-suited to detect HGT events due to
difficulties in associating mobile genetic elements with individual
genomes.
To investigate the dynamics of horizontal gene exchange
between Escherichia coli of the unperturbed gut microbiota, we
use whole genome sequencing to characterize co-existing E. coli
lineages isolated over the first year of an infant’s life. Observing
the transfer and enrichment of a conjugative antibiotic resistance
plasmid, along with subsequent genomic events, in the absence
of antibiotic treatment, we performed in vivo fitness assays
indicating that this resistance plasmid is maintained in a gut
environment despite being costly in vitro.
MATERIALS AND METHODS
Strain Isolation and Population Counts
Fecal samples were obtained from an infant enrolled in the
ALLERGYFLORA study (Nowrouzian et al., 2003). A sample
of the rectal flora was obtained using a cotton-tipped swab at
3 days after birth. The infant’s parents collected fecal samples
at 1, 2, and 4 weeks, and 2, 6, and 12 months of age.
Samples were plated on Drigalski agar plates for the isolation
of Enterobacteriaceae with a detection limit of 102.5 CFU/g
fecal matter. Each morphotype was enumerated separately, and
strain identities of the enumerated morphotypes were confirmed
using random amplified polymorphic DNA (RAPD) typing
(Nowrouzian et al., 2003). Initial confirmation of the RAPD-
typing was confirmed by pulsed-field gel electrophoresis (PFGE).
Isolated strains were subjected to complete serotyping (O:K:H)
(Statens Serum Institute, Copenhagen, Denmark).
From the 5 sampling times positive for E. coli, a total of 13
isolates were selected and stored for further analysis.
Antibiotic Susceptibility and Minimum
Inhibitory Concentration (MIC)
Determination
All isolates were tested for their susceptibility to the following
antibiotics using the disc diffusion method (Oxoid, Sweden):
ampicillin, amoxicillin/clavulanic acid, piperacillin, mecillinam,
cefadroxil, ceftazidime, cefuroxime, cefoxitin, chloramphenicol,
gentamicin, tobramycin, streptomycin, nitrofurantoin, nalidixic
acid, tetracycline, trimethoprim, and sulphonamide. From the
saved isolates, the exact MICs of one isolate per lineage per
sampling point were determined using the broth dilutionmethod
(Table S1; Wiegand et al., 2008).
Genome Sequencing
Genomic DNA from each of the 13 isolates was obtained
using the UltraClean R© Microbial DNA Isolation Kit (Mobio
Laboratories, Inc.). Sequencing was performed by Partners
HealthCare Center for Personalized Genetic Medicine
(Massachusetts, USA) or at the Novo Nordisk Foundation
Centre for Biosustainability (Lyngby, Denmark).
Sequence Analysis
Reads from each isolate were assembled using Velvet (Zerbino
and Birney, 2008). Contigs with <500 bp were filtered and
corrected by aligning reads using Bowtie2 (version 2.1.0)
(Langmead et al., 2009). Single-nucleotide polymorphisms
(SNPs) were called using SAMtools (version 0.1.19) (Li et al.,
2009), and edited using custom biopython scripts (Cock et al.,
2009). Contigs were annotated using the RAST server (Aziz et al.,
2008). SAMtools were also used to determine the number of
SNPs between isolates, where identified variants had a phred
quality score of at least 50 and >90% of the high-quality reads
as the variant. The assemblies from the following isolates where
used as references for SNP-calling: lineage A 2w2, lineage B
2m2 and lineage C 12m2. SNPs occurring in short homologous
regions after genomic deletions or acquisitions were also filtered.
BEDtools (Quinlan and Hall, 2010) was used to calculate read
coverage across genomes and thus identify acquired or deleted
genomic information. MUMmer was used to align sequences
(Khan et al., 2009). Multi-locus sequence type (MLST) groups
were determined using the database hosted at http://mlst.
warwick.ac.uk/mlst/dbs/Ecoli (Wirth et al., 2006).
Phage Identification
The PHAST phage search tool server (Zhou et al., 2011) was
used to identify possible intact phages in the contigs. In addition,
BLAST was used to identify similar previously described phages.
Phage integration sites were determined by aligning contigs
containing the flanking regions of the phage to an earlier isolate
not containing the prophage.
Plasmid Analysis
The PlasmidFinder web-service (http://cge.cbs.dtu.dk/services/
PlasmidFinder) was used to identify replicons in the assembled
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contigs and classify plasmids into incompatibility groups
(Carattoli et al., 2014). Plasmid diagrams depicting read coverage
were drawn in R via custom scripts, and plasmid ring diagrams
were drawn using BLAST Ring Image Generator (BRIG; Alikhan
et al., 2011) with the “-task megablast” option to BLAST.
Additionally, contigs belonging to plasmids (that had a copy
number greater than one) were identified based on their relative
abundance to the genome via BEDTools (Quinlan and Hall,
2010).
Genomic Deletion Verification by PCR
Based on the alignment of contigs to the genome of CFT 073
(NC_004431), flanking primers were designed to show that the
deletion in lineage A was a chromosomal excision. In addition to
show contiguity prior to the deletion, controls were included to
show the occurrence of the deletion only in the lineage A isolate
sampled at 6 months.
In Vitro Conjugation Assay
To test the ability of Lineage B to transfer the pHUSEC41-1-
like plasmid to the plasmid free Lineage A, outgrown overnight
cultures of two lineages were mixed equally and incubated for
12 h. Incubations were done at 37◦C on a solid agar surface as
well as in liquid cultures without shaking. Mating cultures were
plated on LB containing chloramphenicol and ampicillin to select
for transconjugants.
In Vitro Competition Experiments to
Assess the Fitness Costs of the
pHUSEC41-1-Resembling Plasmid
To assess fitness cost, pairwise growth competition experiments
in Davis minimal medium with 25 mg/mL glucose (DM25)
were performed using isolates of lineage A sampled at 2 weeks
and 2 months, respectively, the latter which had acquired the
plasmid closely resembling pHUSEC41-1 (Künne et al., 2012).
The experiment was performed as previously described (Enne
et al., 2005), but in brief, the two isolates were grown overnight
in nutrient broth, and then inoculated into DM25 at a dilution of
1:104 and grown for 24 h. The cultures were then mixed together
in a ratio of 1:1, and then diluted 1:100 into fresh DM25. The
serial passage step was continued for 6 days, corresponding to
∼60 generations of competition. After initially mixing the two
cultures together, and after each 24 h period, the cultures were
diluted appropriately and 100µL were added to Iso-Sensitest
plates (Oxoid, Sweden) in triplicate, with and without 50 mg/L
of ampicillin. Colonies were counted after over-night incubation
at 37◦C, where the mean number of colonies on ampicillin plates
was subtracted from the plates without ampicillin to determine
the mean number of colonies lacking the pHUSEC41-1-like
plasmids. Six replicates of the fitness experiment were conducted.
In Vivo Competitive Fitness Assays
Isolates used in the competitive fitness studies were tagged
with chloramphenicol (CamR) and kanamycin (KanR) resistance
markers, cat and aph(3′)-II genes, respectively, amplified from
cloning vectors of the pZ vector system (Lutz and Bujard, 1997):
lineage A 2w1—Cam
R, 2m—KanR, 6m1—Cam
R, and lineage C at
12m1—Kan
R. The markers were inserted into the chromosomal
araB gene of the lineage A and B strains using the Lambda Red
recombineering system of pTKRED (Kuhlman and Cox, 2010).
The following regions of homology were used for insertions into
araB: 5′- GTAGCGAGGTTAAGATCGGTAATCACCCCTTTC
AGGCGTTGGTTAGCGTT-3′ and 5′-GCCTAACGCACTGGT
AAAAGTTATCGGTACTTCCACCTGCGACATTCTGA-3′.
Previous studies have shown that the inactivation of araB is
fitness neutral in a murine model and that the CamR and KanR
markers do not significantly affect the growth of E. coli (Chen
et al., 2013; Linkevicius et al., 2016).
Female BALB/c mice (5–6 weeks old) were used in all in
vivo experiments (Charles River Laboratories, distributed by
Scanbur). All mice were pre-treated orally with streptomycin as
described previously (Lasaro et al., 2014). Briefly streptomycin
sulfate salt (Sigma-Aldrich) was added to the drinking water
at 5 g/L, along with 5 g/L of glucose to enhance taste, for
72 h followed by 24 h of fresh water (no drug or glucose)
to allow the streptomycin to be cleared from the animal’s
system prior to inoculation. No streptomycin was administered
during the course of infection. Ten mice were administered
100µL containing a 1:1 E. coli mixture by oral gavage
of the examined strains. Feces were homogenized in PBS,
serially diluted, and equal amounts were plated on LA-Cam
(25µg/ml chloramphenicol, selecting for the chromosomal
marker), LA-Kan (50µg/ml kanamycin, selecting for the
chromosomal marker) and either LA-Kan, Amp or LA-Cam,
Amp (50µg/ml kanamycin or 25µg/ml chloramphenicol, and
100µg/ml ampicillin selecting for the pHUSEC41-1 plasmid)
to determine the number of viable bacterial cells as well as
the fraction containing the pHUSEC41-1 plasmid. CFU values
were normalized per gram of tissue (CFU/g). The plasmid was
maintained stably in all competitions and conjugational transfer
between competing strains was assessed through replica-plating.
The competitive index was calculated by dividing the output on
days 2, 4, and 7 by the input on day 0.
Ethics Statement
Animal experiments were performed in accordance with national
(regulation SJVFS 2012:26) and institutional guidelines. The
Uppsala Animal Experiments Ethics Review Board in Uppsala,
Sweden approved all mouse protocols undertaken in this study
under reference no. 154/14. Animal experiments were performed
at the Swedish National Veterinary Institute (SVA) in Uppsala,
Sweden.
RESULTS AND DISCUSSION
Study Material
Our study material was selected from an infant enrolled in
the ALLERGYFLORA study, which was designed to examine
the link between the infant gut microbial colonization pattern,
over the first year of life, and the development of allergies
(Nowrouzian et al., 2003). Fecal samples were cultured for E.
coli and various colony types were assigned to specific lineages
via random amplified polymorphic DNA and enumerated
separately (RAPD; Figure 1). Sampling at 3 days and 1 week
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FIGURE 1 | Sampling and antibiotic resistance profile of the E. coli isolates. A
total of three E. coli lineages (A–C) were sampled from the infant’s intestinal
microbiota over the first year of life. Boxes indicate both the presence of the
lineages and their antibiotic resistance profile to ampicillin (Amp), piperacillin
(Pip), streptomycin (Str), and sulfamethoxazole (Sfx) at the sampling points.
Filled, boxes indicate resistant isolates, and empty boxes indicate sensitive
isolates (see Table S1 for MIC values).
yielded no E. coli isolates. Between 2 weeks and 12 months
a total of three distinct lineages were identified: A, B and C
(Figure 1). The sampling at 2 and 4 weeks after birth yielded
only colonies belonging to lineage A, which were sensitive
to all antibiotics tested (Table S1). At the 2 month sampling
time, lineage B appeared and resistance to the antibiotics:
ampicillin, piperacillin, streptomycin, and sulfamethoxazole was
measured. At this sampling time, the antibiotic resistance profile
of lineage A changed, and subsequent isolates were now resistant
to ampicillin, piperacillin, streptomycin, and sulfamethoxazole,
matching the resistance profile of lineage B. lineages A and B
were both present at the 6months sampling time with no changes
in the antibiotic resistance profile. At the 12 month sampling
time, only lineage B remained, with the addition of lineage
C, which was resistant to sulfamethoxazole. From plate-count
estimations, we observed a consistent decrease in population
numbers of E. coli in the gut of the infant over the first year of life
(Figure 2A). This is in line with the other infants enrolled in the
ALLERGYFLORA study and in parallel with the establishment
of a microbiota dominated by anaerobic bacteria (Nowrouzian
et al., 2003; Palmer et al., 2007).
Genomic Relationship of the Lineages
Isolated from the Gut
A total of 13 isolates from lineages A, B, and C were genome
sequenced with at least one isolate sequenced per lineage per
sampling point. Lineage A included two isolates from the 2 week
sampling time (2w1 and 2w2), one from 4 weeks (4w) and 2
months (2m) and two from 6 months (6m1 and 6m2) lineage B
included two isolates form 2 months (2m1 and 2m2) one from
6 months (6m) and two from 12 months (12m1 and 12m2)
and lineage C isolates included two from 12 months (12m1 and
12m2). To confirm lineage identities of the isolates, we assessed
both the number of SNPs and the amount of total genomic
content shared between lineages by comparing to the first isolate
sampled from each lineage.
Both lineages A and C had ∼90,000 single nucleotide
differences when compared to lineage B (Table S2). Interestingly,
lineages A and C were less different with an order of magnitude
fewer SNP when compared to each other; having ∼7,000 SNPs.
Similarly, when comparing the percentage of the genomic
content shared between the lineages, lineages A and C shared
between 79.7 and 82.3% in common with lineage B, whereas
lineage A and C shared at least 93.6% of the genomic content
(Table S3). While these results indicate that lineages A and C are
more closely related to each other than to lineage B, the number
of SNPs and the differences in genomic content reveal that they
are different lineages. While RAPD-typing of the isolates was
sensitive enough to successfully classify the isolates into the three
distinct lineages, MLST typing assigned both lineage A and C
isolates to ST12, whereas the lineage B isolates belonged to ST782.
Evolutionary relationships amongst the isolates within each
lineage were established based on the SNPs identified by aligning
reads to an isolate from the first time point the lineage was
sampled (Table S4). SNPs identified in isolates from lineages A,
B, and C produced consistent phylogenetic relations that show
a progression in the acquisition of SNPs; indicating that the
samples were representative clones of the lineages (Figure 2B).
Multiple Antibiotic Resistance Plasmid
Transfer in situ of the Gut in the Absence
of Antibiotic Pressure
To identify the genomic changes underlying the acquisition
of antibiotic resistance in lineage A, sequence data collected
from the sensitive isolates (2w1, 2w2, and 4w) were compared
to sequence data from the resistant isolates (2m, 6m1, and
6m2). Two non-conservative genomic mutations in the betaine
aldehyde dehydrogenase (betB) and phosphoenolpyruvate
carboxylase (pckA) genes were identified; however, these
mutations would not be expected to contribute to antibiotic
resistance. Instead, additional genetic information, totaling
90 kb, was found in the resistant lineage A isolates compared
to sensitive lineage A isolates (Figure 1). The newly acquired
genetic information had a read coverage two times greater
than the chromosome, and included conjugative transfer
genes; suggesting a newly acquired plasmid with ∼2 copies per
chromosome. Additionally, the following resistance genes were
identified: the β-lactamase blaTEM−1c, an aminoglycoside 3
′-
phosphotransferase (strA), and streptomycin phosphotransferase
(strB), as well as the dihydropteroate synthase gene (sul2),
conferring resistance to sulfonamides.
The phenotypic resistance patterns (Figure 1) suggested that
the horizontally acquired resistance was transferred from lineage
B to lineage A. Aligning reads from lineage B to the newly
acquired plasmid in lineage A resulted in 100% identity with
only one identified SNP variant. Although we cannot out rule
that the plasmid was already present in lineage A, or transferred
from other constituents of the microbiota, the high degree of
identity between the plasmids, the co-appearance of lineage B
and a matching resistance profile is consistent with lineage B
transferring its antibiotic resistance plasmid to lineage A.
Querying sequence databases yielded the clinically important
conjugative, IncI1-type pHUSEC41-1 plasmid of 91,942 bp (Grad
et al., 2013). Contigs from the isolates in this study aligned
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FIGURE 2 | Population counts and SNP evolution of co-existing E. coli lineages. (A) Fecal population counts of E. coli lineages A, B, and C at different sampling
points during the first year of life of the infant studied. Filled circles indicate the presence of the pHUSEC41-1-like antibiotic resistance plasmid. For comparison, the
mean population levels and ±1 and 2 standard deviations (SD) at the same sampling points for 272 E. coli strains isolated from 128 infants in the ALLERGYFLORA
cohort are indicated in the figure. (B) Phylogenetic trees based on the number of SNPs found in each of the isolates of lineages A and B. The gray values next to each
branch indicates the number of SNPs between isolates.
to pHUSEC41-1 resulted in 99.3% coverage of the plasmid
with an average of 99.0% identity (Figure 3). The alignment
also showed that there were no insertions in the transferred
plasmid compared to pHUSEC41-1. The pHUSEC41-1 plasmid
was initially identified in the E. coli serotype O104:H4 strain
HUSEC41 isolated from a child in Germany with hemolytic-
uremic syndrome (HUS; Künne et al., 2012). This plasmid has
additionally been found in other sequenced E. coli isolates of
different serotypes isolated from patients in France and Finland
(Grad et al., 2013); highlighting the wide dissemination of this
multiple antibiotic resistance plasmid amongst geographically
dispersed E. coli strains.
The pHUSEC41-1-Like Resistance Plasmid
Is Costly in Vitro but Beneficial in Vivo of
the Mouse Gut
Interestingly, the acquisition of the pHUSEC41-1-like resistance
plasmid by lineage A was associated with an initial steep drop
in population counts, from 1010.2 CFU/g of fecal matter in the 4
week sample to 107.8 CFU/g in the 2 month sample (Figure 2A).
To determine whether this decrease related to a fitness cost
imposed on lineage A from carrying the resistance plasmid, we
conducted pair-wise in vitro competition experiments comparing
the growth of a lineage A before and after the acquisition of
the plasmid; namely lineage A 4w and 2m isolates. In these
experiments, carriage of the plasmid incurred a cost of 6.3%
(±1.9%) per generation on lineage A. However, despite the in
vitro fitness cost of plasmid carriage, and the lack of obvious
selection, the lineage persisted in the gut for at least another
4 months; showing an increase in cell counts during this time
(Figure 2A).
We speculated that while the pHUSEC41-1-like plasmid
slowed the growth of lineage A host in vitro, these conditions
do not reflect the natural habitat of the strains and important
environmental factors might contribute to fitness advantage
of plasmid-carried genes in vivo. Therefore, to assess whether
the plasmid provided a fitness advantage in a model gut
environment, we tested the fitness of the plasmid bearing strain
in the mouse gut before and after acquisition of the plasmid.
Here we observed that the plasmid-carrying isolate out-competed
the plasmid free isolate, and that the plasmid conferred a fitness
advantage to lineage A in the mouse gut (P > 0.01; Figure 4A).
The fact that the lineage A transconjugant survived, increased
its population counts, and exhibited a fitness advantage in vivo,
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FIGURE 3 | Transfer of a plasmid mediating antibiotic resistance. Contigs
corresponding to the newly acquired plasmid were identified by analyzing
differences in the read alignment coverage before and after the change in the
resistance profile. Reads from lineage B are mapped to the acquired plasmid
contigs of A, displaying coverage depth. High coverage and identity between
the strains was observed. The acquired plasmid contigs of A were aligned to
the sequence of pHUSEC41-1.
highlights that resistance genes may more readily disseminate,
and persist in healthy individuals never treated with antibiotics,
than previously believed. However, studies examining the cost of
plasmid carriage are often performed in vitro, and disagreement
between in vitro and in vivo fitness measurements observed here,
emphasizes the importance of investigating the persistence of
antibiotic resistance in more natural settings.
While efforts have been devoted to studying the persistence
of multidrug resistance plasmids in clinical E. coli isolates (Porse
et al., 2016), our knowledge on the behavior of natural plasmids
in situ of their native environment is limited (Conlan et al.,
2014, 2016; Porse et al., 2017). While some studies show that
stable inheritance and adaptive traits are crucial for long term
plasmid survival (Simonsen, 2010), others suggest that certain
conjugative plasmids can maintain themselves if present in their
natural habitat of structured biofilms (Fox et al., 2008; Madsen
et al., 2013). A substantial portion of pHUSEC41-1 encodes
the tra genes involved in conjugative transfer. In addition to
the effect of horizontal dissemination on plasmid persistence,
conjugative transfer systems of plasmids have previously been
shown to enhance adhesion and biofilm formation; features that
may provide a survival advantage in the densely populated and
structured environment of the gut (Ghigo, 2001; Fox et al., 2008;
Madsen et al., 2013).
We tested the conjugative ability of the plasmid in vitro as well
as in vivo of the mouse gut and found that the pHUSEC41-1-like
plasmid conjugates at frequencies above 10−6 transconjugants
per donor in all the tested conditions. In the mouse gut, an
average of 10.8% of lineage A population had received the
pHUSEC41-1-like plasmid from the lineage B strain at the
final day 7 time point, indicating that the plasmid is actively
conjugating in this environment.
In addition, pHUSEC41-1 encodes numerous proteins of
unknown function that could potentially benefit its host in vivo,
but further molecular analysis would be required to elucidate
their role in plasmid persistence. However, candidate genes
mediating the in vivo selection of pHUSEC41-1 could be factors
involved in cobalamin biosynthesis (cbiX), DNA repair (impCAB;
(Runyen-Janecky et al., 1999; Bali et al., 2014)), and conjugational
transfer (tra). The CbiX protein can function as the terminal
enzyme in siroheme biosynthesis in E. coli, which is known to
aid iron utilization by its host (Bali et al., 2014). Iron is often
restricted in the human body, and the ability to exploit these
limited iron resources has been linked to increased persistence
of E. coli in vivo (Andrews et al., 2003). pHUSEC-41-1 also
harbors the imp operon, encoding an error-prone DNA repair
system, that has been linked to increased survival following
mutagenesis in a Shigella host and could similarly enhance the
survival of E. coli hosts exposed to stressful conditions of the gut
(Runyen-Janecky et al., 1999).
A Large Deletion Observed in Lineage a
Was Associated with an Increase in
Population Counts in situ
After the acquisition of the pHUSEC41-1-like plasmid, a large
deletion was detected in lineage A isolates at the 6-month
sampling point (Figure 5). The deletion totaled 100.4 kb, aligned
to a contiguous region in E. coli strain CFT 073 (NC_004431)
and PCR assays confirmed the deletion (Figure S1). Annotated
genes located in the region included iron scavenging genes,
such as the iroA gene cluster and the hemolysin activator
protein, peptide antibiotic genes microcin H47 and colicin-E1,
which target E. coli, and antigen 43, which may have a role
in adhesion (Cascales et al., 2007; Selkrig et al., 2012). Lastly,
genes involved in fatty-acid synthesis, carbohydrate, and amino
acid metabolism were also lost as a result of the deletion (See
Table S5 for a complete list). A smaller chromosomal deletion
was also identified in the lineage B 12m1 isolate (Figure 5). The
deleted region totaled 26 kb and included genes characteristic
for horizontally acquired DNA; including P fimbriae encoded by
the pap genes as well as mobile element genes (See Table S6 for
complete list).
At the 2 month sampling time, when lineage B was first
sampled, lineages A and B had roughly the same population
counts, at 107.8 and 107.7 CFU/g, respectively (Figure 2A).
However, in contrast to lineage B, the population counts of
lineage A increased by an order of magnitude at 6m. Upon
receiving a foreign plasmid, antagonistic interactions between
horizontally acquired chromosomal and plasmid factors might
lower the fitness of the host e.g., due to overlapping gene or
regulatory functions and these may be compensated through
deletions (San Millan et al., 2015; Porse et al., 2016). To assess
whether the large deletion, that occurred in lineage A between the
2 and 6 months sampling point, served as an adaptive response
for lineage A, we performed an in vivo fitness assessment in the
mouse gut between lineage A 2m and 6m, representing isolates
before and after the large deletion. We did not find a statistically
significant difference in fitness of the lineage A isolates with
and without the large deletion (Figure 4B), suggesting that the
deletion did not drive the increased population counts more than
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FIGURE 4 | In vivo competition experiments. For each experiment, 10 mice were inoculated orally with equal amounts of two strains to quantify their relative fitness in
a mouse gut environment. (A) The two lineage A isolates, with and without the pHUSEC41-1-like plasmid, were competed to assess the fitness effect of plasmid
carriage in vivo. (B) The fitness effect of the 82kb deletion in lineage A, occurring between the 2 and 6 month time points, was hypothesized to be advantageous, but
no significant fitness increase was measured for the deletion-isolate. (C) Lineage C was competed against the 6 months lineage A isolate to assess the potential role
of lineage C in the disappearance of lineage A. Competitive indexes were analyzed relative to day 2 using the non-parametric Mann–Whitney U-test with a P < 0.05
considered significant and the degrees of statistical significance presented as **P < 0.01 or *P < 0.05.
FIGURE 5 | Overview of lineage genome dynamics. The transfer of a multidrug resistance plasmid from lineage B to lineage A occurred prior to the 2 month sampling
time. The transfer occurred before diversification of the A lineage. At the 6 month sampling point, a Bcep-mu like phage infecting the B lineage was detected. In
addition, both the A and B lineages were infected by lambda-like phages at this time point. A large genomic deletion occurred in the A lineage after the 2 month but
before the 6 month sampling point. No isolates of lineage A were obtained at the final sampling time at 12 months, but a new isolate from lineage C is sampled along
with lineage B.
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plasmid carriage in itself. As samples were not obtained between
the 2m and 6m time points, and a Lambda-like phage infection
also occurred within this time-span, a potential beneficial effect
of the deletion could be outweighed by the subsequent phage
acquisition. Just as acquisition of plasmid DNA can alter cell
homeostasis, features of the acquired plasmid such as conjugation
are known to induce the SOS response, which can increase the
rate of genome rearrangements (Baharoglu and Mazel, 2014).
Incoming Lineage C Shares an IncX
Plasmid with Lineage B and Establishes in
the Gut despite Inferior Fitness in in Vivo
Experiments
Lineage Cwas sampled for the first time at the final 12m sampling
time point. As the related lineage A was not sampled at this
time and the counts of lineage B were the lowest sampled,
we hypothesized that lineage C could be superior in terms
of its ability to survive and compete in the gut. Therefore,
we performed an in vivo fitness assessment in the mouse gut
between the previously most abundant lineage A 6m and lineage
C 12m strains. We found, in contrast to our hypothesis, that
the lineage A 6m isolate out-competed the lineage C isolate in
the mouse gut (P < 0.05; Figure 4C). Although the fitness of
E. coli lineages is likely to vary between the human and mouse
intestine, this result indicates that other factors of the complex
gut environment not related to the appearance of lineage C, such
as interactions with the remaining constituents of the microbiota
or phage predators, may have played a more prominent role in
the disappearance of lineage A. In addition, lineage C harbored a
plasmid of 35.8 kbp, termed pNK117-2, which contained the pilx
conjugation system similar to that of pOLA52 (Norman et al.,
2008; Figure S2). Interestingly, pNK117-2 had 100% similarity to
a plasmid from lineage B and might have been transferred from
lineage B to lineage C. While we cannot demonstrate a second
in situ transfer event, as we did not sample lineage C previously
without pNK117-2, the presence of pNK117-2 in both lineage
B and C with 100% sequence identity further exemplifies how
plasmids can experience rapid dissemination in the absence of
obvious selection.
CONCLUSIONS
This work highlights the advantages of studying the longitudinal
dynamics of co-existing bacterial lineages in the gut microbiota
as a complement to metagenomic sequencing efforts. The power
of this approach is expected to increase as cultivation methods
for representative sampling of the gut microbiota improves
further, and we anticipate that studies augmenting metagenomic
sequencing with genomic sequencing and in vivo fitness models
will provide a richer and more detailed view of the highly
dynamic nature of individual genomes and HGT in the human
gut microbiota. The substantial genome plasticity captured in
this study highlights the dynamic nature of individual genomes
of the gut microbiota. Of particular interest, we identify the
transfer of a multi-drug resistance plasmid at the genomic
level between co-existing bacterial lineages in the unperturbed
human gut. Our findings suggest that, even though antibiotic
resistance genes are not considered beneficial in the absence of
antibiotic selection, they may hitchhike along with other selected
traits. Further studies investigating the molecular mechanisms
responsible for host compatibility and persistence of endemic
antibiotic resistance plasmids in situ will refine our knowledge
on the existence conditions of mobile elements, which will allow
a better understanding of their role in the epidemiology and
evolution of pathogenic bacteria.
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Figure S1 | Large deletion in the genome of lineage A. Contigs from strain A were
aligned to reference genome CFT073. Dark gray colored contigs represent regions
flanking the excision. Pale colored contigs represent the region lost due to the
deletion. Arrows indicate the position of the primers designed based on the
CFT073 genome used to confirm the genomic excision.
Figure S2 | Plasmid map of pHK117-2. Plasmid NK117-2 identified in both
lineage B and C compared to IncX1 plasmids pRPEC180_47 (middle ring, blue)
and pOLA52 (outer ring, green). Open reading frames (ORFs) identified on
pNK117-2 are drawn in the inner most ring in black, with arrows indicating the
reading direction. Annotations for selected ORFs are labeled outside of the rings.
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Table S1 | Antibiotic susceptibility tests of selected isolates. MIC values of
lineages A, B, and C for sampling time points. One isolate per lineage per
sampling time was selected for MIC testing.
Table S2 | SNP comparison lineage A and B. Number of SNPs between
the lineages using selected isolates. The rows of the table indicate the
reads that were used aligned to contigs of the isolate as indicated in
the column.
Table S3 | SNP comparison lineage A and C. Coverage of the total genomic
content between the lineages using selected isolates. The rows of the table
indicate the reads that were used aligned to contigs of the isolate as indicated in
the column.
Table S4 | Within lineage SNPs. Table containing the SNPs from lineage A, B, and
C, respectively, including the annotation and whether the amino acid change was
synonymous or non-synonymous.
Table S5 | Deleted genes from Linage A. List of annotated genes identified in the
deleted chromosomal region of lineage A.
Table S6 | Deleted genes from Linage B. List of annotated genes identified in the
deleted chromosomal region of lineage B.
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Figure S1. Large deletion in the genome of lineage A. Contigs from strain A were aligned to reference genome CFT073. Dark 
gray colored contigs represent regions flanking the excision. Pale colored contigs represent the region lost due to the 
deletion. Arrows indicate the position of the primers designed based on the CFT073 genome used to confirm the genomic 
excision. 
 
Figure S2. Plasmid map of pHK117-2. Plasmid NK117-2 identified in both lineage B and C compared to IncX1 plasmids 
pRPEC180_47 (middle ring, blue) and pOLA52 (outer ring, green). Open reading frames (ORFs) identified on pNK117-2 are 
drawn in the inner most ring in black, with arrows indicating the reading direction. Annotations for selected ORFs are 
labeled outside of the rings. 
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Table S1. Antibiotic susceptibility tests of selected isolates. MIC values of lineages A, B, and C for sampling time points. One 
isolate per lineage per sampling time was selected for MIC testing. 
Lineage              Lineage A                 Lineage B                              Lineage C       
Sampling Time       2w1  4w          2m         6m1 2m1  6m     12m1 12m1 
Antibiotic (ug/mL)                                                                               
Ampicillin          2 2 512 512 512 512 512 2 
Piperacillin        1 1 64 64 32 32 32 0.5 
Mecillinam          0.125 0.125 1 1 1 1 0.5 0.125 
Ceftazidime         0.25 0.25 0.25 0.25 0.0625 0.125 0.125 0.125 
Cefuroxime          8 8 8 8 2 4 2 2 
Cefoxitin           2 4 4 4 8 4 8 2 
Chloramphenicol     1 1 1 1 1 1 1 1 
Gentamicin          0.5 0.5 0.5 0.5 1 1 1 1 
Tobramycin          0.25 0.25 0.5 0.125 0.5 0.25 0.5 0.5 
Streptomycin        2 2 64 128 128 128 128 4 
Nalidixic Acid      1 1 1 1 1 0.5 1 0.5 
Tetracycline        0.5 0.5 0.5 0.5 1 1 0.5 1 
Trimethoprim        4 4 2 4 0.125 0 0.125 0.125 
Sulfamethoxazole    8 16 1024 1024 512 1024 1024 512 
 
 
Table S2. SNP comparison lineage A and B. Number of SNPs between the lineages using selected isolates. The rows of the 
table indicate the reads that were used aligned to contigs of the isolate as indicated in the column. 
 
             Aligned to contigs from 
      Lineage A   Lineage B   Lineage C  
                                         2w2 2m2 12m2 
Reads from                Lineage A 2w2               94346 7324 
                          Lineage B 2m2   95215              94797 
                          Lineage C 12m2  7297 92100              
 
Table S3. SNP comparison lineage A and C. Coverage of the total genomic content between the lineages using selected 
isolates. The rows of the table indicate the reads that were used aligned to contigs of the isolate as indicated in the 
column. 
              Aligned to contigs from   
     Lineage A   Lineage B   Lineage C  
                                     2w2   2m2   12m2 
Reads 
from              
 A 2w2              80.0% 93.6% 
                       B 2m2 82.3%              82.0% 
                       C 12m2 95.5% 79.7%           
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Table S4. Within lineage SNPs. Table containing the SNPs from lineage A, B, and C, respectively, including the annotation 
and whether the amino acid change was synonymous or non-synonymous. 
Lineage A 
        Contig 
number  
 
Position   2w2  2w1   4w   2m  6m1  6m2   Annotation                                      AA Change         
5 27035  A                     G    G    G          G                                                                         
7 282598  G                          A                          Formate hydrogenlyase subunit 2              No 
32 38337  A                          C                          Betaine aldehyde dehydrogenase  Yes 
13 108313  C                          T                          Phosphoenolpyruvate carboxylase  Yes 
12 157912  G                               A                     Putative inner membrane protein               No 
52 28325  C                               A                     Protein fdrA                                   Yes 
239 107  T                               C                                                                                    
93 2581  T                                          C                                                                         
8 11719  G                                          T          type 1 fimbriae (FimD) Yes 
Lineage B 
        Contig 
number   Position   2m2   2m1   6m  12m1  12m2   Annotation                                                AA Change         
12 273551  T                     A                            Putative amidohydrolase                       Yes 
20 13798  T                     A                           
 FIG00639301: hypothetical 
protein                                                        Yes 
590 436  G                     A                            Phage major tail tube protein               No 
91 20935  G                     A                            Alcohol dehydrogenase  Yes 
709 463  G                     A                                                                                                Yes 
141 121  T                     C                                                                                                Yes 
64 121  T                     C                                                                                                Yes 
237 2376  C                     G                           
 IncF plasmid conjugative transfer 
pilin  TraA                                                   Yes 
37 40257  A                     G                           
 LysR family transcriptional 
regulator lrhA                                            No 
389 490  T                     G                            Phage capsid scaffolding protein          Yes 
56 41072  T                     G                           
 Dipeptide transport system 
permease  DppB                    Yes 
58 4945  A                     G                                                                                                Yes 
24 63963  A                     T    T           T          
 Oligopeptide transport system 
permease  OppB                                      Yes 
28 44283  C                     T                           
 Fe2+-dicitrate sensor, membrane 
component                                                Yes 
35 41468  A                     T                            C-terminal domain of CinA type S         Yes 
511 121  C                     T                           
 Adenine-specific 
methyltransferase                                    Yes 
63 19848  A                     T                           
 Type III secretion inner membrane 
protein  Yes 
593 514  C                     T                                                                                                Yes 
778 418  G                     T                                                                                                Yes 
36 2740  T                          A           A           Chaperone protein DnaK                       Yes 
37 78302  T                          A           A           Putative transporting ATPase                Yes 
50 33170  C                          A                       Putative vimentin                                    Yes 
80 12348  G                          A                       D-Galactonate repressor DgoR                 Yes 
12 327228  G                          A                                                                                           Yes 
42 91228  G                          C           C          
 FUSARIC ACID RESISTANCE 
PROTEIN FUSB/FUSC                                Yes 
18 98805  A                          T           T          
 N-succinyl-L,L-diaminopimelate 
desuccinylase                                         Yes 
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Lineage C 
     Contig number   Position  12m1 12m2  Annotation      AA Change 
35 132  T                   C          
      Table S5. Deleted genes from Linage A. List of annotated genes identified in the deleted chromosomal region of lineage A. 
Category   Annotated genes  
Fatty Acid Synthesis                     (3R)-hydroxymyristoyl-[ACP] dehydratase (EC 4.2.1.-)  
 
 3-hydroxydecanoyl-[ACP] dehydratase (EC 4.2.1.60)                                                    
 
3-oxoacyl-[ACP] reductase (EC 1.1.1.100)                                                                         
 
3-oxoacyl-[ACP] synthase                                                                                                    
 
3-oxoacyl-[ACP] synthase (EC 2.3.1.41) FabV like                                                           
 
Acyl carrier protein                                                                                                                
 
Acyl carrier protein (ACP1)                                                                                                  
 
FIG002571: 4-hydroxybenzoyl-CoA thioesterase domain protein                               
 
FIG018329: 1-acyl-sn-glycerol-3-phosphate acyltransferase                                         
 
FIG143263: Glycosyl transferase / Lysophospholipid acyltransferase                        
 
FIGfam138462: Acyl-CoA synthetase, AMP-(fatty) acid ligase                                      
Carbohydrate and Amino 
Acid Metabolism  D-galactarate dehydratase (EC 4.2.1.42)                   
 
D-galactarate dehydratase (EC 4.2.1.42)                                                                           
 
Tagatose-6-phosphate kinase AgaZ (EC 2.7.1.144)                                                          
 
Putative O-methyltransferase                                                                                            
 
Aspartate aminotransferase (EC 2.6.1.1)                                                                          
 
2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase I alpha                 
Iron Scavenging                             Glycosyltransferase IroB                                  
 
ABC transporter protein IroC                                                                                              
 
Trilactone hydrolase IroD                                                                                                    
 
Periplasmic esterase IroE                                                                                                    
 
Outer Membrane Siderophore Receptor IroN                                                                
 
Hemolysin activator protein precursor                                                                             
 
Heme utilization or adhesion of ShlA/HecA/FhaA family                                              
Bacteriocins and Virulence         antigen 43 precursor                                      
 
Colicin-E1                                                                                                                               
 
mannose-specific adhesin FimH                                                                                         
 
 microcin H47 secretion/processing ATP-binding  mchF                                               
 
MchC protein Putative F1C and S fimbrial switch Regulatory protein                        
 
type 1 fimbrae adaptor subunit FimF                                                                               
 
type 1 fimbriae anchoring protein FimD                                                                          
 
type 1 fimbriae major subunit FimA                                                                                   
 
type 1 fimbriae protein FimI2C                                                                
 
YeeV toxin protein                                                                                                                
Other    Transposase   (X4)                                            
 
Putative Transposase                                                                                                           
 
Mobile element protein                                                                                                      
 
Integrase IS, phage, Tn: Transposon-related functions                                                 
  Putative metal chaperone, involved in Zn homeostasis                                                 
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entry exclusion protein 2                                                                                                    
 
membrane: Transport of small molecules (Cations)                                                      
 
FIG021862: membrane protein, exporter                                                                         
 
FIG027190: Putative transmembrane protein                                                                  
 
putative membrane protein     (X2)                                                                                   
 
putative secretion permease                                                                                              
 
putative regulatory protein                                                                                                
 
NgrB                                                                                                                                        
  RNA-Arg-TCT                                                                                                                       
 
 
Table S6. Deleted genes from Linage B. List of annotated genes identified in the deleted chromosomal region of lineage B. 
Category   Annotated genes  
Virulence  putative regulator PapX protein 
 
PapG protein 
 
PapF protein 
 
PapE protein 
 
Fimbrial adapter papK precursor 
 
Periplasmic fimbrial chaperone 
 
Fimbriae usher protein StfC 
 
minor pilin subunit PapH 
 
major pilin subunit PapA 
 
PapI protein 
Iron 
Scavenging   TonB-dependent receptor 
Other   Mobile element protein (X9) 
 
 conserved hypothetical protein; putative exported protein 
 
 hypothetical protein (X4) 
 
 FIG00638040: hypothetical protein 
 
FIG00638658: hypothetical protein 
 
FIG00640659: hypothetical protein 
 
FIG01070050: hypothetical protein 
  FIG00641173: hypothetical protein 
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Abstract
Large conjugative plasmids are important drivers of bacterial evolution and contribute significantly to the dissemination
of antibiotic resistance. Although plasmid borne multidrug resistance is recognized as one of the main challenges in
modern medicine, the adaptive forces shaping the evolution of these plasmids within pathogenic hosts are poorly
understood. Here we study plasmid–host adaptations following transfer of a 73 kb conjugative multidrug resistance
plasmid to naı¨ve clinical isolates of Klebsiella pneumoniae and Escherichia coli. We use experimental evolution, mathe-
matical modelling and population sequencing to show that the long-term persistence and molecular integrity of the
plasmid is highly influenced by multiple factors within a 25kb plasmid region constituting a host-dependent burden. In
the E. coli hosts investigated here, improved plasmid stability readily evolves via IS26mediated deletions of costly regions
from the plasmid backbone, effectively expanding the host-range of the plasmid. Although these adaptations were also
beneficial to plasmid persistence in a naı¨ve K. pneumoniae host, they were never observed in this species, indicating that
differential evolvability can limit opportunities of plasmid adaptation. While insertion sequences are well known to
supply plasmids with adaptive traits, our findings suggest that they also play an important role in plasmid evolution by
maintaining the plasticity necessary to alleviate plasmid–host constrains. Further, the observed evolutionary strategy
consistently followed by all evolved E. coli lineages exposes a trade-off between horizontal and vertical transmission that
may ultimately limit the dissemination potential of clinical multidrug resistance plasmids in these hosts.
Key words: clinical isolates, antibiotic resistance, horizontal gene transfer, ESBL plasmid evolution, IS26 restructuring,
experimental evolution.
Introduction
Conjugative plasmids are key contributors to horizontal gene
transfer and carry a wide variety of accessory genetic elements
important for the ecology and adaptation of bacterial species
(Frost et al. 2005; Norman et al. 2009; Soucy et al. 2015). The
role of plasmids in the dissemination of antibiotic resistance is
increasingly worrisome for human health; allowing patho-
genic bacteria to obtain multiple resistance genes in a single
transfer event (Carattoli 2013). Indeed, strains of Klebsiella
pneumoniae and Escherichia coli carryingmultidrug resistance
plasmids are currently recognized as one of the most urgent
antibiotic resistance problems (WHO 2014). In these strains,
plasmids encoding carbapenemases and extended spectrum
b-lactamases (ESBLs) are of particular concern because they
greatly limit effective treatment options (Davies and Davies
2010; Dhillon and Clark 2012).
Currently, the abundance and persistence of large plasmids
in competitive environments with little or no selection pres-
sure remains an evolutionary puzzle (Simonsen 1991;
Bergstrom et al. 2000). While the range of hosts in which
plasmids can successfully replicate is fairly well understood
(Mazodier and Davies 1991; Carattoli 2009; Jain and Srivastava
2013), our knowledge of the influence of different host back-
grounds on the long-term stability and evolution of natural
plasmids remains limited. A number of studies have demon-
strated that plasmids confer a cost upon entering a naı¨ve host
and that this can be compensated through adaptive evolu-
tion (Bouma and Lenski 1988; Dahlberg and Chao 2003;
Dionisio et al. 2005; Harrison and Brockhurst 2012).
Furthermore, recent studies have used next-generation
sequencing to investigate the genetic basis underlying such
plasmid–host adaptations (Sota et al. 2010; Harrison and
Brockhurst 2012; San Millan et al. 2014; Harrison et al. 2015;
Loftie-Eaton et al. 2015; San Millan et al. 2015). In the case of
small nonconjugative plasmids, plasmid–host adaptations
have been shown to occur via mutations in the plasmid
replication machinery (Sota et al. 2010), in chromosomal
genes interacting with replication proteins (San Millan et al.
2015) or by acquisition of stabilizing traits via interplasmid
transposition (Loftie-Eaton et al. 2015). For plasmid–host
evolution of a conjugative mercury-resistance plasmid to
Pseudomonas fluorescens, adaptation occurred via transla-
tional down regulation caused by inactivation of a host-
encoded two-component system (Harrison et al. 2015).
However, less effort has been made to study the dynamics
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and adaptation of large multidrug resistance plasmids in the
bacterial hosts they are likely to encounter in a clinical
environment.
Here, we investigate the molecular basis for adaptations of
a large plasmid, isolated from a clinical K. pneumoniae strain,
to naı¨ve clinical isolates of E. coli and K. pneumoniae; two
species highly implicated in plasmid mediated dissemination
of multidrug resistance. To determine the factors implicated
in the long-term plasmid survival, we characterize the influ-
ence of the plasmid on maximum growth rate, overall stabil-
ity, and evolutionary potential as well as genetic adaptations
in three novel plasmid–host combinations (fig. 1). We
observe a consistent and rapid adaptation pattern in E. coli
that is dependent on plasmid-borne insertion sequences (ISs)
and driven by the cost a plasmid region encompassing the
main conjugational machinery. We are the first to describe
the role of IS mediated intramolecular restructuring in plas-
mid host-expansion and how these reactions, although
broadly beneficial, were only observed in certain host
backgrounds.
Results
The pKP33 plasmid (fig. 2) was obtained from a K. pneumo-
niae clinical host (Kp33) and sequenced using Pacific
Biosciences RS II single molecule real time sequencing as
well as Illumina MiSeq technology. While the short reads
(150 bp) obtained from the paired-end Illumina MiSeq
run were not sufficient to capture the complex repetitive
nature of the pKP33 plasmid, such as the localization and
orientation of identical mobile genetic elements, the longer
reads offered by single molecule real time sequencing enabled
complete assembly of the plasmid.
The sequence of pKP33 revealed that it belongs to the
IncN incompatibility group. Although IncN plasmids are
able to replicate in a variety of enterobacterial pathogens,
they are most frequently observed in E. coli and K. pneumo-
niae isolates where backbones similar to pKP33 contribute to
the global dissemination of cephalosporin and carbapenem
resistance (Miriagou et al. 2010; Eikmeyer et al. 2012; Carattoli
2013; Conlan et al. 2014). pKP33 carries eleven antibiotic
resistance genes including the endemic CTX-M-15 ESBL var-
iant (Bush and Fisher 2011). These genes confer resistance to
multiple major drug classes including b-lactams (CTX-M-15,
TEM-1, OXA-1), aminoglycosides (aac-(60)-III, aac(60)-lb and
strA, strB), quinolones (qnrB), sulfonamides (sul2) and dihy-
drofolate reductase inhibitors (folA). These were functionally
confirmed by antibiotic susceptibility testing (supplementary
table S1, Supplementary Material online). To support stable
maintenance, pKP33 contains the stb operon known to
encode factors involved in active segregation and regulation
of conjugative transfer (Guynet et al. 2011). In addition, an
ecoRII-dcm restriction–antirestriction pair may function as a
toxin–antitoxin stability system by inhibiting growth of
plasmid-free segregants (Mruk and Kobayashi 2014). The
plasmid backbone shows a typical mosaic structure where
functionally similar gene clusters are flanked by mobile
genetic elements. In pKP33, the IS6 and Tn3 family of ISs
were highly abundant; exemplified by several occurrences of
identical IS26 copies throughout the backbone.
Initial stability of pKP33 in the original K. pneumoniae host
(Kp33) was investigated by serial passaging in the laboratory
for 35 days in the absence of antibiotic selection (supplemen
tary fig. S1, Supplementary Material online). We estimate,
based on the transfer volumes and maximum culture density
that this period corresponds to approximately 280 bacterial
generations. Remarkably, plasmid loss was never detected for
pKP33 in its native host, emphasizing that large plasmids
carrying multiple antibiotic resistance genes can persist for
extended time periods without selection given the right host
environment.
Three clinical strains that did not carry multidrug resist-
ance plasmids (naı¨ve) were obtained to investigate their
response to acquisition of pKP33. The E. coli isolates Ec37
(ST127) and Ec38 (ST1170) originate from clinical UTIs,
belong to the B2 E. coli phylogroup, and share 80% of their
protein families. The naı¨ve Kp08 (ST36) K. pneumonia strain
shares 54% of its protein families with both E. coli strains and
83% with the original pKP33 plasmid ancestor Kp33 (ST301).
FIG. 1. Experimental overview. A large conjugative plasmid (pKP33) originating from a clinicalKlebsiella pneumoniae isolate (Kp33)was transferred
by conjugation into two different Escherichia coli (Ec37 and Ec38) strains and one K. pneumoniae (Kp08) strain isolated from urinary tract
infections (UTIs) and blood infections, respectively. Quantification of the growth rate and plasmid stability was done immediately after plasmid
acquisition (Day 0) as well as following 35 days of serial transfer in plasmid-selective conditions (Day 35—evolved strains). The genome sequences
of the evolved strains were analyzed to determine the genetic adaptations involved in plasmid–host adaptations.
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Additional information on these strains can be found in
table 1 and the full proteome comparison is summarized in
supplementary table S2, Supplementary Material online.
Plasmid Cost and Stability in pKP33-Naı¨ve Clinical
Isolates
While pKP33 was stably maintained in its native host strain in
the absence of selection, this is likely a result of long-term co-
evolution. To study the processes that contribute to plasmid
success in new hosts, we set out to investigate the stability of
pKP33 in naı¨ve clinical E. coli and K. pneumoniae strains. We
transferred pKP33 by conjugation to one K. pneumoniae
(Kp08) and two E. coli (Ec37 and Ec38) clinical isolates (see
table 1). To characterize the influence of the host strain on
the cost of pKP33 carriage we measured the maximum
growth rate as a fitness proxy for UTI pathogens
(Gordon and Riley 1992; Nilsson et al. 2003). The plasmid
imposed a significant burden on all three strains quantified
as a reduction in growth rate of 6%, 11%, and 12.5% for Kp08,
Ec37, and Ec38, respectively, compared to the plasmid-free
ancestor (one-sample t-test. Ec38: P< 0.001; Ec37: P< 0.001;
Kp08: P< 0.001) (fig. 3). While there was no significant differ-
ence in relative growth rate between Ec37/pKP33 and Ec38/
pKP33 (two-sample t-test P¼ 0.3), the burden imposed by
pKP33 on the Kp08 K. pneumoniae strain was significantly
lower than for the E. coli isolates (two-sample t-test Ec38:
P¼ 0.0034; Ec37: P¼ 0.01), implying that host specific factors
influence the fitness cost of the newly acquired plasmid.
Due to the presence of various plasmid borne stability
systems, pKP33 might persist in spite of the burden imposed
on naı¨ve hosts. To investigate the stability of pKP33 in the
naı¨ve strains, serial passaging of five lineages of each strain in
nonselective medium was carried out for 35 days, corre-
sponding to 280 generations of growth (fig. 4A, triangles).
The stability of pKP33 differed between the isolates with
the naı¨ve Kp08 K. pneumoniae strain being the most stable
(50% plasmid-free cells after 12.5 days) and E. coli the least
stable (50% plasmid-free cells after 2.5 and 6 days for Ec37 and
Ec38, respectively) (fig. 4B). Notably, while still detectable in all
Ec37 and Kp08 populations, pKP33 was present in less than
FIG. 2. Genetic map of the pKP33 ESBL plasmid originating from the clinical Kp33 strain. The plasmid belongs to the IncN incompatibility group
and contains accessory genes (orange) involved in metabolism and antibiotic resistance along with several stability mechanisms (blue) and
conjugational transfer machinery (green). Three b-lactamases, including the endemic CTX-M-15 ESBL, are encoded by the plasmid along with
several other antibiotic resistance genes. Furthermore, the plasmid is sectioned by a number ofmobile genetic elements (purple) dominated by the
IS26 insertion sequence (dark purple) as well as predicted genes that encode proteins of unknown function (yellow).
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1% of the population for all three hosts after 35 days of serial
passaging, demonstrating that these new plasmid–host com-
binations are markedly less stable compared to the original
pKP33 host (supplementary fig. S1, Supplementary Material
online).
In order to gain insight into the origin of the observed
instability, we fitted an established mathematical model of
plasmid stability to the measured plasmid stability data
(Proctor 1994). This model describes the ratio of plasmid
bearing to plasmid-free cells as a function of time and
assumes the rate of plasmid loss upon cell division and the
difference in growth rate between the plasmid bearing and
plasmid-free cells as the main drivers of plasmid dynamics
(equation 1—Materials and Methods). We did not include a
parameter for conjugative transfer as pKP33 displayed negli-
gible rates of conjugation in our liquid setup (see supplemen
tary table S3, Supplementary Material online), which is in
agreement with previous studies of IncN plasmid transfer
systems (Bradley et al. 1980). The parameter estimates (see
supplementary table S4, Supplementary Material online) for
segregational loss ranged from 0.0008 to 0.0147 and due to
uncertainty of the estimates, these were not significantly dif-
ferent from 0 for Ec37 and Ec38 (one-sample t-test, P¼ 0.13
and P¼ 0.45 for Ec37 and Ec38, respectively) but only for
Kp08 (one-sample t-test, P¼ 0.0013). This indicates that
the influence of the segregational loss rate on overall plasmid
stability is minor compared to the effect of growth competi-
tion from plasmid-free segregants. Consistent with the
growth rate reduction imposed by the plasmid (fig. 3), the
fitness cost of pKP33 predicted by the model was statistically
significant for all three strains (one-sample t-test; P¼ 0.0054,
P¼ 0.00019, and P¼ 0.012 for Ec37, Ec38, and Kp08, respec-
tively) and determined to be 8.3% (64.14%), 14% (62.85%),
and 4.6% (62.94%) for Ec37, Ec38, and Kp08, respectively.
These estimates of plasmid fitness costs correspond well
with the relative growth rates measured and confirm that
the main driver of plasmid loss was competition between
plasmid-bearing and plasmid-free segregants.
Adaptive Evolution during Antibiotic Selection
Compensates Plasmid Cost in E. coli but not
K. pneumoniae
Based on the plasmid stability experiments without selection,
it seems unlikely that pKP33 can be stably maintained even in
strains closely related to the original host (fig. 4 and supple
mentary table S2, Supplementary Material online). However,
in clinical settings, plasmid transfer and subsequent host
adaptation is likely promoted by selection for plasmid-
encoded functions such as antibiotic resistance. In the pres-
ence of antibiotic selection pKP33 would confer a strong
fitness advantage to an antibiotic sensitive host cell
(supplementary table S1, Supplementary Material online).
Such periods of selection can provide sufficient time for
plasmid–host adaptations to occur, improving plasmid per-
sistence once selection is removed (San Millan et al. 2014).
To investigate plasmid–host adaptation during positive
selection, we repeated the serial transfer experiment in liquid
medium containing cefuroxime (16 mg/ml) selecting for
pKP33 carriage. Five lineages of each host carrying the
FIG. 3. Growth rate effects of novel plasmid acquisition. Plasmid
acquisition leads to a reduction in maximum growth rate relative
to the plasmid-free ancestor. Error bars show 95% confidence inter-
vals of 16 pKP33 carrying biological replicates error propagated with
the variation of 16 biological replicates of the plasmid-free ancestor.
Asterisks indicate significant differences (P< 0.05) and NS a nonde-
tectable difference (P> 0.05).
Table 1. Strains and Plasmids. Clinical isolates were obtained from the Department of Clinical Microbiology at Hvidovre Hospital (Hvidovre,
Denmark).
Strain or Plasmid Designation Characteristics and Comments Reference or Source
Escherichiacoli TOP10 TOP10 Conjugation donor similar to DH10B (leucine auxotroph) Invitrogen
Escherichia coli DY329 DY329 Used for recombineering. W3110 derivative with the geno-
type: DlacU169 nadA:Tn10 gal490 kcI857 D(cro-bioA)
Yu et al. (2000)
Klebsiella pneumoniae CI ESBL 33 Kp33 ST*: 301; Chromosomal bla: SHV27; Plasmids: pKP33 Clinical isolate (urine)
ESBL plasmid from Kp33 pKP33 Size: 67kb; IncN; Resistance genes: TEM-1, OXA-1, CTX-M 15,
strA,strB, aac(60)lb-cr, aac(3)-Iia, qnrB, sul2, folA
Clinical plasmid
Escherichia coli CI 37 Ec37 ST*: 127, Phylogroup: B2*; Resistance profile: None; Plasmids
replicons*: FII (61 kb)
Clinical isolate (urine)
Escherichia coli CI 38 Ec38 ST*: 1170, Phylogroup: B2*; Resistance profile: chloramphe-
nicol; Plasmids replicons*: FIB (9.5 kb) & FIC (136 kb)
Clinical isolate (urine)
Klebsiella pneumoniae CI 08 Kp08 ST*: 36; Resistance genes: fosA, SHV11, oqxB, oqxA;Plasmids
replicons*: FIB(K) (22kb) & IncR (90 Kb)
Clinical isolate (blood)
NOTE.—Asterisks indicate computationally derived information obtained through the CGE Servers (MLST, PlasmidFinder and ResFinder available at: https://cge.cbs.dtu.dk/
services, last accessed August 8, 2016).
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pKP33 plasmid were evolved in parallel and the growth rates
of individual clones from the evolving populations were
measured throughout the 280 generations of the experi-
ment and growth rates were normalized to the plasmid-free
host grown in parallel to account for the effect of general
medium adaptations (fig. 5. See supplementary fig. S2,
Supplementary Material online for absolute values).
A significant increase in relative growth rate was observed
for both E. coli carrying pKP33 when comparing the starting
point (Day 0) to the evolved endpoint (Day 35) (two-sample
t-test: Ec38: P¼ 0.00215, n¼ 10; Ec37: P¼ 0.0154, n¼ 10). At
the end of the adaptation experiment the average evolved
Ec38/pKP33 lineage, now referred to as Ec38/pKP33D. 35, was
indistinguishable from the plasmid-free host (one-sample
t-test: P¼ 0.186, n¼ 5) . In contrast, the K. pneumoniae strain
did not experience a significant improvement during the
experiment (two-sample t-test: P¼ 0.380, n¼ 10).
Our growth rate measurements and stability assays (figs. 4
and 5) revealed that a less costly plasmid–host combination is
more stable on the population level. To test whether the
stability of the evolved plasmid–host combinations were
higher than for the nonevolved ancestors, plasmid stability
was measured again by serial passaging in nonselective
medium for 35 days or roughly 280 bacterial generations
(fig. 4A, circles). A pronounced improvement in the stability
of the evolved E. coli lineages was evident from the
much slower decline in the proportion of plasmid-bearing
cells over time compared to the stability of the nonevolved
lineages (fig. 4B). The strains evolved under antibiotic selec-
tion were able to maintain the plasmid for much longer, with
a significant proportion of the E. coli populations still carrying
FIG. 4. Adaptive evolution increases stability of pKP33 in Escherichia coli hosts. (A) The proportion of plasmid-containing cells in initially plasmid
bearing populations grown without plasmid selection as a function of time. Immediately after receiving pKP33, the naı¨ve Ec37, Ec38, and Kp08
were propagated in nonselectivemedium for 35 days to quantify the stability of the newly received plasmid before any adaptations had taken place
(triangles). To measure the stabilizing effect of plasmid–host adaptations, the serial passaging procedure was applied to the same plasmid–host
combinations evolved for 35 days under plasmid selective conditions (circles). A mathematical model was fitted (lines) to the data points. Error
bars illustrate the standard deviation of five independent lineages. (B) Plasmid half-life comparison. The average half-life of pKP33 in naı¨ve and
evolved lineages was determined from the fitted model and summarized as the number of generations needed for half of the population to be
plasmid-free.
FIG. 5. Adaptive evolution reduces plasmid cost in Escherichia coli. The growth rate of each plasmid–host combination was measured throughout
the evolution experiment and is shown relative to the plasmid-free host thatwas evolved in parallel.Means represent 40 randomly picked clones (8
from each evolving lineage) and error bars show the standard deviation of lineage means. Asterisks indicate a significant improvement fromDay 0
(*P< 0.05, n¼ 5, Dunnett’s test).
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pKP33 after 35 days of serial passaging without antibiotic
selection (one-sample t-test: Ec37: P¼ 0.032, n¼ 5; Ec38:
P¼ 0.0075, n¼ 5). The two E. coli strains shows similar
improvements in stability with a 6.8- and 8.6-fold increases
in pKP33 half-life, respectively compared to the naı¨ve hosts
(fig. 4B). In contrast, we could not detect a significant
improvement in stability of Kp08/pKP33 D.35 compared to
the ancestral Kp08/pKP33 lineage. Comparing the values for
ancestral and evolved Kp08/pKP33 lineages at different time
points reveal that the plasmid containing fraction of the
evolved lineages were not significantly higher than the ances-
tral plasmid–host combination (two-sample t-test: Day 15:
P¼ 0.31, n¼ 5; Day 35: P¼ 0.18, n¼ 5) which is in accordance
with the overlap of parameter estimates from themathemat-
ical model fitted to data points of the ancestral and evolved
Kp08/pKP33 lineages (supplementary table S4,
Supplementary Material online).
Population Sequencing Reveals Large Deletions in
E. coli Evolved Plasmids
To further examine the underlying factors responsible for the
dramatic increase in plasmid stability we sequenced all
evolved lineages at the population level. Sequencing reads
from the evolved strains was mapped to the genome of the
nonevolved ancestor representing the starting point before
plasmid acquisition and a control population of each strain,
evolved without the plasmid, enabling omission of the most
frequent general medium adaptations (see supplementary
table S5, Supplementary Material online). However, the
majority of the chromosomal mutations occurred in viru-
lence genes and none of them could be directly associated
with plasmid stability. See supplementary material S1,
Supplementary Material online for a discussion of genomic
variants.
While no single nucleotide polymorphisms (SNPs) were
identified in the E. coli evolved plasmids, a consistent deletion
of approximately 25 kb (position 8–33 kb, fig. 6A) in pKP33
was observed for all E. coli lineages. Similar deletions were
never observed in any of the evolved K. pneumoniae lineages
(fig. 6B). The consistently deleted region encodes three resist-
ance determinants, a restriction-antirestriction system and
the main conjugation machinery. See supplementary fig. S3,
Supplementary Material online for a detailed view of the
region. Interestingly, deletions were always flanked by IS26
ISs, suggesting that intramolecular transposition or recombi-
nation between these elements allowed for the observed
loop-out dynamics. IS26 is over-represented on bacterial plas-
mids, often associated with antibiotic resistance genes, and
believed to catalyse plasmid reorganization through intramo-
lecular replicative transposition events (Cullik et al. 2010;
Curiao et al. 2011; Partridge et al. 2011; He et al. 2015).
Deletion Dynamics during Adaptation
Due to the positioning of IS26 sequences in the pKP33 back-
bone, partial deletion of the 25 kb region was never observed.
Therefore the deletion dynamics of the entire region were
assumed to correlate with the presence of individual genes
within the region. The trimethoprim (TMP) resistance gene
folA located inside the region (highlighted in fig. 6A) allowed
us to investigate the dynamics of the major deletion by selec-
tive plating of the antibiotic evolved populations on TMP
containing agar plates (fig. 6B). Here, trimethoprim (TMP)
resistance was never lost in neither the original Kp33 K. pneu-
moniae host nor the evolving Kp08/pKP33 lineages, consistent
with a high intramolecular stability of pKP33 in these K. pneu-
moniae strains. Conversely, the E. coli populations showed a
rapid decline in TMP resistance with TMP sensitive mutants
dominating the population within 60 generations of evolution.
Plasmid Deletions Are Responsible for the Observed
Growth Rate Improvements
The rapid fixation of the 25 kb deletion in all evolved E.
coli lineages indicated that the main genetic structure
involved in adaptation was the plasmid backbone. To
verify that the observed improvements were due to the
plasmid deletions and not chromosomal mutations, a
representative evolved pKP33 (now referred to as
pKP33evo) was purified from lineage four of the antibiotic
evolved Ec38/pKP33 D.35 strain and transferred back into
the ancestral strains. Growth rate measurements showed
that the burden of plasmid carriage was indistinguishable
between the ancestral Ec37 and Ec38 strains harboring
pKP33evo and the evolved plasmid–host combinations
(fig. 7). This confirms that the plasmid was the main locus
of adaptation and no chromosomal mutations were
needed for the observed improvements.
We transferred pKP33evo to the naı¨ve Kp08 to investigate
whether the major deletion would confer an advantage
beyond the host in which it evolved (fig. 8).
Interestingly, Kp08 cells harboring the E. coli evolved plas-
mid displayed a marginal advantage in terms of a higher
growth rate, which was borderline significant (P¼ 0.063,
n¼ 48). To gain resolution and test the impact of the pre-
sumed fitness benefit of pKP33evo in Kp08, we conducted a
1:1 pairwise competition experiment by mixing Kp08/pKP33
and Kp08/pKP33 and subjecting these cocultures to 110 gen-
erations of serial transfer. Here, Kp08 carrying the ancestral
pKP33 plasmid was consistently outcompeted in four parallel
competitions against the E. coli evolved pKP33evo (fig. 8B).
These results indicate that the deletion event rather than the
adaptive advantage was the bottleneck preventing plasmid
adaptation in K. pneumoniae.
No Single Locus Is Responsible for the Adaptive
Benefit of the Major Plasmid Deletion
The majority of the deleted region encodes the type 4 secre-
tion system (T4SS) comprising the conjugational transfer
machinery that allows for autonomous horizontal transfer
of the plasmid.
It is generally believed that horizontal transfer comes at the
expense of reduced vertical transfer (Turner et al. 1998) and
that the conjugational transfer machinery imposes a burden
on the bacterial host cell (Zahrl et al. 2006; Fernandez-Lopez
et al. 2014). We hypothesized that the T4SS was the main
component responsible for the fitness cost of the deleted
plasmid region and that the remaining part of the 25 kb
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FIG. 6. Large deletions in the pKP33 plasmid backbone occurred in Escherichia coli but notKlebsiella pneumoniae. (A) The ancestral pKP33 plasmid
compared to the evolved plasmid genomes displayed as a BLAST atlas. All evolved populations of each strain were sequenced at the 280-
generation end point. IS26 elements are indicated in purple with a red outline and the position of the trimethoprim (TMP) resistance gene folA is
highlighted. Lineages are depicted in ascending order from the center. The inner-most circle shows the relative GC content. (B) Heat-map showing
the abundance of TMP resistant cells in the populations grownwith plasmid selection as ameasure of themajor deletion event. Each tile represents
the average of five evolving lineages. None of the pKP33 free strains where resistant to TMP.
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region was codeleted merely as a result of constraints in IS26
localization. To investigate this hypothesis, two pKP33 knock-
out mutants were constructed. In one pKP33 mutant
(pKP33DT4SS) we deleted the T4SS only; while in the other
mutant (pKP33D9-17 kb) themajority of the remaining 25 kb
region containing the kikA, the ecoRII endonucleases as well
as the folA gene was deleted, leaving the T4SS intact. We
tested the ability of the two mutants to transfer autono-
mously and while the pKP33DT4SS did not yield any trans-
conjugants, the pKP33D9-17 kb mutant retained the ability
to transfer by conjugation on par with the intact pKP33
plasmid (see supplementary table S3, Supplementary
Material online). In both mutants, the intermediate part of
the 25 kb region, containing the kor regulatory genes, were
preserved to avoid a growth bias from excessive expression of
the kik/kil or T4SS genes due to the absence of negative
regulation by the KorA and KorB regulators (More´ et al.
1996).
The influence of the targeted deletions on the growth rate
of the E. coli strains was measured along with the ancestral
pKP33 and a 9–30 kb deletion mutant encompassing both
partial knockouts (fig. 9).
There was no significant difference in terms of growth rate
between carrying pKP33 with a targeted knockout of the 9–
30 kb region when compared to the evolved plasmid (two-
sample t-test: Ec38: P¼ 0.374, n¼ 32; Ec37: P¼ 0.158, n¼ 32)
emphasizing that this deleted region was responsible for the
observed plasmidcosts.
Interestingly, the effect of partial knockouts within the
major deleted region differed between the two hosts.
Knockout of the transfer machinery alone (pKP33DT4SS)
resulted in significantly higher growth rates in both strains
compared to the ancestral pKP33 plasmid (two-sample t-test:
Ec37: P< 0.001, n¼ 32; Ec38: P< 0.001, n¼ 32) that were not
distinguishable from the 9–30 kb knockout mutants (two-
sample t-test: Ec37: P¼ 0.115, n¼ 32; Ec38: P¼ 0.20,
n¼ 32). This indicates that the T4SS did indeed impose a
cost on the naı¨ve E. coli strains (fig. 9). Surprisingly, targeted
knockout of the remaining region (pKP33D9-17 kb), leaving
the T4SS region intact, also increased the growth rate of
both E. coli strains and completely ameliorated the cost in
Ec37 (one-sample t-test: P¼ 0.388, n¼ 16) but not in Ec38
(one-sample t-test: P¼< 0.001, n¼ 24) where the T4SS
knockout was more beneficial (two-sample t-test: P¼
0.0087, n¼ 40) compared to the 9–17 kb deletion in this
strain. See supplementary table S5, Supplementary Material
online for an overview of the statistical comparisons made in
this section.
Taken together, this implies that the reduction in growth
rate imposed by the wild type pKP33 plasmid cannot be
attributed to a single factor of the T4SS nor the remaining
part of the 25 kb region alone, and that the exact nature of
the cost varies between closely related strains.
Discussion
Conjugative plasmids are important mediators of horizontal
gene transfer, enabling the direct exchange of multiple genes
to allow rapid adaptation of bacteria to dynamic environ-
ments (Norman et al. 2009; Tamminen et al. 2012; Soucy
et al. 2015). While a plasmid might replicate in, and transfer
between, a diverse set of hosts, little is known about the
factors determining the long-term persistence of endemic
antibiotic resistance plasmids within their compatible range
of host species (De Gelder et al. 2007). Here we simulate the
scenario of novel host invasion of three pathogenic E. coli
and K. pneumoniae isolates by a large clinically relevant
multidrug resistance plasmid. Such transfer events are
likely to take place in dense multispecies communities
such as the human intestinal microbiota, supplying
potential pathogens with a wide array of antibiotic resist-
ance factors (Shoemaker et al. 2001; Sommer et al. 2009;
Sommer and Dantas 2011).
We demonstrate that the host genetic background sub-
stantially influences initial plasmid cost and stability. The
pKP33 plasmid was highly stable in its original Kp33 K. pneu-
moniae host, where the plasmid was maintained throughout
280 generations of culturing in the absence of selection (see
supplementary fig. S1, Supplementary Material online). In
contrast, pKP33 displayed a high degree of instability in the
FIG. 7. Plasmid adaptations are responsible for the increased growth
rate in the evolved Escherichia coli hosts. Growth rates of plasmid–
host combinations before evolution (Day 0), after evolution (Day 35),
and the evolved plasmid (pKP33evo) transferred back into the ances-
tral hosts, shown relative to the growth rate of the ancestral plasmid-
free ancestors. A significant difference determined by two-sample t-
test statistics is indicated with asterisks (P< 0.05) or NS (nonsignifi-
cant, P> 0.05). Top indicators are obtained through comparison to
the plasmid-free ancestor (no difference). All measurements were
done for 24 individually picked colonies and error bars display 95%
confidence intervals of the mean.
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novel hosts, where it was lost in 50% of the population after
20, 48, and 100 generations of growth for Ec37, Ec38, and
Kp08, respectively (fig. 4B).
Confirming previous observations of plasmid evolution
(Heuer et al. 2007; De Gelder et al. 2008; San Millan et al.
2014; Harrison et al. 2015; Loftie-Eaton et al. 2015) we
show that adaptive evolution in conditions selecting for
plasmid carriage can significantly increase plasmid stability
by reducing the fitness cost of an initially costly plasmid–
host association. In addition, we show that nature of these
FIG. 9. Growth rate effects of targeted pKP33 knockouts in ancestral hosts. Engineered deletionmutants of pKP33 were generated in the ancestral
hosts and the growth rate of the resulting variants wasmeasured and depicted relative to the host without pKP33. The 19–30 kb part of pKP33was
deleted (pKP33DT4SS) comprising the conjugational transfer region and compared to deletion of the adjacent 9–17 kb (pKP33D9-17 kb) aswell as
a knockout of both regions (pKP33D9-30 kb). The top panel illustrates the position of the deleted parts (red) in pKP33. Error bars depict the 95%
confidence interval of the mean measurements performed on at least 16 individual clones. A significant difference is indicated by asterisks (two-
sample t-test, P< 0.05).
FIG. 8. The ancestral pKP33 as well as pKP33 evolved in Escherichia coli (pKP33evo) were transferred to the naı¨ve Kp08 Klebsiella pneumoniae
strain. (A) The exponential growth rate was measured for 24 individual colonies of Kp08 carrying the ancestral plasmid before (Day 0) and after
(Day 35) 35 days of serial passaging in plasmid selective medium. These were compared to Kp08 carrying pKP33evo, transferred from the
evolved E. coli. The growth rate improvement of Kp08/pKP33evo compared to Kp08/pKP33 Day 0 was borderline significant (P¼ 0.063). (B)
Direct competition of Kp08 carrying the wild-type pKP33 against the Kp08 carrying the Escherichia coli evolved pKP33evo. Kp08/pKP33evo and
Kp08/pKP33 Day 0 were equally mixed and serially transferred under antibiotic selection to select for both plasmids. The ratio of pKP33 to
pKP33evowas quantified throughout the experiment by spotting on TMP and cefotaxime containing agar plates. Error bars depict the standard
deviation of four replicate experiments.
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costs and the ability to adapt depends on the host
background.
Sequencing of the evolved E. coli populations showed that
the reduced fitness cost of pKP33evo was achieved by delet-
ing a 25 kb plasmid region containing the T4SS involved in
conjugational transfer; an event that was clearly dictated by
the positioning of IS26 elements in the plasmid backbone.
Conjugation is considered costly in terms of vertical transfer
(Turner et al. 1998), and targeted knockout of themain trans-
fer machinery was indeed beneficial in terms of growth rate
for both E. coli strains. Although liquid setups are commonly
used in experimental evolution to rapidly assess a high num-
ber of cell divisions in a controlled environment, we note that
such a setup might overemphasize the trade-offs observed
here, because the conjugational transfer machinery of IncN
plasmids works poorly in liquid environments (see supple
mentary table S3, Supplementary Material online). By meas-
uring the conjugational transfer rates of pKP33 for all strains
in a solid-surface setup we were able assess the potential of
conjugative transfer to compensate the observed plasmid loss
in a structured environment compared to our liquid setup
and evaluate these values against the theoretical minimum
requirement for parasitic maintenance of pKP33 in each
strain (see supplementary table S3, Supplementary Material
online). While pKP33 does show notably higher conjugation
rates when surface associated, these rates are still orders of
magnitude lower than the theoretical minimum rates
required for parasitic plasmidmaintenance in all naı¨ve isolates
(see supplementary table S3, SupplementaryMaterial online),
rendering the conjugational machinery disadvantages in
these strains, even in conditions allowing high transfer rates.
Although it is unlikely that conjugation alone will maintain
pKP33 even in dense, rapidly growing, homogenous popula-
tions similar to the ones investigated here, we note that there
might be other selective advantages of carrying a conjuga-
tional transfer system in natural environments, even if trans-
fer rates are low. We demonstrate that the original Kp33 host
can indeed maintain a plasmid for much longer than even
closely related naı¨ve hosts. As suggested by Bergstrom et al.,
the ability to “sample” different host backgrounds for com-
patibility in diverse bacterial populations increases the oppor-
tunity for a stable plasmid–host relation, which along with
other benefits of the T4SS such as increased biofilm forma-
tion, might improve long-term plasmid survival (Bergstrom
et al. 2000; Ghigo 2001).
Surprisingly, the pKP33 knockout mutants lacking the 9–
17 kb part whilst retaining the T4SS showed an equal or
higher benefit in terms of growth rate compared to the
pKP33DT4SS mutant, indicating that the cost is not exclusive
to the T4SS but stems from multiple loci. While these costs
displayed an additive nature, the relative contribution of each
plasmid region varied between the two closely related E. coli
UTI isolates (fig. 9, table 1 and supplementary table S2,
Supplementary Material online). Whereas the 25 kb region
of pKP33 had a half-life of roughly 60 generations in both
E. coli strains evolved under plasmid selection, Kp08/pKP33 as
well as the original Kp33/pKP33 strain retained the intact
plasmid backbone throughout the evolution experiment.
These observations emphasize the role of host genetic back-
ground in plasmid–host adaptation and highlight the poten-
tial role of stable plasmid donors as reservoirs in long-term
plasmid survival. This is an important realization because it
underlines the irregular fitness landscape navigated by trans-
missible plasmids in heterogeneous populations; a landscape
that is eventually evened out during periods of selection for
plasmid-borne traits, thus increasing plasmid frequency and
opportunity for dissemination and adaptation towards new
hosts. Interestingly, the E. coli evolved plasmid was also bene-
ficial in Kp08 and although selection for compensatory muta-
tions is expected to be weaker in Kp08 than for E. coli due to
the lower cost of plasmid carriage (Qi et al. 2016), the evolved
plasmid dominates the population within 50 generations of
direct competition against Kp08 carrying the ancestral pKP33
plasmid (fig. 8B). Despite this potential competitive benefit of
the large plasmid deletion in Kp08, restructuring was never
observed in Kp08 nor in the original Kp33 host (fig. 6B),
suggesting that the E. coli host were better catalysts of these
adaptations than K. pneumoniae.
While it is reasonable to assume that the majority of intra-
molecular restructuring events lead to deleterious outcomes,
we show that these events can indeed provide important
plasticity for natural selection to work on. There are indica-
tions that the frequency at which recombination events
occur can vary substantially within bacterial species. For
example, Rodrıguez-Beltran et al. show that there is a ten-
dency towards higher frequencies of homologous recombi-
nation in uropathogenic E. coli strains compared to
nonpathogenic E. coli strains (Rodrıguez-Beltran and
Tourret 2015). This has been suggested to increase adaptabil-
ity in their native environment and such differences in muta-
tional events, and in particular homologous recombination,
could explain the differential evolvability of the K. pneumo-
niae strain compared to E. coli UTI isolates. These frequencies
of recombination are suggested to be much higher (>104)
than point mutations (108), which might explain why we
did not observe any SNPs able to compensate the plasmid
imposed costs. Although we can only speculate on themech-
anistic basis for these differences, they seem to correlate with
the number of virulence genes and could also be influenced
by host global regulators known to target horizontally
acquired DNA and influence transposition frequency (Shiga
et al. 2001; Doyle et al. 2007; Rodrıguez-Beltran and Tourret
2015). However, the cause is likely multifactorial and further
investigations are needed to elucidate the exact nature of
these differences.
As demonstrated here, the advancement of long read
sequencing technologies aids greatly in the elucidation of
the complex repetitive plasmid patterns attributed to abun-
dant IS elements and it has become clear that IS elements,
IS26 in particular, play a major role in the organization of
naturally occurring plasmids implicated in health-care asso-
ciated outbreaks (Conlan et al. 2014; Harmer et al. 2014; He
et al. 2015). Whereas it was recently demonstrated that trans-
position of beneficial genes into the plasmid backbone can
improve stability (Loftie-Eaton et al. 2015), we are the first to
describe IS mediated deletions as a driving force of plasmid
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persistence in novel hosts. Whereas sacrificing important
traits such as the conjugational transfer machinery can
seem like an evolutionary dead-end strategy, such rapid
recombination mediated restructuring might confer an
advantage in certain environments (Labat et al. 2005). For a
uropathogenic strain residing in the liquid environment of
the urine bladder, getting rid of costly transfer machinery to
increase growth rate can be a beneficial survival strategy
(Bradley et al. 1980; Gordon and Riley 1992; Nilsson et al.
2003).
While domestication of costly plasmid traits seems like a
common theme in plasmid–host evolution, the means of
cost amelioration are diverse (Modi et al. 1991; Dahlberg
and Chao 2003; Doyle et al. 2007; De Gelder et al. 2008; San
Millan et al. 2014; Harrison et al. 2015). Recent work shows
that the cost associated with carriage of a large conjugative
plasmid in Pseudomonas fluorescens can be compensated by
translational down-regulation attained via chromosomal
mutations alone (Harrison et al. 2015). In contrast, we show
that IS26 mediated deletion of costly plasmid genes can pro-
vide similar benefits.
It is clear that strain specific factors can be highly influen-
tial, and extrapolating observations from single-host experi-
ments to general plasmid behavior in clinical isolates is not a
trivial task (De Gelder et al. 2007). The differences in stability
observed for pKP33 in the K. pneumoniae and E. coli strains
investigated here, suggests that transfer well within the
expected natural host range of a plasmid might be more
difficult than generally assumed. Although the initial toler-
ance, in terms of cost and stability, does seem to correlate
with the relatedness of the strains to the original plasmid host
(see supplementary table S2, SupplementaryMaterial online),
predicting the potential for stability improvements and long-
term survival is not straight forward.
While species dependent constrains have been located to
replication proteins in a nonconjugative broad host-range
plasmid (Sota et al. 2010), our results suggest that dispen-
sable factors of the plasmid backbone can impose similar
limitations to the long-term host range of conjugative plas-
mids. Although chromosomal mutations as well as the pres-
ence of native plasmids in the naı¨ve strains might have
influenced the cost of pKP33 carriage, we expect these
effects to be minimal compared to the major plasmid dele-
tion event. Chromosomal mutations occurred almost exclu-
sively in genes associated with virulence. Such genes are
likely acquired by horizontal gene transfer and might be
involved in the host specific cost patterns observed; possibly
through regulatory interference or antagonistic interactions
between for example membrane associated components of
the deleted plasmid region (Doyle et al. 2007; San Millan
et al. 2015). Although we did not observe any correlation
between pKP33 carriage and retention of native plasmids,
and we did not find any significant functional overlap in
plasmid carried genes when compared to pKP33, we cannot
out rule that the native plasmids of the strains have influ-
enced plasmid cost and evolutionary outcomes (see supple
mentary material S1, Supplementary Material online). We
acknowledge that such minor effects on fitness are hard to
detect given the relatively low resolution of the growth
measurements used here, but might be detectable by
more sensitive fitness assays such as direct competition.
Although IS mediated cost amelioration effectively
improves plasmid persistence, intramolecular restructuring
events might come at the expense of conditionally useful
components such as genes involved in antibiotic resistance
or horizontal transfer, that might ultimately limit plasmid
dissemination. While the evolved plasmid kept most of its
resistance determinants, the trimethoprim resistance gene
folA was consistently deleted along with the T4SS machinery
involved in conjugation. These deletion patterns suggest that
nonconjugative plasmids can evolve as a result of a strain
dependent selection process dictated by transfer associated
costs or collateral deletions to improve short term fitness at
the expense of future niche expansion potential.
Our data suggests that while the selective forces against
plasmid carriage can vary between even closely related iso-
lates, the evolutionary solution might be more general and
even broadly beneficial in strains to which genetic resolution
is not immediately accessible.
Although the radical restructuring observed here ulti-
mately narrows the plasmid host range by constraining its
dissemination, such ongoing dynamics might help explain
the dominance of nonconjugative plasmids in sequence
databases (Smillie et al. 2010; Shintani et al. 2015). Further
investigations of the mechanisms underlying plasmid per-
sistence and the role of transposable elements herein are
important to understand and prevent our current epi-
demic of multidrug resistance. Such studies shall prefer-
entially be carried out on relevant specimen of clinical
importance to directly improve our understanding of
the barriers and opportunities implicated in successful
plasmid dissemination that will provide us with the
knowledge necessary to control and predict the rapid
emergence of multidrug resistant pathogens.
Materials and Methods
Bacterial Strains, Plasmids, and Culture Conditions
The E. coli and K. pneumoniae strains used in this study were
isolated from urinary tract and blood infections by the
Department of Clinical Microbiology at Hvidovre Hospital,
Denmark. The antibiotic resistance profile of the strains was
evaluated by broth dilution antibiotic susceptibility testing
(Wiegand et al. 2008) and summarized along with genotypic
information in table 1 and supplementary table S1,
Supplementary Material online. Culturing was generally
done with shaking in lysogeny broth (LB) medium at 37C.
M9 minimal medium lacking leucine was used for counter-
selection of donors in the conjugation experiments.
Cefotaxime (2 mg/ml) was added to ensure stable plasmid
maintenance during culturing of strains harboring ESBL plas-
mids and TMP (16 mg/ml) was added when appropriate to
prevent deletions of the 25 kb plasmid region containing the
folA gene.
Porse et al. . doi:10.1093/molbev/msw163 MBE
2870Downloaded from https://academic.oup.com/mbe/article-abstract/33/11/2860/2271987
by guest
on 22 November 2017
Plasmid Transfer and Conjugation Assays
Large plasmids were transferred to clinical isolates via either
conjugation or direct electroporation when possible. For
transfer by conjugation, the TOP10 strain (Life
Technologies, USA) was used as donor strain due to its
high competence and leucine auxotrophy. Following incuba-
tion with the donor strain, cells were scraped of the agar
surface, washed in isotonic salt water and plated on M9
minimal medium agar plates lacking leucine but containing
cefotaxime for plasmid selection. Transconjugants were veri-
fied as b-galactosidase positive (blue colonies) on X-gal con-
taining LB plates. For all conjugation experiments, the donor
and recipient strains were grown with appropriate antibiotics
to midexponential phase and washed in isotonic salt water
before mixing 1:1. Conjugation was performed in either liquid
LB medium or on a solid LB agar surface incubated without
shaking at 37C. For transfer rate quantification, conjugation
was carried out for 2 h and the cells were plated on selective
plates to quantify donors, recipients, and transconjugants.
Plasmid Evolution and Stability Experiments
Five parallel lineages of each plasmid-carrying strain were
passaged once daily, in selective medium to ensure plasmid
inheritance during the evolution experiment, and subse-
quently without selection to assess plasmid stability. Serial
passaging was performed in 96-well plates containing
150 ml LB medium. Each day of the experiment, 1 ml culture
was transferred to the corresponding well of a new plate by
pin replication. Plates were incubated at 37C and subjected
to medium shaking at 400 rpm. The plasmid selection (cefur-
oxime, 16 mg/ml) used for the evolution experiment did not
reduce the growth rate of plasmid bearing strains compared
to growth in LB without antibiotics.
Growth Rate Measurements
Growth rate was measured as the maximum increase in opti-
cal density (OD) over time during exponential growth. OD
measurements were conducted in 96-well plates containing
150 ml LB/well by the ELx808 plate reader (BioTek, USA).
Breathe-Easy (Sigma-Aldrich) film was applied to minimize
evaporation duringmeasurements. OD at 600 nmswasmeas-
ured with 5min intervals for maximum 16h and incubated
with medium shaking at 37C between measurements.
Colonies were picked into a pre-inoculation plate andwere
grown for 2–3h with shaking at 37C before inoculation of
the final measurement plate.
Pairwise Competition
Two O/N cultures were diluted to the same OD and mixing
equally in LB medium. Cefotaxime (1 mg/ml) was added to
prevent plasmid loss. The competition was carried out in
1.5ml cultures and a volume of 1.5 ml was transferred to a
fresh well every 24 h. From OD measurements the number
of generations was estimated to 10 generations/day. The
ratio of the competitors was determined as the fraction of
colonies on TMP agar plates compared to plates containing
cefotaxime (performed as in “Plasmid deletion and loss
quantification”).
Plasmid Deletion and Loss Quantification
Plasmid loss was measured as sensitivity to cefotaxime;
assuming loss of the CTX-M-15 gene. While quantifica-
tion was done at the population level, periodic verifica-
tion of plasmid-free colonies was carried out by testing for
the presence of the remaining plasmid carried resistance
determinants. Deletion of the 9–30 kb plasmid region was
measured as sensitivity to TMP, indicating the absence of
the folA TMP resistance gene. Frozen culturing plates
were thawed completely and 10-fold dilutions (101–
108) were made in isotonic salt water. After thorough
mixing of each dilution, 5 ml spots were placed on selec-
tive and nonselective agar plates (2 mg/ml cefotaxime or
16 mg/ml TMP). After absorption of the liquid, plates were
incubated O/N at 30C to ensure countable colony sizes.
CFUs of the lowest countable dilution (<70 CFU) were
quantified and the ratio of resistant to total cells was
calculated.
Mathematical Modelling of Plasmid Stability
Amathematical model derived in Proctor (1994) was fitted to
plasmid loss data using the nls2 package in R (version 3.0.1).
The model assumes that the population dynamics of a plas-
mid bearing population can be described by differential equa-
tions modelling the dynamics of plasmid containing
dPc=dt ¼ cPc  NPcð Þ  ðl  NPcÞ, and plasmid-free cells dPf
=dt ¼ cPf  NPfð Þ þ ðl  NPcÞ respectively.
Where Pc denotes plasmid containing cells and Pf
denotes plasmid-free cells. Here, c is the growth rate
and m is the segregational plasmid-loss rate. An equation
describing the plasmid-free fraction as a function of time
can be derived:
Fpc ¼
ðlþ qÞFpc;t0
ðlþ qð1 Fpc;t0ÞÞ eðlþqÞt þ qFpc;t0
(1)
Here, the starting number of plasmid containing cells is
Fpc;t0 and the differential growth rate (cPf  cPcÞ is summar-
ized in the parameter q.
Whole Genome and Plasmid Sequencing
Genomes and whole population DNA samples were extracted
using the DNeasy Blood & Tissue Kit from QIAGEN (QIAGEN,
Netherlands). Sample libraries for Illumina sequencing were
prepared using the TrueSeq Nano and Nextera XT kits
(Illumina, USA). All reference genomes and plasmids were pre-
pared using the TrueSeqNano kit andmechanical shearing. The
remaining sequencing libraries were prepared using theNextera
XT employing enzymatic fragmentation. Sample concentra-
tions were measured on a Qubit fluorometer (Life
Technologies, USA) and analysed with the Agilent 2100
Bioanalyzer (Agilent, USA) for fragment length distributions.
Libraries were sequenced paired-end on a MiSeq sequencer
(Illumina, USA) with sample amounts ensuring coverage of
>30X. In addition, pKP33 was sequences using the Pacific
Biosciences RS II single molecule real time sequencing technol-
ogy. PacBio library preparation and sequencing was performed
by TheNorwegian High-Throughput Sequencing Centre (NSC)
Survival and Evolution of a Large Multidrug Resistance Plasmid . doi:10.1093/molbev/msw163 MBE
2871Downloaded from https://academic.oup.com/mbe/article-abstract/33/11/2860/2271987
by guest
on 22 November 2017
(Oslo, Norway). Sequenced genomes and short read data from
the pKP33 evolved populations are deposited within the
BioProject: PRJNA325878.
Sequence Analysis
All sequencing data was processed and analysed using the CLC
Genomics Workbench software from CLC Bio (QIAGEN,
Netherlands). Further analysis and preparation of final graphics
was conducted in R (version 3.0.1). Annotation was done using
the RAST server (Aziz et al. 2008). All annotations were man-
ually inspected and updated via BLAST searches if deemed
necessary. Reads from sequenced evolved genomes were
mapped to reference genomes via the “Map reads to refer-
ence” feature in CLC. SNP’s and small INDELS were detected
automatically using the “Quality based variant detection” tool.
Read mappings were manually inspected for each contig to
identify larger INDELS. Variants resulting from ambiguous read-
mappings were excluded from the variant analysis.
BLAST Analysis and Sequence Comparison Using
GView
Consensus sequences of the evolved plasmids were
extracted from read mappings to pKP33 and the cut-off
for inclusion was set to 5 coverage, corresponding to
approximately 10% of the average read coverage. These
were blasted against the pKP33 plasmid reference using
the GView web-server available at: https://server.gview.ca/,
last accessed August 8, 2016. The blastn algorithm was
used to generate a circular BLAST atlas using the following
settings: e value cut-off was set to 1010, alignment length
cut-off to 100 bp, percent identity cut-off to 85% and the
genetic code to “Bacterial and Plant Plastid”. The layout of
the output was edited in the GView Java stand-alone appli-
cation accessible from the results page.
Generating Plasmid Knock Out Mutants
Recombineering in the E. coli DY329 strain was performed as
previously described (Yu et al. 2000). Targeted deletions were
made by introducing a chloramphenicol resistance cassette
from the pKD3 vector (Datsenko and Wanner 2000) into the
pKP33 plasmid backbone. The T4SS regionwas targeted using
primers with the following flanking regions: 50-TTAAA
TCTGCAATCAACAGAAGATAGTGAGTAAGGAGAAAGT
ATGACCAC-30 and 50-AGAAATATAGCCTGCGTCAATCG
TTTCTGCCGTGAGGGTACCGCTTTCCC -30; deleting the
approximately 10 kb part of pKP33 containing the main con-
jugational transfer region. A plasmid mutant with the 9–
17.6 kb (pKP33D9-17 kb) region deleted was created using
the following homologous regions: 50-CTTCCATTCCGCC
CATTTTTAGAAAATTTCGTGTCCATGCGATCAGGTTA-30
and 50-GATTTACGTGCATAGCCGATTTTCATTCTTTTCT
CGCTAATTAGTTATGG-30. A combination of both deletions
from 9 to 30 kb was made using: 50-GATTTACGTGCATA
GCCGATTTTCATTCTTTTCTCGCTAATTAGTTATGG-30
and 5-AGAAATATAGCCTGCGTCAATCGTTTCTGCCGTG
AGGGTACCGCTTTCCC-30 as homology regions. All dele-
tions were confirmed by PCR and subsequent Sanger
sequencing (Macrogen, Korea).
Supplementary Material
Supplementary material S1, tables S1–S5, and figures S1–S3,
are available atMolecular Biology and Evolution online (http://
www.mbe.oxfordjournals.org/).
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Supplementary table S1. Minimal inhibition concentrations selected antibiotics. The resistance 
phenotype of pKP33 was tested in a non-resistant strain background. Red numbers indicate 
increased tolerance compared to the plasmid-free host. In addition, the MIC values for the naïve 
clinical isolates carrying pKP33 or pKP33evo was tested for cefutaxime, trimethoprim and 
streptomycin.  
These values were: >1024 µg/ml for cefotaxime for the evolved as well as the ancestral plasmid in all 
strains. Trimethoprim was >16 µg/ml for the ancestral plasmid in all strains and 2 µg/ml (same as the 
plasmid free strains) for the evolved plasmid in all isolates carrying the evolved plasmids. The MICs 
for streptomycin were 256 µg/ml for both the ancestral and evolved plasmid in Ec37 and Kp08, 
whereas a value of 512 µg/ml was measured for both plasmid variants in Ec38.  
Drug   MIC value (µg/ml) 
Cefotaxime >16 
Piperacillin >128 
Piperacillin+Tazobactam 128 
Gentamicin >32 
Ciprofloxacin >1 
Trimethoprim >16 
Kanamycin >50 
Amikacin >32 
Streptomycin >32 
Tetracycline 1 
Chloramphenicol 2 
Meropenem 0.125 
 
 
Supplementary fig. S1. Stability of pKP33 in the native KP33 host.   
Stability of the pKP33 plasmid in the K. pneumoniae host from which it was initially isolated. Plasmid 
stability was quantified via spot assaying on plasmid selective and non-selective agar plates. The 
end-point was validated by streaking 100 colonies on selective medium (cefotaxime and 
Trimethoprim) to confirm 100% plasmid presence. The results are shown as the proportion of 
resistant to total cells during 35 days (280 generations) of serial transfer in non-selective medium. 
Error bars show standard deviation of five replicates and depict the variation involved in the 
measurements. 
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Supplementary fig. S2. Absolute growth rate measurements during adaptive evolution.  
Doubling times was calculated from measurements obtained after day 0, 5, 15, 25, 35 of the 
evolution experiment; corresponding to app. 0, 40, 120, 200, 280 bacterial generations. Each point 
represents the mean measurement of eight randomly picked clones from each lineage during 
evolution. Asterisks indicate a significant difference (*P < 0.05, n = 5, two-sample t-test) from the 
evolving plasmid-free lineages.     
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Supplementary table S2. Proteome comparison.  
An in silico proteome comparison was performed using the CMG-Biotools software package (Vesth 
et al. 2013) to assess the number of shared protein families between the strains studied. Here a 
shared family is considered if the alignment is 50% identical and the length of the alignment is at 
least 50% of the longest protein. The table shows the number of shared protein families between 
each pair of strains (lower left corner) as well as the fraction calculated in per cent of the largest 
proteome in the comparison (top right corner).   
 Ec37 Ec38 Kp08 Kp33 Proteome size 
Ec37  80% 54% 56% 5001 
Ec38 4004  54% 55% 4718 
Kp08 2833 2812  83% 5253 
Kp33 2814 2792 4346  5032 
 
Supplementary table S3. Conjugation frequencies.  
Conjugation experiments were performed in liquid LB (without shaking) as well as on a solid LB agar 
surface to estimate transfer rates (γ) using the methodology by Simonsen et al. 1990.  
According to Stewart and LeǀiŶ’s ĐƌiteƌioŶ ;LeǀiŶ aŶd Steǁaƌt ϭϵϳϳͿ:           
the minimum requirement in terms of conjugative transfer rate (γmin) for a plasmid to be parasitic 
depends on the population density ( ), the fitness cost (α) of plasmid carriage, the growth rate (ω) 
and the rate of loss by segregation (τ). As we have estimated these parameters for all the naïve 
clinical isolates, we were able to approximate the minimal rate of conjugation needed to 
compensate the fitness cost and segregational loss rates observed for pKP33 in these strains 
(assuming that increased conjugation does not increase the fitness cost) and compare them to the 
actual transfer rate of pKP33 in each strain.   
Strain Liquid transfer rate (γl) Solid transfer rate (γs) Mininum transfer rate γmin 
Ec37/pKP33 5.03E-14 4.81E-13 1.29E-09 
Ec38/pKP33 4.21E-13 1.35E-12 1.83E-09 
Kp08/pKP33 7.17E-14 1.23E-11 1.01E-09 
Kp33/pKP33 9.57E-12 2.19E-11 NA 
Ec37/pKP33Δ9-17kb 2.23E-14 3.79E-12 1.40E-10 
Ec38/pKP33Δ9-17kb 7.80E-14 6.23E-12 6.58E-10 
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Supplementary table S4. Best fit parameter values for a plasmid stability model of ancestral (day 
0) and evolved (day 35) plasmid-host combinations.  
A mathematic model assuming segregational loss (µ) and differential growth rate (ρ) as the main 
drivers of plasmid instability was fitted to plasmid loss rate obtained from either ancestral  or 
evolved plasmid-host combinations (fig. 4A). Summery statistics of models fitted to plasmid loss-
data from each lineage is shown. We were unable to fit the model to data from two lineages 
(ancestral Ec38/33 lineage 3 and evolved Ec37/33 lineage 4) due to high variation in the 
measurements or too few non-zero data points. The estimates for µ are relatively uncertain owing to 
the few data points obtained in the beginning of each datasets and negative estimates were set to 0. 
Here the estimate of µ is biased by the rapid outgrowth of plasmid bearing cells, making it hard for 
the model to distinguish between the two parameters. P-values were determined by a two-sample t-
test comparing parameter values from day 0 and day 35 to assess the effect of evolution.     
Strain   Day Segregation rate (µ) SD (µ) P-value µ      Plasmid cost (ρ)   SD ρ P-value ρ  
Ec37/p33 0 0.0147 ±0.026 
 
8.3 % ±4.14 % 
 Ec37/p33 35 0.0079 ±0.0033 0.57 -0.3 % ±1.23 % 0.001 
Ec38/p33 0 0.0008 ±0.016 
 
14.0 % ±2.85 % 
 Ec38/p33 35 0.0008 ±0.0061 0.99 0.4 % ±3.37 % <0.0001 
Kp08/p33  0 0.0060 ±0.002 
 
4.6 % ±2.94 % 
 Kp08/p33  35 0.0067 ±0.0033 0.68 1.6 % ±3.35 % 0.17 
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Discussion of genomic variants 
Although plasmid adaptations had the dominant role in the improved persistence of pKP33 in E. coli, 
a minor or transient role of chromosomal mutations cannot be out ruled.   
Most non-synonymous mutations detected in the remaining genome of the strains were found in 
genes annotated as virulence factors such as adhesions, fimbriae or iron scavenging proteins and 
could not be directly associated with plasmid stability. No mutations in non-coding regions of the 
genomes were consistently associated with all lineages or with any known regulatory elements e.g. 
promoter regions. Attenuation of virulence is often observed in asymptomatic urinary tract E. coli 
isolates where deletions or point mutations are often present in adhesion factors (Klemm et al. 
2006; Roos et al. 2006). As virulence factors are redundant in our setup, and inactivation hereof 
might lead to growth rate improvements or perhaps a stronger association with the liquid phase due 
to decreased adhesion, attenuation is likely to impose a selective advantage (Roos and Ulett 2006). 
Furthermore, plasmid cost has been associated with excessive gene expression and interaction with 
horizontally acquired genes (Doyle et al. 2007; Harrison et al. 2015; San Millan et al. 2015). This, 
along with the presence of pKP33 encoded UmuC mutagenic DNA polymerase, might explain the 
increased tendency to mutate in virulence and phage-derived proteins in plasmid bearing lineages 
(Maor-Shoshani et al. 2000). Another interesting observation is that many chromosomal variants 
occur in genes encoding periplasmic or surface associated proteins (e.g. FtsK, PapC, KpsD and 
fimbrial proteins) which could be involved in antagonistic interactions with the membrane 
protruding T4SS or the putitative membrane protein STY461 of the deleted 25kb region in pKP33. If 
such interactions took place, the effect of chromosomal mutations must have been significantly 
lower than improvements attained from the deletion of plasmid genes, as the evolved plasmid alone 
is able to compensate the growth rate reduction to the same degree as the evolved plasmid-host 
combination (fig. 7). One consistent mutation, resulting in amino acid change from tyrosine to 
histidine, in the ftsK gene occurred in the chromosome of three out of five evolved Kp08 lineages. 
FtsK is a membrane located multi-domain protein involved in coordination of chromosomal 
segregation (Crozat et al. 2015). Considering the position of this variant in a variable non-essential 
linker domain and lack of correlation with stability or measureable growth rate improvements we do 
not assume an important role of this mutation in plasmid adaptation.     
The indigenous plasmids of the naive isolates ranged from 7kb to 138kb in size and the IncFII of Ec37 
as well as the IncFIC of Ec38 contained genes involved in conjugative transfer. The large (IncR of 
Kp08, IncFII of Ec37 and IncFIC of Ec38) plasmids contained genes associated with virulence such as 
toxin, siderophore and adhesions/fimbriae encoding genes. An all against all blast comparison at the 
protein level revealed that the two Kp08 plasmids (IncR and IncFIB(K)) were the only plasmids 
containing genes with similar function to those found in pKP33. Both plasmids contained the error-
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prone polymerases UmuC and UmuD, which might lead to elevated mutation rates (Maor-Shoshani 
et al. 2000). Apart from these genes, no other e.g. similar toxin-antitoxin systems, IS26 elements, or 
genes involved in gene regulation, that could have implications for the stability and evolution of 
pKP33, were found in the native plasmids of the naïve strains. While all Ec37 lineages, including the 
lineage evolved without pKP33, retained their native IncFII plasmid throughout the evolution 
experiment, the endogenous incF plasmids (IncFIC and IncFIB) of Ec38 were lost in all but one pKP33 
evolved lineage, which retained the IncFIC plasmid. However, the loss of endogenous plasmids was 
not exclusively associated with the presence of pKP33, as the Ec38 lineage evolved without pKP33 
had also lost both plasmids by the end of the experiment. None of the two native (IncFIB(K) and 
IncR) plasmids of Kp08 where lost in neither the pKP33 carrying lineages nor the pKP33 free control. 
For Ec38, we note that the native plasmids did not have a substantial effect on the growth rate upon 
pKP33 acquisition as the evolved plasmid-host combination (which had lost all its native plasmids) 
was indistinguishable from the ancestral strain (containing the native plasmids) transformed with 
the evolved pKP33 plasmid.  
As for the remaining genomic content of these strains, we cannot rule out the possibility that factors 
such as titration of global regulators or antagonistic interference between virulence mediators could 
have influenced the stability and evolutionary outcome observed here.      
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Supplementary table S5. Non-synonymous genetic variants.   
Non-synonymous SNP and small in-del variants found by population sequencing and comparison to the 
ancestral reference genome of each strain. The position and amino acid change, insertion (Ins) or deletion (Del) 
is iŶdiĐated ƌelatiǀe to the ƌefeƌeŶĐe geŶoŵe seƋueŶĐed ďefoƌe adaptiǀe eǀolutioŶ. ͞Total ǀaƌiaŶts͟ is the total 
number of variants across all lineages. Annotations were derived from the Rapid Annotations using Subsystems 
Technology (RAST) server (Aziz et al. 2008) and manual BLAST analysis via NCBI.  
 
  
Strain Position Nature of mutation Gene product Function  
Total 
variants 
No. of mutated 
lineages 
Kp08 
Contig14, Pos: 185456 & 
185528 Tyr440His & Tyr464His Cell division protein FtsK Coordinates cell division 4 3 
Kp08 Contig13, Pos: 121476  Ala653Thr  RnfC 
Involved in electron 
transport 3 3 
Kp08 Contig12, Pos: 200895 Ala280Thr 
FKBP-type peptidyl-prolyl 
cis-trans 
 isomerase FkpA precursor  Chaperone; protein folding 2 2 
Kp08 Contig27, Pos: 20285  Ala183Val 
Alanine transaminase (EC 
2.6.1.2) Amino acid metabolism 1 1 
Kp08 
Contig14, Pos: 195113 & 
195116  Met11Val & Val12Leu 
 
Anaerobic dimethyl 
sulfoxide reductase chain C  Anaerobic respiration 2 1 
Kp08 Contig45, Pos: 9844  Frameshift 
Putative cell division protein 
precursor 
 
1 1 
Kp08 Contig12, Pos: 65936  Frameshift 
Transcriptional activator 
NhaR Osmotic stress 1 1 
Ec37 Contig34, 5616  Gln106Arg 
Periplasmic fimbrial 
chaperone 
Involved in fimbriae 
synthessis 4 4 
Ec37 
Contig4, Pos: 4920, 
5885,5890 & 6269  
Ins, Del, Tyr158Asn & 
Pro284Leu KpsD Exopolysaccharide synthesis 4 3 
Ec37 Contig11, Pos: 98610  Val12Ala 
Type 1 fimbriae regulatory 
protein FimE  fimbriae, pathogenicity 1 1 
Ec38 Contig25, Pos: 375  Val710Ala 
Outer membrane usher 
protein PapC P-fimbriae, pathogenicity 2 2 
Ec38 Contig13, Pos: 104962  Leu99Phe Prophage tail fiber protein Phage component 2 2 
Ec38 Contig1, Pos: 372253  Leu74Phe 
Leucine-responsive 
regulatory protein Lrp Global regulator 1 1 
Ec38 Contig1, Pos: 111174  Pro46Leu Lipoate synthase LipA Lipoate biosynthesis 1 1 
Ec38 Contig5, Pos: 85177  Cys130Tyr 
Redox-sensitive 
transcriptional activator 
SoxR Oxidative stress response  1 1 
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Supplementary fig. S3. Linear representation of the 8-33kb part of pKP33  
A 25kb part of the plasmid flanked by IS26 insertion sequences was deleted in all evolved E. coli lineages. 
Annotated genes are classified as accessory (orange), stability (blue), conjugational transfer (green) or mobile 
genetic elements (pink/purple).      
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Supplementary table S5. Overview of statistical comparisons.   
A summary of the statistical comparisons made to assess the effect of plasmid knockout mutants on 
the growth rate of the naïve E. coli isolates. Two-sample t-test comparisons were done unless the 
comparison was made to the plasmid-free ancestor to which the growth rate was normalized and 
the variance propagated. Here a one-sample t-test (to test a difference from 0) was made.  
Strain 1  
 
Strain 2 n P-value 
Kp08/pKP33 x Kp08/pKP33evo 48 0.063 
EĐϯϳ/pKPϯϯΔϵ-30kb x Ec37/pKP33evo 32 0.158 
EĐϯϴ/pKPϯϯΔϵ-30kb x Ec38/pKP33evo 32 0.374 
Ec37/pKP33 x EĐϯϳ/pKPϯϯΔTϰSS 32 < 0.001 
Ec38/pKP33 x EĐϯϴ/pKPϯϯΔTϰSS 32 < 0.001 
EĐϯϳ/pKPϯϯΔTϰSS x EĐϯϳ/pKPϯϯΔϵ-30kb 32 0.115 
EĐϯϴ/pKPϯϯΔTϰSS x EĐϯϴ/pKPϯϯΔϵ-30kb 32 0.2 
Ec37 x EĐϯϳ/pKPϯϯΔϵ-17 kb 16 0.388 
Ec38 x EĐϯϴ/pKPϯϯΔϵ-17 kb 24 < 0.001 
EĐϯϴ/pKPϯϯΔTϰSS x EĐϯϴ/pKPϯϯΔϵ-17 kb 40 0.0087 
EĐϯϳ/pKPϯϯΔϵ-17 kb x EĐϯϴ/pKPϯϯΔϵ-17 kb 40 9.61E-05 
EĐϯϳ/pKPϯϯΔTϰSS x EĐϯϴ/pKPϯϯΔTϰSS 48 0.016 
Ec37/pKP33 D. 35 x Ec37/pKP33evo 48 0.172 
Ec38/pKP33 D. 35 x Ec38/pKP33evo 48 0.396 
EĐϯϳ/pKPϯϯΔTϰSS x Ec37/pKP33evo 48 0.00169 
EĐϯϴ/pKPϯϯΔTϰSS x Ec38/pKP33evo 48 0.0608 
EĐϯϳ/pKPϯϯΔϵ-17 kb x Ec37/pKP33evo 48 0.31 
EĐϯϴ/pKPϯϯΔϵ-17 kb x Ec38/pKP33evo 48 < 0.001 
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Abstract 
A transition towards sustainable bio-based chemical production is important for green growth. 
However, productivity and yield frequently decrease as large-scale microbial fermentation 
progresses, commonly ascribed to phenotypic variation. Yet, given the high metabolic burden and 
toxicities, evolutionary processes might also constrain bio-based production. We experimentally 
simulated large-scale fermentation with mevalonic acid-producing Escherichia coli. By tracking 
growth rate and production, we uncovered how populations fully sacrifice production to gain fitness 
within 70 generations. Using ultra-deep (>1000x) time-lapse sequencing of the pathway populations, 
we identified multiple recurring intra-pathway genetic error modes. This genetic heterogeneity is 
only detected using deep sequencing and new population-level bioinformatics, suggesting that the 
problem is underestimated. A quantitative model explains the population dynamics based on 
enrichment of spontaneous mutant cells. We validate our model by tuning production load and 
escape rate of the production host and apply multiple orthogonal strategies for postponing 
genetically-driven production declines.  
 
Keywords: Genetic heterogeneity, scale-up, evolutionary robustness, metabolic burden, pathway 
stability, population half-life, insertion sequence, polymerase slippage 
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Introduction 
Bio-based production of chemicals and fuels is important to develop a more sustainable society. 
However, it remains difficult to scale up many processes that rely on engineered organisms to 
produce industrially relevant quantities of bio-compounds, which frequently require 100 m3 
fermentation volumes. Indeed, a lack of robustness of synthetic production strains is considered a 
main challenge for implementing large-scale bioprocesses 1,2. Furthermore, despite advantages such 
as higher volumetric productivity, the industrial implementation of continuous fermentation is often 
limited by appearance of non-producer cells 3–5. Indeed, declining productivity constrains the 
economic feasibility of most fermentation reactions to shorter fed-batch operations 6, ultimately 
limiting our societal transition towards bio-based chemical and fuel production.  
 
Poor performance of bio-based processes is speculated to arise from phenotypic cell-to-cell variation 
rather than single nucleotide polymorphisms (SNPs) 7,8. Suboptimal physical reactor conditions such 
as limited aeration and stochastic gene expression are thought to underlie population 
heterogeneities 9–11. As such, sub-populations have been observed to temporarily cease production, 
then resume production at an unpredictable time 12. In addition, the high-level cellular biosynthetic 
activity required for economically viable bioprocesses might reduce the fitness of producer cells 
enough to select for non-producing mutant cells during industrially relevant time-scales. Such 
genetic heterogeneity would be more detrimental than temporal phenotypic variations, as genetic 
heterogeneity results in the irreversible loss of production from a subpopulation in the fermentation 
tank. 
 
The fitness cost of biosynthesis is pathway-specific and arises from metabolic loads such as enzyme 
synthesis, DNA synthesis, protein misfolding and drains on endogenous metabolites (required for 
glycolysis and redox power), but it can also result from the accumulation of toxic intermediates and 
by-products 13–18. We eŵploǇ the teƌŵ ͞pƌoduĐtioŶ load͟ to the sum of these effects, which present 
a selective disadvantage for productive cells in direct competition with non-productive cells. The 
fitness of a production organism can be improved in a variety of ways, including rational engineering 
19, adaptive laboratory evolution 20,21, functional metagenomics 22, and fermentation optimization 
23,24. Despite recent progress, production organisms still retain a fitness cost that cannot be 
eliminated that is directly linked to the burden of non-natural biosynthetic productivity. Accordingly, 
production cells may be selected against in competition with more fit non-producing cells. However, 
the extent to which such evolutionary processes limit fermentation output remains unclear and 
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depends on eventual population size, production load, and the number of cell divisions required to 
reach industrial fermentation scales.   
 
Generating the fermentation population inside an industrially sized 200 m3 fed-batch bioreactor 
involves a gradual scale-up from a master cell bank aliquot and requires approximately 60-80 cell 
generations to reach population sizes of approximately 1020 cells. Such time-scales and population 
sizes could allow for both the generation and selection of non-producing organisms and might allow 
these organisms to reach substantial densities in the final fermentation population.  
 
One mechanism that led to non-producing cells in early engineered bioprocesses is the loss of 
plasmids that encode components of the biosynthetic pathway. Strategies have been developed to 
limit the loss of plasmid-borne pathway cassettes, including punishing mis-segregation using 
plasmid-encoded selection genes, toxin-antitoxin systems and chromosomal integration of  the 
pathway genes 25–27. However, maintenance of the biosynthetic pathway cassette does not preclude 
the accumulation of genetic errors targeting pathway genes or central metabolic host genes in trans, 
which leads to a loss of biosynthetic activity and potentially improved fitness. Indeed, limiting the 
mutation rate in Escherichia coli by deleting error-prone DNA polymerases and chromosomal 
insertion sequences (ISs) has led to higher end-point L-threonine productivity and overexpressed 
recombinant protein titer 28,29. Such reports suggest that genetic heterogeneity resulting from 
processes other than gene loss might play a key role in limiting fermentation productivity. However, 
the actual mechanism and population-level dynamics of such genetically-driven production 
disruption remains poorly understood, preventing the establishment of a framework for explaining 
and addressing such production failure modes.  
  
In this study, we investigate the phenotypic and genotypic dynamics of E. coli strains engineered to 
produce mevalonic acid over time-scales relevant to industrial-scale fermentations. Mevalonic acid is 
a precursor to the important secondary metabolite class of isoprenoids, acting as a chemical building 
block for colorants, medicines, flavors, fuels and fragrances 30. Using ultra-deep, time-lapse 
sequencing of the fermentation populations, we resolve diverse, previously difficult-to-decipher and 
non-canonical IS transposition events that limit production.  
Results 
Stability of the mevalonic acid-producing phenotype 
We wanted to study the phenotypic dynamics of mevalonic acid-producing E. coli over industrially 
relevant time-scales. Inoculation of large fermenters typically involves gradual scale-up from an 
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aliquot of a master cell bank by serial growth in vessels of increasing volume 4. During these 
cultivations, the original clone, giving rise to the master cell bank aliquots, proliferates through > 60 
cell generations (Supplementary Table 1). To experimentally simulate this growth process, we 
serially transferred production strain lineages every eight hours for a total of nine times, 
corresponding to approximately 80 cell divisions (generations) (Fig. 1A). Specifically, we cultured five 
parallel lineages of an E. coli TOP10 clone harboring an induced mevalonic acid pathway plasmid 
(pMevT) maintained under constant antibiotic selection to prevent plasmid loss (Online Methods). 
To analyze phenotypic and genetic population dynamics, we sampled and freeze-stocked the 
growing populations every eight hours.  
 
Figure 1. Stability of the mevalonic acid-producing phenotype. A) Large-scale industrial production of 
mevalonic acid was simulated through serial transfer of five parallel mevalonic acid-producing populations. 
The length of the fermentation simulation was chosen to mimic the generation number of a fermentation 
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population in a 200 m
3
 fermentation tank. Production populations were sampled every eight hours for 
subsequent phenotypic and genotypic testing (Supplementary Table 2). B) Population-level average local 
growth rates were determined for parallel populations over the course of the experiment (Online Methods). 
The means are shown relative to the last time point (absolute value 0.84 hr
-1
). A transition of the mean 
population growth rate is observed after 35 generations, in which the population growth rate increases to a 
stable phenotypic state after 70 generations, alleviating the measured production load (Supplementary Fig. 1). 
C) Mevalonic acid titers during the simulated fermentations. The means are shown relative to the earliest time 
point (Supplementary Table 3) and were calculated from five parallel lineages of the E. coli TOP10 mevalonic 
acid-producing clone. Error bars denote the standard error of the means.  
Engineered biosynthesis of mevalonic acid proceeds from acetyl-CoA units through condensation to 
acetoacetyl-CoA (by AtoB) and HMG-CoA (by ERG13) prior to reduction with NADPH to form 
mevalonic acid (by tHMGR) 30–32. Growth impairment from mevalonic acid production in E. coli arises 
largely from the 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) intermediate, which interferes with 
central fatty acid metabolism and the cell membrane 19. As a result of high-level mevalonic acid 
production, our production strain had a 30 % production load, measured relative to a non-producing 
control strain harboring a pathway-excised plasmid (Supplementary Fig. 1).   
 
To assess the dynamics of the population fitness during the experiment, we evaluated population 
growth rates (Online Methods). The average population growth rate gradually increased as a 
function of generation number, following a sigmoidal pattern that stabilized at a new level after 60-
75 generations (Fig. 1B). The population growth rate at the beginning of the experiment was 28 % 
below the final population growth rate, highlighting a considerable change in fitness of the 
simulated fermentation populations (Fig. 1B). This factor combines all fitness changes over the 
simulated fermentations, e.g. also possible remaining loads of the IS-disrupted pathway.  Notably 
still, the difference was similar to the measured production load (30 %).  
 
Next, we determined the mevalonic acid titer of each sampled population throughout the simulated 
fermentation (Fig. 1C). Starting from generation 34, product titers began a decline by several 
percent per generation before leveling off at undetectable concentrations around generation 70. 
The onset of the decline in mevalonic acid production coincided with the increase in population 
growth rate and followed an inversely proportional pattern to the increased growth rate. 
Population-level growth rates were negatively highly correlated with production titers; following an 
exponential decline (R2 = 0.99) (Supplementary Fig. 2). This correlation demonstrates how 
mevalonic acid production was reduced as more fit non-producers took over the fermentation 
population. 
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Modeling and measuring production decline during large-scale fermentations 
   
Figure 2. Mathematical modeling is consistent with the observed mevalonic acid production titer in 
experimentally-simulated fermentations over time. A) Producer cells mutate from the production state at a 
specific escape rate, thereby alleviating the production load (fitness cost of production) (Supplementary Item 
1). B) The best fit of the mathematical model (Supplementary Table 5) to the observed mevalonic acid titer 
throughout laboratory-simulated mevalonic acid fermentations (relative to earliest time point, Supplementary 
Table 3). Error bars indicate the standard errors of the means (n = 5). For reference, possible reactor sizes 
corresponding to particular generation numbers are shown (Supplementary Table 1). C) Modeled fractions of 
producer cells remaining in the population, in which producer cells irreversibly mutate to non-producers at 
various escape rates. The magnitude of the production load drives the rate by which spontaneously formed 
non-producers will enrich the population.  
 
Antibiotic resistance and plasmid loss dynamics have previously been studied using population 
dynamical models 33–36, but related analysis has not expanded to gene instabilities of metabolically 
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engineered production organisms. To elucidate evolutionary factors of biotechnological production 
decline, we developed a simple, two-state deterministic model for the population structure of 
engineered production strains during fermentation (Fig. 2A, Supplementary Item 1). In our model, a 
fermentation population contains producing and non-producing cells with different growth rates 
resulting from the production load. The escape rate describes the transition of producing cells to 
non-producing cells and represents the combined action of all disruptive mutations that abolish the 
production load (Fig. 2A). This escape rate depends on numerous factors, including host mutation 
rate, the size of the genetic targets that abolish production when mutated, and the susceptibility of 
the genetic targets to recombination or other deleterious genetic events. Owing to production load, 
the producer cells will be gradually outcompeted by non-producers. The magnitude of the 
production load determines the rate by which spontaneously formed non-producing cells will enrich 
in the population. This model offers a simplified description of the population dynamics during 
fermentation and can be represented with two coupled ordinary differential equations 
(Supplementary Item 1). Solving these equations yields the respective growth functions of producing 
and non-producing cells over time, assuming a single producing cell as the starting point, constant 
escape rate, production load and no nutrient limitation (Supplementary Item 1). To incorporate 
effects of likely discrete escape events, we also generated a stochastic version of our model 
(Supplementary Item 4). However, for large populations (>1000 cells), a deterministic model 
captures an average of the population dynamics and is computationally more efficient due to the 
existence of an exact analytical solution (Supplementary Table 4) 37,38. 
 
To assess the applicability of our model, we fitted it to the experimentally determined production 
stability (relative product titers) by non-linear regression to predict the escape rate and production 
load (Fig. 2B). Using the experimentally determined production load (30 %, Supplementary Fig. 1), 
the model estimated an effective escape rate of 2.5   10-8 generation-1 (CI95%: ±1.2 10-8) 
(Supplementary Table 5). Such good fit of the production stability data is consistent with our 
assumption of a genetic basis for production decline.  
 
Our model describes how the fraction of producing cells in the fermentation population will decline 
sigmoidally over time when a production load is involved in bio-based production (Fig. 2C). Notably, 
the initial decline determined by the escape rate is low (Fig. 2C) and difficult to detect 
phenotypically. The production load mainly determines the half-life steepness of this transition, 
whereas the escape rate largely shifts the timing of the transition. To explore this concept, we 
calculated the fraction of producer cells over time in specific cases, with production loads of 0-30 % 
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and escape rates of 10-5 – 10-8 generation-1 (Fig. 2C). We found that slight changes to either 
parameter have dramatic consequences for the maintenance of producing cells in a fermentation 
population. These model predictions describe how significant improvements in fermentation end-
performance can result from reductions in production load or escape rate.  
 
Production decline originates within pathway genes  
Many genome-encoded cell functions are necessary for maintaining biosynthetic production, and 
any disruption offers an evolutionary trajectory for an engineered strain to re-gain fitness at the 
expense of production. In a cell factory strain, proteome and genome adaptations might limit 
metabolic productivity through changes to specific or global transcription factors, protein folding 
control or precursor fluxes. We therefore wanted to test whether the production plasmid from the 
evolved populations still conferred mevalonic acid production to a non-evolved host. Plasmid 
populations were extracted from the five end-points and re-introduced into fresh E. coli TOP10 
strains. The transformed cultures did not show any detectable mevalonic acid production, 
demonstrating that the mevalonic acid pathway had been disrupted to incapacitate its biosynthetic 
potential. Additionally, we found no SNPs in the genomes of nine randomly selected colonies from 
the end-point populations relative to the ancestral strain (Supplementary Table 6). 
 
Ultra-deep sequencing reveals the dynamics of the pathway disruption landscape  
To investigate the genetic basis of production failure at the population level, we ultra-deep-
sequenced the heterologous mevalonic acid biosynthetic pathway from three lineages at five 
sampling points during the experimentally simulated fermentation, and all five at the generation 70 
end-point (paired-end 2 x 150bp Illumina sequencing at average depth of 7,200 X, Online Methods).  
Prior studies of cell heterogeneity applied SNP analyses to cultured production strains, yet these 
studies found no evidence of genetic variance 7. We similarly found a lack of SNPs above 1 % 
frequencies in our mevalonic acid pathway end-point populations (Supplementary Fig. 4). However, 
we observed that a declining share of the reads mapped to the production plasmid sequence (Fig. 
3A), indicating structural rearrangements of the biosynthetic pathway or other critical parts. This 
observation prompted us to develop a bioinformatics approach to analyze genetic heterogeneity 
focusing on structural rearrangements and insertions.  
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Figure 3. Inferring invasion of deep-sequenced fermentation cell populations by foreign genetic material. A) 
Percentage of total reads mapped to the production plasmid sequence declined over the course of the 
fermentation (cell generations) (error bars depict std. error of the mean, n = 3, except generation 70: n = 5). B) 
Analysis of mapped reads indicated insertion sequence (IS) transposition owing to the presence of crossed-
over broken read mappings representing IS insertion and the duplication of target sites, also evident from 
elevated target site sequencing coverage (Supplementary Fig. 5).  
 
Notably, we observed that reads not mapping to our production pathway frequently exhibited a 
near perfect partial alignment to our production pathway. We termed such reads broken reads and 
focused our analysis on these reads (Online Methods). The consensus sequence of several of the 
unaligned broken read ends showed perfect identity to the termini of insertion sequences (ISs) and 
tn1000 (also known as gamma-delta), which are mobile elements resident in the E. coli TOP10 
genome. Accordingly, we speculated that these broken reads result from integration of ISs within 
the production pathway. Notably, the gap between the right and left breakpoints usually exhibited 
signature lengths of 3-12 bp, suggesting possible IS target sites (Fig. 3B). At several high-frequency IS 
target sites, a clear rise in insertion site coverage was observed, likely resulting from duplication of 
the target insertion region (Supplementary Fig. 5) 39.  
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To quantify disruption dynamics, we tracked the fraction of position-specific coverage relative to 
corresponding coverage of non-disrupted reference sequences (Fig. 4A) (Online Methods). We 
generally detected the position-specific presence of such disruptions in the pathway populations at 
frequencies down to 0.04 % (three reads).  
 
We found that during the experimentally simulated fermentation, six specific positions in atoB and 
ERG13 of the metabolic pathway were disrupted by IS10, IS186 and IS5 insertions, jointly 
constituting > 91 % at the end-points, generation 70 (Fig. 4A). While the atoB and ERG13 pathway 
genes became increasingly disrupted during the experiment, the final pathway gene tHMGR 
remained free of disruptions (Fig. 4A). This striking degree of preservation of the tHMGR gene is 
probably due to the cytotoxicity of HMG-CoA 19, the substrate of tHMGR. Spontaneous mobile 
element disruptions of tHMGR likely became toxic in cells with active atoB and ERG13, as these cells 
would accumulate cytotoxic HMG-CoA concentrations. Because several atoB disruptions were also 
enriched despite the presence of a chromosomal copy, it is very likely that enriched insertions within 
atoB also abolish ERG13 activity by means of IS-mediated transcriptional termination 40 owing to the 
operon structure of the mevalonic acid biosynthetic pathway. 
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Figure 4. Genetic pathway stability of a mevalonic acid-producing E. coli TOP10 clone in parallel lineages. A) 
Time-lapse high-depth sequencing revealed rising frequencies (population fractions) of mobile element 
insertions. B) The production plasmid pMevT, which encodes the genes atoB, ERG13 and tHMGR in the 
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mevalonic acid pathway. C) Total enrichment of mobile elements in plasmid populations over the 
experimentally simulated fermentation period along with the model fit. D) Individual enrichment of host 
mobile elements in production plasmid populations over the simulated fermentation, and their percent-wise 
enrichment per generation in the exponential range (generations 30-53) (regression statistics in 
Supplementary Table 7). For all the graphs, the error bars indicate standard errors (n = 3, except at generation 
70: n = 5). 
 
Given that complete production loss was observed in the populations, we speculated that other 
mobile elements could explain the remaining 9 % fraction. As a strategy to fully resolve the 
population reads, we mapped all reads to the 24 unique mobile element subgroups in the E. coli 
DH10B genome 41 i.e. not detecting for loci-specific dynamics (Online Methods). We found that joint 
mobile element coverage relative to the original pMevT approached 99.9 % (std. err. = 1.1 %) at 
generation 70 (Fig. 4C). A spectrum of ten host mobile element subgroups each transposed to a 
frequency above 0.01 % in the end-point populations (Fig. 4D). 
 
Using ultra-deep sequencing data to infer population structure is more direct than relative 
production titers because of prior knowledge of the initial, pure starting point and no requirement 
for sample re-cultivation. By fitting the time-resolved total mobile element fractions to our 
production stability model, we improved the confidence of the prediction and estimated an escape 
rate of 8.7   10-8 generation-1 (CI95%: ±0.2 10-8) (Supplementary Table 5). We therefore fitted our data 
without a pre-determined production load to see how well the model could estimate both 
parameters freely. From sequencing-based stability data alone, the model very confidently predicted 
an alleviated production load of 28.1 % (CI95%: ±0.1 ) and a revised escape rate of 2.1   10-7 
generation-1 (CI95%: ±0.1 10-7) (Supplementary Table 5). The predicted 28.1 % production load is 
notably similar to the experimentally determined 30 % production load. An escape rate of 2.1  10-7 
generation-1 corresponds well to previously observed mobile element transposition rates into the 
selectable cycA gene in E. coli DH10B 41. The escape rate of our simple model assumes a complete 
cellular transition from producing to non-producing behavior upon escape. Within each cell, escape 
begins with a single plasmid mutation, which upon cell divisions is increasingly selected towards a 
pure non-producing plasmid population (10-15 copies for p15A-origins), potentially giving rise to an 
intracellular escape heterogeneity. The process towards intracellular escape fixation is driven by 
uneven plasmid segregation and increasingly selective advantage with each additional pathway 
escape. Consequently, the effective production escape rate kescape captures the average rate of these 
combined processes and therefore likely underestimates the single-copy IS insertion rate.  
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Given the lack of selectable composite elements in ISs such as antibiotic resistance genes, 
spontaneous insertion rates have traditionally been harder to detect for ISs than for transposons 
carrying selectable features. Ultra-deep time-lapse sequencing strategies similar to this study should 
thus be useful to further elucidate the molecular fundamentals of bacterial IS transposition. On a full 
cell population basis, broad-spectrum enrichment of ten unique mobile element subgroups was 
detected to final frequencies below 1 % (Fig. 4D). No apparent correlation between genomic IS copy 
number and the enrichment rate was observed (Fig. 4D), as exemplified by subgroups IS2 and IS5, 
which enriched slowly although present at 12 and 13 genomic copies, respectively. This behavior is 
in contrast to the 27 % per generation enrichment of IS10, IS186, which are present at only three 
and four host copies. IS10 and IS186 thus enriched to 93 % of the end heterologous mevalonic acid 
pathway population. 
 
Target site selection of mobile elements is influenced by specific consensus sequences and 
molecular activities, such as on-going transcription 40. The consensus IS10 target site was present in 
tHMGR, the p15A origin and the f1 origin 39, but insertions were not detected in these loci since 
disruption of these elements would likely not be advantageous for growth. Instead IS10 insertions 
were observed in non-canonical sites within the atoB and ERG13 genes. It is surprising that IS10 
disrupts the production load through such non-canonical target consensus (Supplementary Fig. 6), 
and this observation suggests that the spectrum of some ISs is far wider than previously thought.  
 
Tracking broken read dynamics throughout the experimentally simulated fermentation also allowed 
us to estimate non-mobile element structural variations that were enriched in the populations, and 
to compare these variations to those without apparent fitness advantages that merely remained at 
constant frequencies during the experiment. Structural variations detected in the pathway 
terminator region were not enriched (Supplementary Fig. 7), and thus likely did not influence 
production. Such variations might have been observed as artificial noise owing to secondary 
structure formation during sample preparation. We also searched for signs of direct-repeat 
homologous recombination, but this was not observed, likely owing to the lack of repetitive 
sequences larger than 18 bp in the pathway plasmid. 
The relatively high estimated production escape rate (2.1   10-7 generation-1) is also consistent with 
the low presence of enriched pathway SNPs (Supplementary Fig. 5), given the basal SNP formation 
rate of 10-10 bp-1 generation-1 42 . 
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To assess whether the genetic error modes were host-dependent, we repeated the experiment with 
similar procedures using a cell bank of a different production strain, E. coli K-12 strain XL1 (Online 
Methods). The end-points of five parallel-cultured populations were deep-sequenced to map the 
error landscape. Comparison of the error modalities in the two different strains revealed both 
recurrent motifs as well as clone-specific mechanisms (Supplementary Fig. 8).  
 
Model-guided optimization of production stability  
As described by the mathematical model, reductions in production load and escape rate represent 
powerful approaches to improve strain stability. To explore these, we sought to improve production 
stability by both media and strain engineering to limit the production load and escape rate, 
respectively. 
 
The production load resulting from HMG-CoA cytotoxicity is speculated to result from a destabilized 
lipid membrane due to inhibitions in early-step lipid biosynthesis 24,  which may be countered by 
elevated medium osmotic pressure 43. We therefore quantified the growth rate of mevalonic acid-
producing and non-producing populations in a range of NaCl concentrations. At higher osmotic 
pressure (7.5-12.5 g/L NaCl), we found that the growth rate of pure non-producing cultures was 
reduced relative to producing cultures, minimizing the original 30 % growth inhibition to 18-28 % 
(Fig. 5A).  
 
Our model predicts that a reduction of the production load from 30 % to e.g. 22 % would improve 
the half-life of producing cells from 47 to 63 generations (Fig. 5B). For processes operating in 
bioreactor-scales >50m3, such improved stability could provide a crucial enhancement of the 
product yield and titer. We thus experimentally simulated another long-term fermentation with the 
same cell bank (h2m0) using one such optimized medium composition (10 g/L NaCl). We measured 
the mevalonic acid production of the population during the fermentation simulation. The production 
dynamics showed a clear improvement in stability and a slightly less sharp transition of the 
population (Fig. 5C), matching the reduced selective advantage of production loss. Indeed, the best 
model fit to this production stability profile (Supplementary Table 5) estimates a reduced production 
load at 21 % (CI95%: ±0.9 %). This is very close to the measured production load (Fig. 5A) and 
corresponds to an extension of the production half-life from 54 to 66 generations. The HMG-CoA 
accumulation of mevalonic acid production is associated with osmotic and oxidative stress24. Cross-
protection in osmotic and oxidative stress response of E. coli44 may thus also explain why elevated 
osmotic pressure in part alleviated the HMG-CoA growth inhibition. The observed, reduced basal 
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mevalonic acid production may also explain the reduced growth inhibition of these cells 
(Supplementary Table 3). 
  
Figure 5. Reducing production decline by optimization of spontaneous escape rate and production load. A) 
Limiting the production load of mevalonic acid production by supplementing medium with elevated NaCl 
concentrations (i.e. minimizing the growth-advantage of mutation). This reduction is evident by the growth 
rate difference of pure producing and non-producing populations. Growth rates depicted relative to fastest 
growing condition and production load calculated as relative growth rate difference. Error bars depict std. 
error (n = 6). B) Predicted half-life of a producing cell population with a 2.1 10-7 generation-1 escape rate and 
corresponding production loads estimated from modulated NaCl levels in panel A. C) Utilizing a reduced 
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production load and escape rate respectively to extend production half-life in experimentally simulated long-
term fermentations, evaluated by mevalonic acid production titers (relative to earliest time point) 
(Supplementary Table 3).  Results shown for a TOP10 host (h2m0) in standard (n = 5, grey data points) and in 
optimized medium (n = 4, generation 49: n = 3, blue data points) and for an MDS42 host (h10m0) with reduced 
escape rate (n = 4, orange data points). Error bars depict std. error of the mean. Lines represent best fits to 
population fraction model at a 2.1 10-7 generation-1 escape rate (Supplementary Table 5). Data for TOP10 host 
in std. medium also shown in Fig. 2B is included for comparison.  
 
Reducing the escape rate offers an alternative strategy that is especially favorable when production 
loads are difficult to minimize. Due to the observed impact of IS-dominated pathway disruptions, a 
host strain lacking ISs should prevent this escape mechanism. To benchmark the dynamics in such 
chassis, we transferred the metabolic pathway (pMevT) to a previously generated, genome-reduced 
and IS-free E. coli K-12 strain MDS42 45. We simulated a long-term fermentation with this host strain 
using our standard medium and quantified the dynamics of mevalonic acid production (Fig. 5C). The 
marked improvement in production stability supports the hypothesis that lack of host genomic ISs 
significantly improves production stability, leading to good preservation of production at the end-
point of the fermentation simulation (89 generations). However lower escape rate error modes 
resulting from SNPs and non-homologous recombination may impact stability on a longer term. 
Further, the fitness-neutral genome reductions guiding the construction of MDS42 45 may not 
necessarily be neutral to metabolic production performance, as indicated by the lower mevalonic 
acid titer in the MDS42 host (Supplementary Table 3). 
 
Discussion  
Bio-based production is a central contributor to the transition of our society towards a greener and 
more sustainable future. However, large-scale bioprocesses are hampered by high yield and 
productivity requirements, and many new processes cannot be made commercially viable due to 
declining performance at the scale-up step. Prior work has focused on the phenotypic variance that 
can contribute to the reduced performance of bio-based processes 48. While IS elements have been 
shown to disrupt production phenotypes, the role of evolution and genetic mechanisms in 
production decline is not well characterized.  
In this study, we experimentally simulated the time-scales and population sizes of large-scale 
bioprocesses in production of the key biochemical building block, mevalonic acid. We introduced a 
simple framework that captures population dynamics of engineered production strains. We 
demonstrated in several different host strains that evolution substantially affects population 
structure over industrial time-scales, with direct ramifications for bio-based process performance. 
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While ultra-deep sequencing has advanced the understanding of heterogeneities in human disease 
evolution 49, so far no studies have investigated the potential for biotechnological evolution at 
population depth, in part possibly due to difficulties in resolving structural variations by short-read 
sequencing of populations. We observed that pathway error modes are dominated by a broad 
spectrum of IS insertions in non-canonical target sites. These remove or alleviate the production 
load, and the error modes differ between strains and clone banks, but appear rapidly in a 
population.  
 
We find that two key parameters influence the probability and speed by which evolution can impact 
cell factory stability: the escape rate, which is the rate by which non-producing mutants are 
generated in a population, and the production load, which manifests a lower fitness of producing 
cells in direct competition with non-producers. Based on these parameters, a two-state 
mathematical model accurately describes the essential population dynamics of experimentally 
simulated fermentations. By de-convoluting stability into its two principal parameters, the model 
provides a quantitative framework for evaluating the scale-up process, such as the long-term impact 
of a loaded pathway enzymatic step. This model describes genetic heterogeneity at the population-
level and assumes a two-state transition from producer to non-producer cell, which may not be 
adequate e.g. for pathways operating with several independently loaded biosynthetic genes. Further 
the model assumes growth without nutrient limitations and a constant escape rate and production 
load. Average experimental estimations appear to approximate the load well (Supplementary Fig. 
S1), and may help isolate the production escape rate averages. However, escape rates may be 
stimulated by different molecular stresses, e.g. in the final phase of bioreactor growth, which are 
unaccounted for in our simulation. In this study, we have approximated the industrial use of 
gradually increasing seed train sizes under which most cell divisions occur, by strict passing of 
cultures in exponential phase throughout the study and shown good fit to a simple model. Thus, 
integration of dynamic models with time-resolved phenotypic and genotypic data, may help guide 
an investigator to separate load and mutational effects during production strain and process 
development to more rationally accommodate evolutionary process limitations.  
  
Our results offer a potential explanation of why lab-scale yields and titers might not accurately 
predict large-scale fermentation performance following a scale-up procedure, despite vector 
maintenance. The observed pathway disruptions occur within a plasmid population maintained by 
selection. We find that these dynamics of pathway disruption are similar to those of segregational 
plasmid loss 33, although they act at different rate scales and are characterized by a diversity of 
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mutational error modes (Fig. 4). As an example, our model predicts that an initially pure producing 
population, with a production load of 30 % and an escape rate of 10-7 generation-1, will shift to 96 % 
non-producing cells over 60 generations, corresponding to a bioreactor of 2 m3. Remarkably, the 
same population at lab-scale (age of 37 generations) might appear high performing with less than 3 
% non-producers in the population. Because the majority of product is synthesized when the 
fermentation population reaches the final density in industrial-scale production, it is crucial to 
investigate the population genotype at this point and not simply extrapolate phenotypic 
performance from lab-scale experiments. Time-lapse ultra-deep sequencing represents a valuable 
approach for determining error modes, occurrence rates and their alleviated loads at an early stage. 
Such ultra-deep sequencing may also be applied to existing scaled-up fermentations, previously 
thought to be free of heterogeneity. 
 
Common industrial practice employs production strain clone banks stocked as frozen aliquots. 
Genetic errors in only a few cells might reside in the starting seed although the population appears 
healthy for a considerable number of divisions. Seeding fermentations from the same cell bank clone 
therefore generates a highly recurring stability profile. Cell bank aliquots should therefore be 
evaluated for rare pre-existing mutations that disrupt production and could be selected for during 
production scale-up. Deep-sequencing of master cell bank aliquots could be applied for this purpose.  
 
Considering that production load improvements by even a few percent can substantially improve 
stability (Fig. 2C), the specific contributors to production loads must be addressed for each pathway 
and host cell considering a final large-scale process. For example, reducing the production load from 
28 to 23 % should extend the production half-life by 10 generations (assuming a constant escape 
rate of 2.1 10-7 generation-1). 
Practical strategies will be required to reduce factors of production load, including medium 
optimization, improved balancing of pathway gene expression and the cellular export of toxic by or 
end products. Poor balancing may favor accumulation of toxic pathway intermediates which carry 
particularly high potential as a production load. Because intermediates are intracellular, associated 
toxicities selectively target the producing cells. In this case, adding genes to degrade toxic by-
products or to dynamically redirect pathway flux, and the use of specific metabolite- or stress-
induced pathway promoters, may be advantageous for limiting production load 50–52. In the rare 
cases of growth rate-coupled production, semi-continuous processes have been commercialized to 
improve productivity, such as R-lactic acid in Lactobacillus 53. 
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In attempts to improve stability, systems for maintaining metabolic pathways through multiple 
chromosomal integrations are often used54,55 while stabilizing duplications may also result randomly 
during optimization56. Still, integrated pathways remain subject to intra-pathway disruptions by 
SNPs, mobile genetic elements and illegitimate recombination, but independence of the individual 
integration sites means that escapes will not spread in the intracellular pathway population by 
means of uneven segregation such as some plasmid systems permit. Independently propagated 
pathway copies may thus provide stabilization in addition to easier antibiotics-free pathway 
maintenance, which today appears as the major advantage of chromosomal integration. Yet multiple 
integrations require significantly longer construction protocols, especially at >50 copies and when 
limited to IP-free engineering. Future studies should investigate the changes in intra-pathway escape 
dynamics of such multi-copy, chromosomally integrated production pathways. Based on our results, 
removal of mobile elements from the genomes of microbial production strains 58 is a relevant first 
step for long-term stabilization and the enabling of toxic and burdened pathway expression. 
Mechanistically, escape via homologous recombination points can be avoided e.g. by synonymous 
codons57. Such strategies postpone the onset of significant genetic heterogeneity (Fig. 5C).  
 
Dynamic fermentation population models might serve as technical tools to predict the necessary 
reduction in escape rate or production load for a particular bioreactor size. Knowledge of stability 
dynamics should ensure a more holistic evaluation of strains by taking into account the potential for 
rapid performance loss. By characterizing and modeling the interplay between spontaneous genetic 
errors in-depth and their selection by metabolic burden and pathway toxicity, we have shown the 
paths for their synergistic impact on pathway stability. Furthermore, we have demonstrated how 
engineered reductions in both production load and escape rate can improve stability. We expect 
that the results, methodologies and their implications will open new opportunities for metabolic 
engineers in the quest to develop sustainable and industrially scalable bioprocesses.  
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Online Methods 
 
Strains 
E. coli K-12 parental strains below were used to construct the strains analyzed (Table 1) using 
the specified plasmids (Table 2). 
 
 E. coli TOP10, similar to DH10B (Invitrogen) 
F– mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara, leu) 7697 galU 
galK rpsL (StrR) endA1 nupG 
E. coli XL1 (Agilent) 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacI
q
 Z∆Mϭ5 TnϭϬ (Tetr)] 
E. coli MDS42 (͞MDS42 LowMut͟, SĐaraď GeŶoŵiĐs)  
MG1655 genome-reduced for all ISs, fhuACDB, endA and more 45. 
 
Standard chemical transformation or electroporation was used for gene introduction.  
 
For test in experimentally simulated fermentations, single colonies were cultured and stored at -
80 deg. C to serve as working clone banks (designated by m numbers) following standard 
industrial practice 59. 
 
Table 1. Strains analyzed in this study. 
Strain Plasmid Parental E. coli K12 
strain 
Chromosomal 
editing 
Clone banks 
h2 pMevT TOP10 - m0, m1, m2, 
m3 
h8 pMevT4 TOP10  - m0 
XL1-pMevT pMevT XL1 - m0 
h10 pMevT MDS42 - m0 
h9 pMevT4 MDS42 - m0 
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Plasmids 
pMevT4 was generated by PstI digestion of pMevT followed by re-ligation of the backbone using 
T4 DNA ligase and standard molecular biology methods, excising the metabolic pathway 
cassette (atoB, ERG13, tHMGR). 
PCRs were conducted by standard procedures with Phusion U DNA polymerase (Thermo). Uracil-
excision cloning was performed by approx. equimolar mixing of the respective purified PCR 
pƌoduĐts ;Taďle ϯͿ iŶ a ϮϬ μL ƌeaĐtioŶ iŶĐludiŶg Ϯ μL FastDigest ďuffeƌ ;TheƌŵoͿ, Ϭ.ϳϱ μL USER 
enzyme (NEB) and 0.75 uL FastDigest DpnI (Thermo). The reaction incubated for 60 minutes at 
37 deg. C followed by 20 minutes at 25 deg. C, and was subsequently co-transformed with 
pSIM6 into chemically competent E. coli TOP10 cells. 
 
Table 2. Plasmids used to generate strains.  
Plasmid Relevant features Reference 
pMevT plac:atoB-ERG13-tHMGR:trnnB, cam
R
, p15A (Martin et al., 2003) 
pMevT4 plac:trrnb, cam
R
, p15A This study 
 
 
Media 
For all cultivations, standard 2xYT characterization medium was used unless otherwise stated:  
2xYT medium: 10 g/L yeast extract (Sigma-Aldrich), 16 g/L tryptone (Bacto), 5 g/L NaCl (pH 
adjusted to ϳ.ϬͿ suppleŵeŶted ǁith ϯϬ μg/ŵL ĐhloƌaŵpheŶiĐol aŶd ϱϬϬ μM isopƌopǇl β-D-1-
thiogalactopyranoside (IPTG). 
For genetic transformations, SOC medium was used. SOC consisted of 5 g/L yeast extract, 20 g/L 
tryptone (Bacto), 10 mM NaCl, 2.5 mM KCl, 20 mM MgSO4 and 20 mM D-glucose. 
 
Experimentally simulated long-term fermentation by continuous growth of mevalonic acid-
producing E.coli  
Five parallel lineages of the pMevT-harboring TOP10 clone bank h2m0 were inoculated into 
aerated cultures (EVO2) (Table 3). Each culture contained 25 mL medium and was grown for 8 
hours at 30 C with horizontal shaking at 250 rpm. After 8 hours, 0.5 mL broth was inoculated 
into 25 mL fresh medium and incubated under the same conditions for another 8 hours. At each 
passage, the OD600 was recorded to determine the accumulated number of cell divisions (Table 
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SϮͿ. CoŶstaŶt pathǁaǇ iŶduĐtioŶ ;ϱϬϬ μM IPTGͿ ǁas applied to ŵiŵiĐ ĐoŶstitutiǀe pƌoŵoteƌ 
designs, as the advantages of late induction (e.g., using plac) would be unattainable industrially 
owing to inducer cost 6. The simulation was repeated (EVO8) . For EVO8, four of five lineages 
were randomly selected for subsequent analysis. 
 
Table 3 Experimentally simulated long-term fermentations. For growth progressions, see 
Tables S2 and S9. 
 
EVO no. Strains Culture 
conditions 
Clone banks Lineages Deep-sequenced 
seeds 
EVO2 h2  2xYT, 30 deg. C m0 c6-c10 All: s9 
c6,c8,c10: s2-s6 
EVO2B XL1-MevT 2xYT, 37 deg. C m0 c1-5 s6 
EVO8 h2 2xYT+5g/L NaCL, 
30 deg. C 
m0 c1-4 - 
h10 2xYT, 30 deg. C m0 c6-9 - 
 
Repeated simulated long-term fermentation with different E. coli host strain XL1 
Five parallel lineages of the pMevT-harboring E. coli XL1 clone bank (XL1-MevT) were inoculated 
into aerated cultures (EVO2B) (Table 3). Each culture contained 50 mL medium and was grown 
for 12 hours at 37 C with horizontal shaking at 250 rpm to match the slower growth of XL1. 
After 12 hours, 1 mL broth was inoculated into fresh medium and incubated under the same 
conditions. At each passage, the OD600 absorbance was recorded.  
Simulated long-term fermentation with pathway-coupled essential gene expression  
Four parallel lineages were inoculated from respectively four h2 and kle1#1 master clone banks 
into aerated cultures and was cultured at 32 deg. C (EVO10) (Table 3), but otherwise following 
same methods as the first simulated long-term fermentation.  Randomly, three lineages of 
respectively h2 and kle1#1 were selected for subsequent analysis. At each passage, the OD600 
was recorded to determine the accumulated number of cell divisions (Table S9). Three of four 
lineages were randomly selected for subsequent analysis. 
High-depth DNA sequencing and analysis 
Upon each passage to new medium, 1.8 mL of the grown culture was stored at -20 C. Similarly, 
1.8 mL of grown culture was stored at the simulated fermentation end. Production plasmid 
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populations were subsequently purified from each time point using a standard plasmid 
purification kit (Macherey-Nagel). The samples were then prepared for Miseq sequencing using 
the Neǆteƌa XT ǀϮ set A kit ;IlluŵiŶaͿ peƌ ŵaŶufaĐtuƌeƌ͛s iŶstƌuĐtioŶs ǁith the additioŶ of tǁo 
͚liŵited-ĐǇĐle PCR͛ ĐǇĐles.  
Sequencing was performed in a pooled run with 150 bp paired-end reading. CLC Genomics 
Workbench (version 8.5) was used for initial bioinformatics analysis. First, the reads were 
mapped to the reference pMevT sequence (Addgene #17815). Broken aligned reads were 
identified using the CLC Genomics Workbench tool Breakpoint analysis to yield a table of the 
consensus broken unaligned reads and their abundance (maximum three miss-matches allowed 
in the mapped read region, p-value for the fraction of unaligned reads set to 0.0001) to obtain 
an initial overview of occurred structural variation. The fraction of mobile element coverage to 
plasmid coverage was calculated by mapping of reads to the 24 unique E. coli DH10B mobile 
element sequences and the reference plasmid. Subgroups IS10R and IS10L were combined as 
IS10 and IS1A, B and F as IS1. Position-specific mobile element/reference coverage was 
calculated by mapping 80 bp sequences consisting of respectively the corresponding 40 bp 
reference plasmid and 40 bp mobile element sequence or 80 bp reference plasmid sequence. 
These ŵappiŶgs ǁeƌe peƌfoƌŵed ǁith the aligŶŵeŶt settiŶg ͚gloďal͛ aŶd ideŶtitǇ fƌaĐtioŶ set to 
͚Ϭ.ϲ͛. MappiŶgs ǁithout aŶǇ ƌeads ĐoǀeƌiŶg aĐƌoss the ŵoďile eleŵeŶt juŶĐtioŶ ǁeƌe 
disregarded. Single-nucleotide polymorphisms (SNPs) and short deletions were called using the 
CLC Genomics Workbench Low Frequency Variant Detection tool with a 1 % required 
significance level and 0.25 % minimum frequency (unless otherwise specified). The SNP 
frequencies in the sequenced populations were calculated by division with their respective 
coverage values. 
Five SNPs found in the plasmid backbone at >99% frequencies in the initial seed were regarded 
as present in the starting plasmid. The deep-sequencing data is available via the ArrayExpress 
repository (accession no: E-MTAB-5862). 
 
Whole-genome sequencing of single colonies 
DNA for whole-genome sequencing from single colonies was extracted from a grown 2 mL 
culture using a standard DNA extraction kit (Qiagen), but otherwise prepared as above for a 
pooled Miseq run. For identification of SNPs, reads were mapped to the public available DH10B 
genome, and detected for using the Low Frequency Variant Detection tool of CLC Genomics with 
a minimum detection frequency of 80 %. 
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Measurement of mevalonic acid production by HPLC 
UpoŶ eaĐh passage to a fƌesh Đultuƌe, ϵϬϬ μL ŵediuŵ ǁas ŵiǆed ǁith ϵϬϬ μL ϱϬ % glǇĐeƌol aŶd 
stored at -80 C. FolloǁiŶg the siŵulated feƌŵeŶtatioŶ, eaĐh populatioŶ saŵple fƌoŵ a Ϯϱ μL 
glycerol stock was used to inoculate 15 mL medium, and the culture was incubated at 30 C with 
shaking at 250 rpm for 54-ϱϴ houƌs. FolloǁiŶg iŶĐuďatioŶ, ϯϬϬ μL aliƋuots ǁeƌe tƌeated ǁith Ϯϯ 
μL ϮϬ % sulfuƌiĐ aĐid. Saŵples ǁeƌe ǀigoƌouslǇ shakeŶ aŶd theŶ spuŶ doǁŶ at ϭϯ,ϬϬϬ g foƌ Ϯ 
minutes. Supernatant (medium) samples were injected into an Ultimate 3000 HPLC running a 5 
mM sulfuric acid mobile phase (0.6 mL/min) on an Aminex HPX-87H ion exclusion column (300 
mm × 7.8 mm, Bio-Rad Laboratories) at 50 C. A refractive index detector was used for 
detection. A standard curve for mevalonic acid was generated with mevalonolactone (Sigma-
Aldrich) dissolved in 2xYT medium supernatant of an engineered non-producing strain incubated 
under same conditions. 
 
Measurement of population growth rates 
To measure population growth ƌates, ϭ.ϱ μL aliƋuots of statioŶaƌǇ-phase cultures grown for 
pƌoduĐtiǀitǇ aŶalǇsis ;as desĐƌiďed iŶ the pƌeǀious seĐtioŶͿ ǁeƌe used to iŶoĐulate ϮϬϬ μL 
medium in microtiter plate wells. The microtiter plate was sealed with a Breathe-Easy 
polyurethane seal ;USA SĐieŶtifiĐͿ aŶd ǁas iŶĐuďated at ǁith ͞fast͟ ĐoŶtiŶuous shakiŶg iŶ aŶ 
ELx808 kinetic plate reader (BioTek), which measured the OD630 value every ten minutes. 
Background-subtracted OD630 values were computed using the measurements from un-
inoculated wells. The local growth rates were computed for each background-subtracted OD630 
value by regressions in rolling windows of five measurement points and background-subtracted 
OD630 values. To represent the growth rates in the actual fermentation simulations, the average 
was computed of the local growth rates where the background-subtracted OD630 was > 0.04 and 
< 0.4. R script appended (Supplementary Item 2). 
Simulation of producer fraction over time and fit to model 
The coupled ODE system (Supplementary Item 1) was solved using Maple 2015. Solution growth 
functions were then combined to yield a function for the fraction of producer cells in time 
(Supplementary Item 1). Non-linear regression was performed to fit to this model with the nls2 
R package (Supplementary Item 3). A stochastic version of the model was constructed by 
employing the algorithm of Gillespie to simulate discrete mutational events of our system in a 
stochastic manner 61. We assume that each event (e.g. cell division and mutation) occurs 
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according to probabilities scaled with the parameters obtained from the deterministic fit of our 
data (production load: 30 %, escape rate: 2.1  10-7) (Supplementary Item 4). 
Data and code availability 
Deep-sequencing data from the study (Figures 3 and 4) have been deposited in ArrayExpress 
under ID code E-MTAB-5862 . 
R scripts used to process raw growth data and fit to model are provided in Supplementary Items 
2 and 3. R script for running stochastic version of model is provided in Supplementary Item 4. 
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Table S1. Calculated number of cell divisions (generations) needed to occupy the bioreactor type specified 
at the respective OD600 or number of cells. 
Bioreactor type 
Number of 
cells OD600 Volume (L) 
Accumulated 
generations 
Strain 
construction 2 10
11
 1                0.01 L  38 
Laboratory-scale 2 10
15
 100                     2 L  51 
Industry-scale 2 10
17
 100                 200 L  57 
Industry-scale 2 10
18
 100              2.000 L  61 
Industry-scale 1 10
19
 100            10.000 L  63 
Industry-scale  2 10
20
 100          200.000 L  67 
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Table S2. Average determined number of generations undergone by the experimentally simulated 
fermentation from the mevalonic acid-producing h2m0 and h10m0 clone banks (in EVO2 and EVO8), 
accumulated and at the individual 8-hour passages (seeds) (standard error shown +/-, for EVO2 n = 5, 
EVO8 n = 4).  
Growth 
tube 
(seed) 
New 
generations  
(-80 stock) 
Accumulated 
generations  
(-80 stock and 
sequenced 
sample) 
Accumulated 
generations  
(15 mL re-grown 
stock for 
analysis) 
Experimentally 
simulated 
fermentation ID 
and lineages 
Strain 
clone 
bank 
Bank 
culture  
18.4 18.4 28.1 EVO2 c6-c10 h2m0 
s1 5.1 +/- 0.02 23.5 33.2 EVO2 c6-c10 h2m0 
s2 6.2 +/- 0.03 29.7 39.4 EVO2 c6-c10 h2m0 
s3 5.6 +/- 0.04 35.3 45.0 EVO2 c6-c10 h2m0 
s4 5.8 +/- 0.03 41.1 50.8 EVO2 c6-c10 h2m0 
s5 5.6 +/- 0.05 46.7 56.4 EVO2 c6-c10 h2m0 
s6 5.8 +/- 0.02 52.5 62.3 EVO2 c6-c10 h2m0 
s7 5.7 +/- 0.00 58.2 67.9 EVO2 c6-c10 h2m0 
s8 5.7 +/- 0.01 63.9 73.6 EVO2 c6-c10 h2m0 
s9 5.6 +/- 0.01 69.6 79.3 EVO2 c6-c10 h2m0 
Bank 
culture  18.4 18.4 28.1 
EVO8 c1-4 h2m0 
s1 9.8 +/- 0.03 28.2 37.9 EVO8 c1-4 h2m0 
s2 5.8 +/- 0.04 38.1 47.8 EVO8 c1-4 h2m0 
s3 5.6 +/- 0.02 43.9 53.6 EVO8 c1-4 h2m0 
s4 5.7 +/- 0.02 49.5 59.2 EVO8 c1-4 h2m0 
s5 5.7 +/- 0.02 55.2 64.9 EVO8 c1-4 h2m0 
s6 5.6 +/- 0.01 60.9 70.6 EVO8 c1-4 h2m0 
s7 5.8 +/- 0.00 66.5 76.2 EVO8 c1-4 h2m0 
s8 5.7 +/- 0.01 72.3 82.0 EVO8 c1-4 h2m0 
s9 5.7 +/- 0.02 77.9 87.6 EVO8 c1-4 h2m0 
Bank 
culture  18.4 18.4 28.1 
EVO8 c6-c9 h10m0 
s1 9.3 +/- 0.29 27.7 37.4 EVO8 c6-c9 h10m0 
s2 6.3 +/- 0.21 34.1 43.8 EVO8 c6-c9 h10m0 
s3 5.8 +/- 0.07 39.9 49.6 EVO8 c6-c9 h10m0 
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s4 5.7 +/- 0.01 45.6 55.3 EVO8 c6-c9 h10m0 
s5 5.6 +/- 0.01 51.2 60.9 EVO8 c6-c9 h10m0 
s6 5.7 +/- 0.01 56.9 66.6 EVO8 c6-c9 h10m0 
s7 5.6 +/- 0.00 62.5 72.2 EVO8 c6-c9 h10m0 
s8 5.7 +/- 0.01 68.1 77.8 EVO8 c6-c9 h10m0 
s9 5.6 +/- 0.01 73.8 83.5 EVO8 c6-c9 h10m0 
s10 5.7 +/- 0.01 79.4 89.1 EVO8 c6-c9 h10m0 
 
 
Figure S1. Related to Figure 1. Load of producing mevalonic acid (h2m0, red) as measured by 
comparison to growth of pathway-excised, non-producing control (h8, blue). Growth rates were 
dependent of the phases of growth, and therefore for quantification we use an average in the 
background-subtracted OD630 region 0.04-0.40, which we quantified to 30 % (n = 8) (Online 
Methods).  
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Figure S2. The relation between population growth rate average and mevalonic acid titer of h2m0 and 
long-term cultured populations (n = 5) (relative to eaƌliest data poiŶt iŶ siŵulated feƌŵeŶtatioŶ ͞EVOϮ͟. 
Relative mevalonic acid titer is respectively A) non-treated, and B) log-transformed) resulting in the 
respective regressions shown as lines (grey area depicts 95 % confidence interval of regression): A:  y = -
0.21x + 0.84, R
2
  = 0.97, p = 2.0 10
-6
, and  
B:  y = 0.968 - 0.13 e
x
, R
2
 = 0.99, p = 1.3 10
-8 
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Table S3. Related to Figure 1. Measured mevalonic acid titers (g/L) in earliest time point from the 
indicated simulated fermentation, se: standard error of the mean (EVO2: n = 5, EVO8: n = 4, EVO10: n = 3). 
 
Strain clone bank Simulated 
fermentation ID 
Cultivation condition Mevalonic acid (g/L) 
+/- se 
h2 m0 EVO2 Std. medium, 30 deg. C 1.2 +/- 0.04 
h2 m0 EVO8 Opt. medium, 30 deg. C 0.9 +/- 0.04 
h10 m0 EVO8 Std. medium, 30 deg. C 0.5 +/- 0.05 
h2 m1, m2, m3 EVO10 Std. medium, 32 deg. C 1.3 +/- 0.04 
kle1#1 m1, m2, m3 EVO10 Std. medium, 32 deg. C 1.0 +/- 0.04 
h11 m0, m2, m3, 
m4 
EVO13 Std. medium, 30 deg. C 1.3 +/- 0.05 
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Table S4. Variation in the cell divisions (generations) till first mutation by four replicate runs of a 
stochastic version of our population escape model (script in Supplementary Item 3), performed on an 8-
Đoƌe desktop Đoŵputeƌ ;IŶtel® Coƌe™ iϳ-4770K CPU @ 3.50GHz × 8). Computation time scales with 
number of cells and ran >3 days to observe a first mutation (escape) in all four replicates.  
 
 
 
 
 
 
 
 
Table S5. Related to Figure 2. Production loads and escape rates estimated from fermentation 
simulations by fit to model or by pure-culture measurements. 
Parameter Strain and 
condition 
Method 
Data source 
Estimate value (generation
-
1
) and  p-value  
Production load 
h2m0, relative 
to h8 
std. medium 
Growth rate average Pure-culture 
growth curves  
30 % 
Escape rate h2m0,  
std. medium 
Fit to model using pure-
culture determined 
production load 
Production over 
time 
2.5 10
-8 
(p-value = 0.0012) 
Escape rate h2m0, 
std. medium 
Fit to model using pure-
culture determined 
production load 
Total IS fraction 
over time (from 
deep-seq) 
8.7 10
-8 
(p-value < 0.0001) 
Production load h2m0,  
std. medium 
Free fit to model Total mobile 
element fraction 
over time (from 
deep-seq)  
28 % 
(p-value < 0.0001) 
Escape rate h2m0,  
std. medium 
Free fit to model Total mobile 
element fraction 
over time (from 
deep-seq) 
2.1 10
-7
  
(p-value < 0.0001) 
 
Production load 
h2m0, relative 
to h8 
opt. medium 
Growth rate average Pure-culture 
growth curves 
23 % 
Production load h10m0, 
relative to h9 
Growth rate average Pure-culture 
growth curves 
26 % 
Replicate Generations to first mutation No. of cells 
1 19.42837 705542 
2 19.44143 711956 
3 20.23096 1230621 
4 20.99365 2087940 
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std. medium 
Production load h2m0,  
std. medium
 
Fit to model with NGS-
determined escape rate 
Production over 
time 
26 %  
(p < 0.0001) 
Production load h2m0,  
opt. medium 
Fit to model with NGS-
determined escape rate 
Production over 
time 
21 %  
(p < 0.0001) 
 
 
Table S6. SNPs found in the chromosomes of colonies picked from streaks from the end-point 
experimentally simulated fermentations of h2m0 ;std. ŵediuŵ, ͞EVOϮ͟Ϳ. SNPs ǁeƌe ideŶtified afteƌ 
mapping of reads to the publicly available genome sequence of E. coli DH10B (accession CP000948). SNPs 
were called at minimum coverage of 15, maximum coverage of 1000. Three colonies (k1-3) were 
randomly picked from lineage c6, c8 and c10 respectively.  
Sample colony Region Type Reference Allele Coverage Frequency 
 
Probability 
TOP10 4272971 Insertion - T 36 97.22 1 
c6s9k1 4272971 Insertion - T 25 100 1 
c6s9k2 4272971 Insertion - T 24 100 1 
c6s9k3 4272971 Insertion - T 46 97.83 1 
c8s9k1 4272971 Insertion - T 35 97.14 1 
c8s9k2 4272971 Insertion - T 40 95 1 
c8s9k3 4272971 Insertion - T 42 100 1 
c10s9k1 4272971 Insertion - T 25 100 1 
c10s9k2 4272971 Insertion - T 24 100 1 
c10s9k3 4272971 Insertion - T 46 97.83 1 
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Figure S4. Mean frequencies of three detected single nucleotide variants in the dynamically sampled 
lineages c6, c8 and c10 of the experimentally simulated long-term fermentation of E. coli h2 m0, at a 
minimum detection level of 0.1 %. Error bars denote standard error (n = 3). 
 
 
 
Figure S5. Related to Fig. 3. Number of mapped reads (coverage) at the reference plasmid positions in the 
proximity of a high-frequency IS10 insertion, likely resulting from duplication of the target recognition 
region (data from three parallel h2m0 lineages c6, c8 and c10 shown following seed 9). 
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Table S7. Related to Fig. 4. Summary statistics of linear regressions of log-transformed mobile element 
subgroup fractions with cell divisions. Enrichment rates were calculated by linear regression of log10-
transformed mobile element frequencies in the exponential phase seeds s2-s6 for the three time-lapse 
sequenced samples lineages c6, c8 and c10. 
IS 
subgroup Estimate Std. Error t value Pr(>|t|) R
2
 
IS10 0.103524 0.006623 15.63 0.000569 0.98 
IS186 0.099346 0.004302 23.09 0.000178 0.99 
IS5 0.052057 0.006731 7,734 0.0045 0.95 
IS1 0.05529 0.007353 7,519 0.004875 0.95 
IS3 0.066145 0.004971 13.31 0.000917 0.98 
IS150 0.015975 0.003622 4.41 0.021625 0.86 
tn1000 0.083741 0.003768 22.23 0.000199 0.99 
IS2 0.022302 0.005604 3.98 0.028387 0.84 
IS911 0.01759 0.00377 4,667 0.0186 0.88 
IS30D 0.03692 0.01234 2,993 0.05799 0.75 
 
 
 
 
Figure S6. Consensus sequence for ten IS10 insertion sites observed in the deep-sequenced pMevT 
plasmid populations, as analyzed using WebLogo 3 
62
. This observed consensus deviated from a previously 
reported consensus target sequence of IS10: NGCTNGACN 
63
 .  
WebLogo 3.5.0
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Figure S7. Exemplary structural variation (pMevT plasmid backbone, region 4500-6500 bp featuring the 
rnnB terminator and f1 origin) without enrichment over the course of the experimentally simulated 
fermentation of E. coli h2m0 ͞EVOϮ͟ ;ďƌeakpoiŶt fƌeƋueŶĐǇ = ďƌeakpoiŶt ƌeads peƌ ĐoǀeƌageͿ liŶeages Đϲ, 
c8 and c10, sampled after seed 2 (s2) and final seed 9 (s9).  
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Figure S8. Recurring mobile element disruptions within the load-carrying genetic regions of the mevalonic 
acid pathway in two E. coli production cell banks as assessed by ultra-deep sequencing of pathway 
populations at the end of experimentally simulated long-teƌŵ feƌŵeŶtatioŶ ;͞EVOϮB͟Ϳ ǁith E. coli Top10 
(h2m0) and XL1 (XL1-MevTm0) hosts. Error bars indicate standard errors (n = 5), and dashed lines connect 
elements recurring across the Top10 and XL1 experimentally simulated fermentations. 
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 Supplementary Item 1 
A simple mathematical model for the fraction of producers in time is established by solution of an 
ordinary differential equation system (eq1 and eq2) with analogy to models of plasmid loss 
dynamics
33
. 
p(t): producer cells in time 
np(t): non-producer cells in time  : specific growth rate 
ρ : pƌoduĐtioŶ load = ϭ -       
(eq1):   
                             
(eq2):                                   
 
Non-producer cells are converted from producer cells at a rate kescape and such non-producers 
alleǀiate a ƌeduĐtioŶ iŶ gƌoǁth ƌate due to pƌoduĐtioŶ load ρ. The solutioŶ gƌoǁth fuŶĐtioŶs ;eƋϯ aŶd 
eq4) assume a pure initial inoculum of a single, producing cell, and can be found by first solving eq1 
and inserting the resulting p(t) in eq2.  
 
(eq3):                       
(eq4):      =                                                =              ρ μ                    ρ μ   μ     
 
From these, the fraction of producers in time (eq5) can be derived.  
(eq5): 
                                                                                                                                         
Further, by defining up relative to unp = ϭ, the ŵodel is oŶlǇ depeŶdeŶt oŶ the ƌelatiǀe gƌoǁth ƌate ;ρͿ 
and the escape rate (kescape) 
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S1 Item 2 
#Script to analyze growth rate measurement 
#Required packages 
library(ggplot2) 
library(reshape2) 
library(scales) 
library(plyr) 
library(drc) 
library(zoo) 
library(stringr) 
 
 
#Define TimeConverter function 
TimeConverter <- function(z){ 
  cTime <- as.character(z[,1]) 
  Time <- (sapply(strsplit(cTime,":"), 
                  function(x) { 
                    x <- as.numeric(x) 
                    round(x[1]*60+x[2]+x[3]/60, digits = 0) 
                  } 
  ) 
  ) 
  return(Time) 
} 
 
#Mac 
data <- na.omit(read.delim("~/Google Drive/CFB/Metabolic fitness dynamics (Andreas og Peter)/R scripts/151130 data/c6-c10_s1-s9_Data.csv", 
header=T, skip =0, sep = ";")) 
map <- read.csv("~/Google Drive/CFB/Metabolic fitness dynamics (Andreas og Peter)/R scripts/151130 data/c6-c10_s1-
s9_Growth_map_EVO2_populations.csv",sep=";", header = T, colClasses = c(rep("character", 2), "numeric")) 
 
#Convert time to min 
names(data)[1] = "Time" #Standardize naming 
data$Time <- TimeConverter(data)  
 
#AP: Melt the data if not in long format already 
x.data <- melt(data, id = "Time")  
 
 
#AP: Match values from mapping file to data 
x.data$Strain<-map[match(x.data$variable, map$Well),2] 
x.data$Replicate<-as.factor(map[match(x.data$variable, map$Well),3]) 
names(x.data)<-c("Time","Well","OD","Strain","Replicate") 
 
x.data$OD<-as.numeric(x.data$OD) 
 
#Set bgOD: 
avg.bkg = 0.115 
 
#Subtract background 
x.data$bkgOD <- x.data$OD - avg.bkg 
#PR: Add ln data 
x.data$lnOD <- log(x.data$bkgOD) 
 
#Add time in hours 
x.data$Timehr <- x.data$Time/60 
 
 
#PR: First subset x.data to exclude the BKG wells 
x2.data <- subset(x.data, lnOD != "NA" & Strain != "BKG") 
x2.data$lnOD <- as.numeric(str_replace_all(x2.data$lnOD, "Inf", "0")) 
x2.data$lnOD <- as.numeric(str_replace_all(x2.data$lnOD, "NA", "0")) 
x2.data$lnOD <- as.numeric(str_replace_all(x2.data$lnOD, "NaN", "0")) 
 
#AP: Define the window size of rolling regression 
WinSize <- 5 
 
#AP: Define time and OD values for regression: 
x <- as.numeric(x2.data$Timehr) #E.g. hours or minutes. 
y <- as.numeric(x2.data$lnOD) 
z <- as.data.frame(cbind(x,y)) 
 
#Standardize naming: 
names(z)<-c("Time","lnOD") 
 
#Fit data with a  
RollFit<-rollapply(zoo(z), width=WinSize,  
function(Z) {  
reg<-lm(formula=Time~lnOD, data = as.data.frame(Z)) #Apply linear regression to lnOD against time.  
cbind(1/coef(reg)[2],summary(reg)$r.squared)}, #calculate 1/slope  
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by.column=FALSE, align="right") 
 
#Standardize naming: 
names(RollFit)<-c("LocalGrowthRate","Rsquared") 
 
#Attach to existing dataframe *NB: Fit values start at the row corresponding to WinSize! 
x3.data <- cbind(x2.data[WinSize:nrow(x2.data),],as.data.frame(RollFit)) 
 
xr.data<-subset(x3.data) 
 
 
 SI Item 3 
R script 
library(nls2)  
 
#Load total mobile element fractions (NGS-determined) 
ISobs <- data.frame(c(29.7,35.3,41.1,46.7,52.5,69.9)) 
colnames(ISobs)[1] <- "generations" 
ISobs$fraction <- c(0.991197834,0.980170492,0.919041917,0.733211699,0.338929329,0.000657726) 
z <- nls2(fraction ~ ((u+ro))/((u)*exp((u+ro)*generations)), data = ISobs, 
          start = list(u=0.005,ro=0.1), control = list(maxiter = 5000)) 
summary(z) 
 
SI Item 4 
 
R script  
#Load required libraries 
library(ggplot2) 
library(foreach) 
library(doParallel) 
 
#setup parallel backend to use multiple processors 
cl<-makeCluster(4) 
registerDoParallel(cl) 
 
 
###set parameters for growth of producers (gP), non-producers (pNP) and escape rate (k)### 
parms=c(gP=0.72,gNP=1,k=2.1E-7)  
initial=c(P=29, NP=1) 
time.window=c(0, 15) 
 
# define how state variables for cell division and mutational escape 
processes <- matrix(0, nrow=3, ncol=2, 
                    dimnames=list(c("birth P", 
                                    "Escape P", 
                                    "birth NP"), 
                                  c("P","NP"))) 
 
processes[1,1]=1 #If birth of P 
processes[2,1]=-1 #If escape of P 
processes[2,2]= 1 
processes[3,2]=1 #If birth of NP 
 
# process probabilities 
probabilities <- function(state){ 
  P<-state[1] #Define parameters 
  NP<-state[2] 
  gP<-parms[1]; gNP<-parms[2];k<-parms[3] 
   
  a1<-gP*P #P birth 
  a2<-k*P #Escape 
  a3<-gNP*NP #NP birth 
   
  a<-c(a1,a2,a3)  
  names(a)<-c("a1","a2","a3") 
  a 
} 
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### Initiate parallelized loop: ### 
ls <- foreach(n = 1:4) %dopar% { 
   
  # initialize state and time variables and write them into output table 
  state <- initial 
  time <-  time.window[1] 
   
  # define output dataframe 
  output <- data.frame(t=time, 
                       P=state["P"], NP=state["NP"], 
                       row.names=1) 
   
   
  #start timer to get time of  simulation  
  strt<-as.numeric(Sys.time()) 
 
 #Define stop-conditions for each simulation e.g. fraction of producers or absulute time (in seconds) 
  while(state["P"]/(state["P"]+state["NP"])>0.5 & as.numeric((Sys.time()-wst))<252000){ 
     
    #calculate process probabilities for current state 
    a<-probabilities(state) 
     
    #WHEN does the next process happen? 
    tau<-rexp(1,rate=sum(a)) 
     
    #update time 
    time = time+tau 
     
    #WHICH process happens after tau? 
    act<-sample(length(a), 1, prob=a) 
     
    #Update states 
    state<-processes[act,]+state 
     
    #write into output 
    output <- rbind(output,c(time,state)) 
  } 
   
  #Add info on e.g. replicate and parameters 
  output$ER <- "2.1*10^-7" #Escape rate 
  output$rep <- n #Replicate 
  output$frac <- output$P/(output$P+output$NP) #Producer fraction 
 
  #Write each simulation to a file (optional) 
  write.table(output, file=file.path("File path", paste("Filename",".txt", sep="")), 
              sep="\t", row.names=F) 
   
  output 
   
} 
 
#Show simulation time 
as.numeric((Sys.time()-wst))/60/60 
 
#End parallelization 
stopCluster(cl) 
 
#Combine output to a dataframe 
SDF<-as.data.frame(ls[[1]]) 
 
for( i in 2:length(ls)) { 
  SDF <- rbind(SDF,as.data.frame(ls[[i]])) 
} 
 
#Calculate generations 
SDF$Gen <- log10(SDF$P+SDF$NP)/log10(2) 
 
#Plot output  
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ggplot(SDF, aes(x = Gen, y = frac, color = as.factor(rep)))+ 
  geom_line(size=1)+ 
  ylab("Producer fraction")+ 
  xlab("Generations")+ 
  ggtitle("Stoch. simulation") 
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Abstract 
Elucidating the factors governing the functional compatibility of horizontally transferred genes is 
important to understand bacterial evolution, including the emergence and spread of antibiotic 
resistance, and to successfully engineer biological systems. In silico efforts and work using single-
gene libraries have suggested that sequence composition is a strong barrier for the successful 
integration of heterologous genes. Here we sample 200 diverse genes, representing >80% of 
sequenced antibiotic resistance genes, to interrogate the factors governing genetic compatibility in 
new hosts. In contrast to previous work, we find that GC content, codon usage and mRNA-folding 
energy are of minor importance for the compatibility of mechanistically diverse gene products at 
moderate expression. Instead, we identify the phylogenetic origin, and the dependence of a 
resistance mechanism on host physiology, as major factors governing the functionality and fitness of 
antibiotic resistance genes. These findings emphasize the importance of biochemical mechanism for 
heterologous gene compatibility, and suggest physiological constraints as a pivotal feature orienting 
the evolution of antibiotic resistance.   
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Introduction 
A distinct feature of prokaryotes is their ability to share genetic material via horizontal gene 
transfer1. Such open-source evolution provide rapid access to the genetic innovations that 
continuously shape bacterial genomes2. The transfer of genes between bacteria happens primarily 
via transferrable genetic elements such as plasmids, phages or direct DNA uptake (transformation)3. 
Although such transfer events are believed to occur frequently in nature, the fundamental forces 
governing the establishment and maintenance of successfully transferred genes are poorly 
understood2,4. Because foreign genes may lose functionality or impose a high biological cost in new 
hosts, this gap in our understanding also limits current synthetic biology efforts focused on 
engineering novel functions into biological systems5,6.   
From computational studies of sequenced genomes, the tendency of a gene to be transferred has 
been inferred to depend mainly on ecological and phylogenetic factors1,4. As physical proximity of 
donor and recipient bacteria is generally required for transfer, ecology has been suggested as a 
strong dissemination barrier4. However, the broad-host range of some transfer mechanisms, and the 
ubiquitous presence of antibiotic resistance genes across environments, suggest that ecological 
barriers are largely governed by functional constrains7,8. Indeed, numerous studies reveal a 
functional bias of transferred gene categories, with factors performing largely independent tasks, 
e.g. those involved in secondary metabolism or virulence, being transferred more often than genes 
encoding highly interactive proteins involved in transcription and translation9–12. Furthermore, 
metagenomic analyses of DNA from different environments suggest that genes involved in antibiotic 
resistance are highly confined by phylogeny indicating that genomic factors are important for the 
acquisition or maintenance of foreign genetic material4,13,14. In support of this idea, in silico studies 
have shown a bias in the nucleotide composition of transferred genes in relation to the recipient 
genome, and suggest that sequence parameters influence successful gene integration15–17. 
Specifically, a role of the codon usage and GC-content on the functional integration of acquired 
genes has been inferred due to their potential role in gene expression and fitness18,19. Upon 
successful transfer, host compatibility and selection is crucial for the long-term persistence of newly 
acquired genetic material, as costly genes will eventually be lost through purifying selection20–23. 
Experimental studies characterizing the phenotypic effects of synonymous sequence variation have 
largely focused on a limited set of phenotypes and most current data is obtained from fluorescent 
protein expression24–26. However, recent work by Kacar and Garmendia et al. showed an increased 
fitness cost of replacing the elongation factor Tu (a highly conserved protein involved in translation) 
with its distant homologs in E. coli, and similar results have been obtained by Lind et al. when 
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replacing ribosomal subunits in Salmonella typhimurium27,28. While the fitness cost of expressing 
these core translational genes could not be attributed to differences in sequence composition, 
Amorós-Moya et al. showed that sub-optimal codon usage of a highly-expressed chloramphenicol 
acetyl transferase resistance gene resulted in lower resistance levels and overall host fitness29.   
Although existing studies provide interesting clues on the relation among sequence composition, 
gene expression and fitness, the relevance of these findings regarding the functionality of diverse 
naturally occurring accessory genes involved in antibiotic resistance is not clear.  
Antibiotic resistance genes are ubiquitously present on mobile genetic elements that allow their 
extensive dissemination among bacteria3. Given the stagnation in antibiotic discovery, the increasing 
prevalence of multidrug resistant bacteria constitutes an urgent threat to public health that 
motivates a deeper understanding of the forces governing the dissemination and long-term 
maintenance of antibiotic resistance genes30–32.   
Antibiotic resistance is conferred through five major mechanisms: i) enzymatic drug inactivation, ii) 
active drug efflux, iii) modification of drug target, iv) replacement of the drug target with a resistant 
variant, and v)  regulatory shifts towards a more resistant phenotype33. The diversity of mechanisms 
through which antibiotic resistance is achieved makes antibiotic resistance genes a valuable model 
system for investigating the factors that may affect the functional compatibility of transferable 
genes in general.  
In this study, we employed a synthetic bottom-up approach by sampling a broad sequence space of 
200 diverse open reading frames annotated as antibiotic resistance genes. Via experimental profiling 
of these genes, we discovered that resistance mechanisms and the phylogenetic relatedness of 
donor and recipient species act together as important determinants of gene functionality and fitness 
cost. Consequently, we suggest that these effects dominate the potential transfer barriers imposed 
by sub-optimal sequence composition of heterologous genes.    
 
Results 
By clustering all genes of major publicly available antibiotic resistance gene databases, and selecting 
the most abundant genotypes, we obtained 200 genes for DNA synthesis (see materials and 
methods, Supplementary Fig. 1a and Supplementary Table 1). The selected clusters represented the 
most abundant genes in resistance gene databases (>80%, Supplementary Fig. 1a) and accounted 
for 98 % of the total dataset homologues in general sequence databases (NCBI NT and Genomes) 
(Supplementary Fig. 1b).  
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Fig. 1 | Database mechanistic and phylogenetic diversity of 200 synthesized genes. (a) Biochemical functions 
of the included antibiotic resistance genes obtained via Resfams. These genes are grouped into five major 
mechanistic categories (relative abundance shown in parenthesis): DrugMod = Drug inactivating enzymes 
(56.5%), Efflux = Efflux pumps (14%), Reg = Regulators (5%), ResTarget = Redundant/resistant target (14.5%), 
TargetMod = Target modifying/binding proteins (10%). (b) Gene counts stratified by resistance class and 
fractionated by resistance mechanisms. (c) Phylogenetic and drug class distributions of the included genes. 
Genes that could be identified (97% identity) in one or more genomes deposited in RefSeq were quantified for 
each bacterial phylogenetic class. The colouring of each bar depicts the distribution of the annotated 
resistance. Drug class aberrations: Chl = Chloramphenicol, Bla = β-lactams, Ami = Aminoglycosides, Mul = 
Multiple drug classes, Sul = Sulfamethoxazole, Tet = Tetracyclines, Flq = Fluoroquinolones, Unk = Unknown, Tri 
= Trimethoprim, Van = Vancomycin, Dcy = D-cycloserine, Lin = Lincosamides, Mac = Macrolides.  
 
The 200 selected genes vary widely in resistance mechanisms, targeted drug classes and 
phylogenetic dissemination (Fig. 1, Supplementary Table 1). 64% of the selected genes were 
associated exclusively with Gram-negative organisms, and of the remaining genes, 13 % were found 
in Gram-positive organisms, and 10.5 % were found in both Gram-negative and Gram-positive 
organisms (Fig. 1c). However, 12.5 % of the genes had not been associated with a particular host 
organism (mostly genes found via metagenomic functional selections). The selected genes were 
annotated to confer resistance to 11 distinct drug classes via 23 distinct biochemical functions that 
can be divided into five major mechanistic categories based on their Resfam annotations (Fig. 1a and 
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b)34. In addition to genes annotated to confer resistance towards known drug classes, genes 
annotated to confer antibiotic resistance but without defined antibiotic resistance profiles were 
included as a consequence of their high abundance in the public antibiotic resistance databases. All 
of these genes were annotated as having regulatory or efflux functions but were not associated with 
specific drug classes in the literature (Supplementary Table 1).  
Functional characterization of putative resistance genes reveals diverse functionality and growth 
profiles 
The 200 selected genes were cloned in a low-expression setup in E. coli MG1655 (Supplementary 
Fig. 1). All genes were subjected to 20 phenotypic tests and growth rate measurements. Specifically, 
the resistance towards 20 antibiotics comprising 12 chemical classes was assessed. A gene was 
considered a functional resistance gene if it conferred a resistance phenotype of at least a 2-fold 
increase in the minimal inhibitory concentration (MIC) compared to that of E. coli MG1655 carrying 
the empty vector (Supplementary Table 2). Clones displaying a resistance phenotype were 
subjected to growth rate assessments under non-selective conditions and further antibiotic 
susceptibility testing in a range from 2- to 30-fold the MIC (Fig. 2). 
Whereas only 32% of the 200 tested genes could be identified in E. coli genomes deposited in NCBI’s 
RefSeq database, 63 % of the genes displayed at least one resistance phenotype in E. coli. The 
resistance phenotypes were distributed unequally among the drug classes, with genes annotated to 
confer resistance towards tetracyclines, sulfonamides, β-lactams and fluoroquinolones having a high 
proportion (> 80%) of functional variants. By contrast, D-ala ligases, which confer resistance to D-
cycloserine in E. coli, as well as genes annotated to confer resistance towards polymyxins or multiple 
drug classes, showed the lowest proportion of functional genes in our experimental setup (Fig. 2, 
Supplementary Table 1). Genes conferring resistance towards β-lactams, aminoglycosides, 
chloramphenicol and trimethoprim showed the highest average levels of resistance, whereas those 
conferring resistance towards fluoroquinolones and D-cycloserine displayed the lowest average 
increase in resistance compared to the susceptible WT (Fig. 2). This difference in resistance level 
between drug classes was statistically significant (ANOVA, P < 0.001). We further investigated if the 
level of resistance could be attributed to differences the codon adaptation index (CAI), GC-content 
and mRNA-folding energy; however we could not detect any significant correlations between these 
sequence parameters and the resistance level for the total dataset nor within resistance classes 
(Supplementary Fig. 3).  
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Fig. 2 | The resistance level and relative growth rate of each functional resistance gene in E. coli. The 
heatmaps show the resistance profile (fold change in MIC compared to E. coli MG1655 carrying the empty 
expression backbone) for all functional resistance genes and are grouped by drug class. The β-lactamases (left) 
are clustered by their molecular (Ambler) classes as shown in parentheses
35
. Bars represent the mean of at 
least three repeated growth measurements and are normalized to E. coli MG1655 carrying the empty 
expression vector. Error bars show the std-error of the mean. The genes highlighted in red are present in 
sequenced E. coli genomes deposited in NCBI’s RefSeq genome database. The drug classes are as follows: Chl = 
Chloramphenicol, Bla = β-lactams (Amx = Amoxicillin, Mec = Mecillinam, Cfu = Cefotaxime, Azt = Aztreonam, 
Mep = Meropenem), Ami = Aminoglycosides, Mul = Multiple drug classes, Sul = Sulfamethoxazole, Tet = 
Tetracyclines, Flq = Fluoroquinolones, Tri = Trimethoprim, Dcy = D-cycloserine, Lin = Lincosamides, Mac = 
Macrolides, Col = Colistin, Fos = Fosfomycin, Nit = Nitrofurantoin, Van = Vancomycin. Grey coloured drugs 
were tested, but no genes conferred resistance towards these in E. coli.   
Sequence composition is not a major compatibility barrier of acquired resistance genes 
As 68% of the tested genes from our data set have not yet been identified in E. coli genomes, our 
dataset is well suited for studying factors relevant to the functionality of resistance genes evolved in 
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a foreign genetic context. The selected genes varied widely in their base composition (Fig. 3), which 
has previously been hypothesized to affect functional expression and successful gene transfer 16,18,19. 
The codon usage of an incoming gene might influence its protein expression and it is generally 
believed that the CAI is important for heterologous gene integration18,24,36,37. Surprisingly, we found 
that the average E. coli CAI of functional resistance genes was slightly lower compared to that of the 
non-functional genes (Mann-Whitney U-test, P = 0.014; Fig. 3a). Yet, we found no significant 
difference in the average GC-content (Mann-Whitney U-test, P = 0.11) (Fig. 3b) between the 
functional and non-functional genes. To investigate whether interactions between these and other 
parameters would influence the outcome of our analysis, we built a multivariate logistic regression 
model (Supplementary Table 3). The inclusion of GC-content did not significantly change the 
predictive power of the model compared to CAI alone (P = 0.70), suggesting that the effect of the CAI 
showed a limited dependence on GC-content (Fig. 3d). The folding energy of the N-terminal of a 
transcript may also influence gene expression24,26,38, however, N-terminal mRNA-folding energy did 
not predict functionality, nor resistance level of functional genes, in our logistic regression model 
(Fig. 3c, Supplementary Fig. 3 and Supplementary Table 3).  
 
Figure 3 | Divergent sequence composition is not a major barrier for functionality of a foreign antibiotic 
resistance gene in E. coli. a) Comparison of the codon usage between functional and non-functional genes b) 
Comparison of the GC-content between functional and non-functional genes c) Comparison of the mRNA N-
terminal folding energy between functional and non-functional genes d) Functional and non-functional genes 
are dispersed throughout the sequence space. Point shape indicates whether a gene has been observed 
exclusively in Gram-negative organisms, Gram-positive organisms, in both Gram-positive and Gram-negative 
organisms, or has not yet been associated with a sequenced genome (Uncultured).   
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Although gene functional compatibility exhibited little dependence on sequence composition, it may 
affect the fitness cost in new hosts. As a proxy for fitness, we measured the growth rate of E. coli 
expressing each of the functional resistance genes (Fig. 2). Compared to E. coli carrying the empty 
expression vector, the impact of expressing a resistance gene on the growth rate ranged from a 
slight increase to more than a 30 % decrease in growth rate (Fig. 2 and Supplementary Fig. 4).  
 
The reduced growth rate resulting from expression of a resistance gene differed significantly 
between the drug classes to which the genes conferred resistance (one-way ANOVA, P > 0.001; Fig. 
2), but the impact on growth did not differ between mechanistic categories (one-way ANOVA, P = 
0.38; Supplementary Fig. 5). The gyrase-protecting qnr fluoroquinolone resistance genes showed 
exceptionally low costs compared to other resistance classes, especially the D-alanine-D-alanine 
ligases. These confer D-cycloserine resistance in E. coli through target replacement, and had a high 
negative impact on growth rates (Fig. 2).   
Contrary to current thinking, some antibiotic resistance genes from the qnr and dfr families were 
slightly advantageous to E. coli in the absence of antibiotic selection (Fig. 2). We detected beneficial 
growth patterns of qnrA as well as qnrS1, which are found, for example, in Shigella and Salmonella 
species that are closely related to E. coli, but not for the qnr genes found in more distantly related 
species. Despite a tendency towards a trade-off between resistance level and growth rate for target-
modifying (r = 0.62, P =0.04), this trend was opposite for resistant target (r = -0.61, P =0.06) and 
efflux mediators (r = -0.59, P =0.12), and no correlation was observed between growth reduction and 
resistance level for the drug modifying mechanistic class (r = 0.02, P = 0.84; Supplementary Fig. 6). 
  
It has previously been recognized that gene level parameters such as the CAI and GC-content of 
codon-scrambled genes can influence host fitness when expressed in E. coli24,25. E. coli expressing the 
trimethoprim resistance gene dfrG of the dihydrofolate (dfr) family, originating from Staphylococcus 
aureus, displayed a lower growth rate compared to E. coli expressing dfr genes of Gram-negative 
origin (Fig. 2). Indeed, the dfrG gene had a low GC-content (32%) and CAI (0.17), which we 
hypothesized could negatively influence the growth of E. coli. To test whether base composition 
could be optimized to decrease the growth reduction imposed by dfrG, we synthesized a codon-
optimized variant with a higher GC-content (55%) and CAI (0.66). However, this variant did not show 
a significant growth improvement compared to the wild-type dfrG gene when expressed in E. coli 
(Mann-Whitney U-test, P = 0.1; Supplementary Fig. 7), suggesting that factors beyond the 
nucleotide sequence are responsible for the differential cost.   
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To assess the general trend in our dataset, we investigated the correlations between growth rate 
effects and the CAI, GC-content, N-terminal mRNA-folding energy and gene length (Fig. 4). Although 
there was a tendency towards higher growth rates in genes with an increasing CAI, in contrast to 
previous studies on sequence variants of gfp24,25, we found no significant correlation between these 
individual sequence parameters and the growth rate of E. coli for our diverse set of antibiotic 
resistance genes.   
 
Figure 4 | The cost of resistance gene acquisition shows little or no dependence on sequence composition. 
(a) The CAI showed a small (r = -0.11) but non-significant (P = 0.22) correlation with growth reduction. 
Similarly, the GC-content(r = -0.04) (b), N-terminal mRNA-folding energy (r = -0.04) (c) and gene length (r = 
0.03) (d) did not correlate significantly with the growth reduction experienced by E. coli upon receiving the 
resistance genes in our expression setup (P > 0.05).    
A multiple linear regression model of our growth data against the CAI, GC-content, N-terminal 
mRNA-folding energy and gene lengths explained virtually no variations in the growth rate (R2= -
0.01, P = 0.6; Supplementary Table 4). This result indicated that other factors dominate the 
potentially minor growth effects imposed by the base and codon composition in our dataset.  
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Resistance mechanism is a major determinant of gene functional compatibility   
The functional compatibility of a gene in a new host may depend on its interaction with specific 
components of host physiology and metabolism9. Antibiotic resistance genes mediate their 
phenotype through a wide range of cellular interactions, with some mechanisms being dependent 
on specific host structures, e.g., ribosomal structure or the cell envelope for target modifying and 
efflux mechanism respectively, whereas drug modifying enzymes act directly on the antibiotic 
compound33. Although we observed a small significant difference in the proportion of functional 
genes for different targeted drug classes (χ2, P = 0.031), we also noted that genes annotated to 
confer resistance to a specific drug class are frequently dominated by specific resistance mechanisms 
(Fig. 1b)39. Accordingly, the mechanistic category of a gene was far better at predicting the 
functionality of a gene transferred to E. coli (χ2, P < 0.001) than the targeted drug class alone. This 
result suggested that certain resistance mechanisms are easier to integrate into a novel host 
physiology than others (Fig. 5a and Supplementary Table 3). The highest proportion of functional 
genes was found among the drug-modifying enzymes, including the β-lactamases and 
aminoglycoside transferases, with most genes conferring high levels of resistance (Fig. 5a), and this 
distribution was not significantly biased by the phylogenetic affiliation of these genes (χ2, P = 0.08) or 
whether they had previously been identified in E. coli (χ2, P = 0.77). By contrast, genes conferring 
resistance through efflux and regulatory mechanisms were least likely to function in E. coli, in which 
only 28.5 % and 10 % of genes displayed resistant phenotypes, respectively. These findings are 
consistent with the hypothesis that genes involved in limited cellular interactions are more likely to 
be functionally compatible in a new host9.  
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Fig. 5 | Distribution of functional genes on phylogenetic affiliation within drug classes and resistance 
mechanisms.  
(a) Functionality and resistance level of the resistance genes belonging to the different mechanistic categories. 
DrugMod = Drug inactivating enzymes, TargetMod = Target modifying/binding proteins, ResTarget = 
Redundant/resistant target, Efflux = Efflux pumps, Reg = Regulators. (b) The number of functional genes 
annotated as conferring resistance towards each drug class are coloured according to their affiliations with 
Gram-negative organisms (G-neg.); Gram-positive organisms (G-pos.); both Gram-negative and Gram-positive 
organisms (Both); or none of currently sequenced genomes in RefSeq (Uncul.). The number of functional genes 
out of the total genes within each class is indicated above the bars. (c) The average 16S rRNA distance 
between E. coli and all RefSeq genomes where each gene has been identified correlated with the growth 
reduction inflicted by each gene. A linear regression model was fitted to the subsets of genes interacting with 
the drug (n = 74) and cellular components (n = 27), respectively, were phylogenetic data was available. Cell-
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interacting mediators include those that conferred resistance via target protection or modification, provision 
of a resistant target, efflux or regulatory interactions. Drug-interacting genes conferred resistance through 
modification or breakdown of the antibiotic without interfering directly with host physiology. Shades 
represent the standard-error of the linear fit. (d) The phylogenetic distance from E. coli for functional and non-
functional genes tested in E. coli. The mean is shown for the subsets of drug-modifying (blue dashed line) and 
cell-interacting (orange solid line) resistance mediators.  
Phylogenetic distance affects fitness for cell-interacting resistance mechanisms   
If the activity of a gene-product is detrimental for functional genetic integration due to suboptimal 
physiological interactions, we would expect the phylogenetic relatedness of the donor and recipient 
species to influence the functional compatibility and fitness cost newly acquired genes. This 
hypothesis was supported by the fact that the deviation in GC-content from the E. coli average 
(50.8% GC) was a stronger, although still not significant, predictor of the growth reduction resulting 
from gene expression (r = 0.16, P = 0.07; Supplementary Fig. 8) compared to the absolute GC-
content (Fig. 4b). As GC-content varies among phylogenetic groups, this trend could be a proxy for 
the cellular environment, in which a gene has evolved, rather than a direct effect of sequence 
composition (Supplementary Fig. 9). Indeed, a higher average growth rate was observed for genes 
affiliated with Gram-negative organisms compared to those that were exclusively associated with in 
Gram-positive organisms or both (Supplementary Fig. 10. Mann-Whitney U-test, P = 0.03).  
 
To further investigate the basis of the fitness costs of gene expression, we derived a distance 
measure based on the average 16S rRNA sequence identity between E. coli and the genomes in 
which the gene has been identified. Using this 16S rRNA based evolutionary distance measure, we 
found a correlation between the cost of a gene and the relatedness of its genomic context to E. coli 
(r = 0.29, P = 0.003). Whereas the relative burden of expressing drug-modifying enzymes was 
independent of phylogenetic relatedness of the typical hosts of a gene to E. coli (r = 0.04, P = 0.56; 
Fig. 5c), we found the main drivers of this correlation to be the genes that directly interact with cell 
factors (r = 0.74, P < 0.001; Fig. 5c). This correlation was not biased by differences in cell-interacting 
mechanistic categories (ANOVA, P = 0.93; Supplementary Fig. 11), targeted drug classes (ANOVA, P = 
0.57) or phylogenetic groups (ANOVA, P = 0.23; Supplementary Fig. 12).   
These results suggests a trade-off between adaptation towards one host and being broadly 
functional across phylogeny, which is further supported by the higher cost of genes disseminated 
across Gram-positives and Gram-negatives (Supplementary Fig. 10).     
 
While there was an unequal distribution of functional genes among Gram-classes (χ2, P = 0.002), the 
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phylogenetic affiliation, measured as the average 16S rRNA-based distance between genomes 
harbouring the gene, was not significantly correlated with gene functional compatibility when all 
genes in our dataset were considered (Mann-Whitney U-test, P = 0.84). Although a bigger difference 
was observed when cell-interacting genes were considered in isolation, this difference was still not 
significant (Mann-Whitney U-test, P = 0.23; Fig. 5d). However, when excluding native E. coli genes 
(Supplementary Table 5), a highly significant dependence of functionality on phylogenetic distance 
for cell-interacting proteins (Mann-Whitney U-test, P < 0.001), but no change for drug-interacting 
resistance mediators (Mann-Whitney U-test, P = 0.57), was observed. For this subset of genes, the 
effect of phylogenetic differences was dominated by genes conferring resistance through target 
replacement (Mann-Whitney U-test, P = 0.031) and efflux mechanisms (Mann-Whitney U-test, P = 
0.015). However, while the Gram-class affiliation was not a significant predictor of functionality for 
efflux, target replacing and regulatory genes (χ2, P > 0.05), genes originating from Gram-negatives 
were significantly overrepresented in functional target-modifying resistance mediators (χ2, P > 
0.005). These observations further support the importance of resistance mechanism and genomic 
relatedness for gene functional compatibility.   
 
Discussion   
To better understand the factors underlying functional compatibility and the fitness cost of genes in 
new hosts, we assessed a set of diverse antibiotic resistance genes spanning a wide range of 
sequence compositions and mechanisms. We found that a substantial proportion of genes, not 
previously observed in E. coli, were functional despite huge sequence deviations, in the CAI and GC-
content, from the E. coli genome average. Interestingly, we found that sequence composition, 
including the CAI, N-terminal mRNA-folding energy and GC-content, was a poor predictor of 
functional compatibility and fitness cost (Fig. 3 and 4). Previous studies have shown that the 
expression level of codon-randomized gfp variants is mainly affected by the N-terminal mRNA-
folding energy; however, strong negative effects of mRNA folding are expected to be counter-
selected in naturally occurring genes, and we found no significant correlation with this parameter 
and functionality in our diverse gene set24,38. Although we did not assess the effect of sequence 
composition on expression levels directly, our results suggested that gene expression is not trivially 
linked to phenotypic output as is the case for fluorescent proteins (Supplementary Fig. 2)24. By 
virtue of resistance phenotypes, we were able to measure end-point functionality directly to avoid 
indirect, e.g. protein-level, measurements that might not reflect correct phenotypic integration.  
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Using antibiotic resistance genes as a model for transferable accessory genes, we experimentally 
showed that the mechanism of the gene-product is more important for its functional compatibility 
than the gene sequence composition (Fig. 5a). The results obtained for the antibiotic resistance 
genes included here are likely to apply more broadly to horizontal gene transfer, and our 
experimental results support the “complexity hypothesis” originally proposed by Jain et al., which 
state that highly interactive gene products are less likely to undergo horizontal transfer 9,40,41. 
Although we did not assess protein interactions directly, we observed that genes encoding 
regulators and efflux pumps, which are dependent on regulatory networks or cell envelope 
structures, were the least likely to function when expressed in E. coli compared to genes encoding 
enzymes that act directly on the drug (Fig. 5a); this result signifies that the extent of physiological 
decontextualization dictates the likelihood of selection following gene transfer. While the trend 
towards higher costs of target modifying mediators conferring high-level resistance might be 
expected, the lack of, and even opposite tendencies, observed for the remaining mechanistic classes, 
suggests that high resistance and low fitness cost might not be opposing features (Supplementary 
Fig. 6).  
 
The biological cost of functionally expressing a new gene is an important factor that potentially 
determines the reversal of antibiotic resistance upon cessation of antibiotic use22. Fitness effects are 
believed to affect the long-term success of gene transfer events as well as the robustness of 
engineered biological systems, and the origins of these costs have been suggested to stem from 
suboptimal sequence composition18,42,43. Notably, in our setup of moderate expression, our growth 
measurements did not detect a significant influence of the sequence-level parameters previously 
suggested to influence the growth rate of E. coli expressing heterologous proteins24,25. These studies 
employed libraries of lower or similar sequence-level diversity compared to our dataset, albeit with 
a narrow mechanistic focus (GFP and ɸ29 DNAP), and observed that the CAI and GC-content 
affected the growth rate of E. coli24,25. Yet, in line with our observations, Knöppel and Lind et al.44 
were unable to measure a significant fitness effect of parameters such as GC-content and length of 
random DNA inserts containing a variable number of open reading frames of unknown functions 
when expressed from a single copy on the chromosome44. However, we acknowledge that these 
effects exist and may be measured by more sensitive fitness assays or at higher expression levels 
than the ones used here. Compared to the linear influence on the growth rate of E. coli expressing 
gfp and ɸ29 DNA polymerase genes within the narrow GC-range (40.4–53.7%) observed by 
Raghavan et al., our data suggests that the possible effect of GC-content is non-linear, and that the 
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deviation from the host genome is more important than the absolute GC-content (Fig. 4b and 
Supplementary Fig. 8)25,44.  
While previous studies have found a correlation between fitness and evolutionary distance for 
homologs of E. coli genes involved in translation27,28, we show that these effects are also evident for 
accessory genes with non-essential and diverse functionalities, which may contribute to the 
phylogenetic barriers more generally observed for horizontal gene transfer1,13,45. These fitness 
effects correlated with the relatedness of the donor and recipient species and were independent of 
sub-mechanistic- and phylogenetic categories (Supplementary Fig. 11 and 12). Interestingly, 
although phylogenetic distance was a much stronger predictor of growth influence than the 
deviation in GC-content, the correlation between GC–deviation and phylogenetic distance might 
explain the small deviation in GC-content observed for transferred genes and their recipient 
genomes (Supplementary Fig. 9)15. However, by demonstrating the dependence on cellular 
interactions and showing that GC optimization of the dfrG gene did not improve its cost, GC-content 
may be a confounder rather than the cause of the fitness effects observed here.  
 
We found that sequence-level properties have a limited impact on heterologous gene fitness or 
function and are therefore unlikely to be the dominant causal factors confining genes within specific 
phylogenies. Instead, biochemical mechanisms have strong impacts on heterologous gene fitness 
that are proportional to the phylogenetic distance to its customary host. The notion that the 
functional compatibility of cell-interacting proteins is dependent on phylogenetic relationships 
supports a shift in focus away from sequence composition and metabolic constraints as limiting 
factors in horizontal gene transfer. Interestingly, the positive effects observed for certain members 
of the dfr and qnr families, implicated in DNA gyrase protection and folate metabolism, might even 
enhance their persistence in the absence of antibiotic selection, when exchanged between closely 
related species.   
Importantly, our data suggested that antibiotic resistance genes interacting directly with the drug 
are more likely to function and be maintained when transferred to a new host. Historically, drug-
interacting resistance mechanisms, e.g., aminoglycosides, chloramphenicol and β-lactam resistance, 
have emerged faster following the introduction of the drug class in question, compared to e.g. 
macrolide and vancomycin resistance, which are mediated largely through modification of the 
cellular targets 46. For aminoglycosides, drug-modifying genes were detected regularly since the late 
1940s, whereas ribosome-modifying methyltransferases were first detected in the early 2000s47. 
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The detailed phenotypic information on individual resistance genes obtained here will be an 
important resource for ranking the risk of resistance genes and predicting their evolution against 
existing and future drugs32,48. However, knowledge on antibiotic use, co-selection, regulatory or 
compensatory interactions in a range of hosts is still needed for accurate predictions49. Coupling our 
findings to factors such as drug usage and ecology of pathogens may allow the construction of 
predictive models to help guide rational drug usage and development of novel drug classes that are 
less susceptible to resistance development32. Finally, the concepts derived in this study may also 
guide metabolic engineering or synthetic biology efforts when heterologous proteins are needed to 
engineer any kind of robust biological system5,6.     
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Methods 
Database construction and gene synthesis  
All resistance gene entries from the ARDB, CARD and Lahey Clinic β-lactamase databases (Accessed 
Dec, 2014) and functional selection studies were downloaded 34,50–53. A total of 4253 unique 
sequences were obtained after clustering at 99% nucleotide identity using CD-HIT software 54, and 
these sequences were further clustered at 80% identity resulting in 839 gene clusters. These clusters 
were first sorted according to the mean number of BLAST hits obtained in NCBI to include the most 
abundant genes and then sorted on cluster size to limit the inclusion of housekeeping genes that are 
often conserved and occur in small clusters. The 200 largest clusters were selected based on the 
modal sequence length of each cluster. Trimming was performed using GeneMarkS to only include 
the longest open reading frame of each sequence 55. Due to synthesis and cloning limitations, genes 
longer than 1970 bp were excluded, and Xbal and AscI sites were synonymously removed by manual 
sequence inspection. Two primer binding sites for amplification of the entire gene and a unique 
barcode were added to each of the 200 sequences (Supplementary Fig. 2). Finally, the sequences 
were ordered as gBlocks® through Integrated DNA Technologies (IDT, Coralville, Iowa, USA). All genes 
and the data obtained for each functional gene is available in Supplementary Table 1.     
 
Gene dissemination and genomic context analysis  
To assess gene association with sequenced genomes, BLAST comparisons were performed at a 95% 
identity alignment cut-off, and validated through EMBOSS Matcher pairwise, against NCBIs RefSeq 
database (67,704 entries; last performed October 2016). The rarefaction analysis of nucleotide 
databases (Supplementary Fig. 1b) was performed at a 90% identity and 90% coverage cut-off 
against the NCBI nucleotide and genomes databases. To quantify the dissemination distance of 
those antibiotic resistance genes with respect to E. coli, we chose one representative 16S rRNA from 
each genus carrying each ARG in RefSeq. The host distance was then calculated using EMBOSS 
Matcher pairwise alignment between E. coli 16S rRNA and representative 16S rRNA for the ARG-
carrying genomes and reported as the percent mismatches in the total alignment of the E. coli 
reference 16S rRNA gene.   
 
Cloning and expression of gene library   
The pZAT vector backbone (Supplementary Fig. 2) was derived from the medium copy p15A based 
pZA21 vector 56 by exchanging the resistance marker with the Sh ble Zeocin resistance gene (Thermo 
Fisher Scientific, Waltham, MA, USA) and inserting the low/medium strength BBa_J23110 promoter 
of the iGEM parts registry (http://parts.igem.org). This backbone was PCR amplified using primers 5’-
AATTTGGCGCGCCCATCAAATAAAACGAAAGGC-3’ and 5’-AATTTTCTAGATCTCCTCTTTAATGCTCGC-3’ to 
create Xbal and AscI digestible overhangs. The PCR-product (25 µL) was subsequently treated with 
0.5 µL DpnI restriction enzyme (Thermo Fisher) overnight (O/N) at 37°C to remove residual template 
and subsequently PCR purified (NucleoSpin® Gel and PCR Clean-up kit from Macherey-Nagel, 
standard protocol). In 200 individual reactions, the vector backbone was combined with each 
synthetic gene block in a reaction containing Xbal and AscI restriction enzymes (Thermo Fisher). The 
reactions were incubated at 37°C for 1 h, followed by heat-inactivation of the enzymes at 80°C for 20 
min. Subsequently, the 20-µL reactions were ligated by adding 0.5 µL T4 ligase and 3 µL ATP (5 mM) 
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and incubated at room temperature O/N. The 5-µL ligation product was used to transform 50 µL E. 
coli MG1655 chemically competent cells followed by recovery at 37°C for 3 h. Transformed cells 
were selected on Zeocin-containing plates (40 µg/ml), and correct insertion of gene blocks was 
verified by colony PCR and subsequent sequencing using primers 5’- TATGCCGATATACTATGC-3’ and 
5’- AAGCACTTCACTGACACC-3’.    
 
Antibiotic susceptibility testing  
The minimal inhibitory concentration of all 20 included antibiotics was measured for all library 
clones as well as E. coli MG1655 carrying the empty vector backbone (pZAT). One colony of each 
clone was inoculated in 180 µL LB/well (with 40 µg/ml Zeocin added for backbone selection) for 
overnight (O/N) pre-culturing at 37°C. Ninety-six-well plates were prepared with 100 µL MHB2 
medium (Sigma) per well, containing the respective antibiotics, at concentrations 2x, 5x, 10x and 30x 
the MIC of E. coli MG 1655/pZAT (Supplementary Table 2). Three replicate plates were inoculated 
with 5·105 cells and incubated for 18 h at 37°C with shaking at 250 rpm (Titramax 1000, Heidolph). 
Endpoint optical density (OD) was measured at 600 nms (Synergy H1, BioTek®), and the MIC was 
defined as the highest concentration with less or similar absorbance as the E. coli MG1655/pZAT 
(negative control) subjected to the same antibiotic concentration. 
 
Growth rate measurements   
The growth rate of each functional clone was measured as the maximum increase in optical density 
(OD) over time during exponential growth. Individual colonies were picked and placed onto a pre-
inoculation plate and grown for 2-3 h with shaking at 37oC before inoculation of the final 
measurement plate. Breathe-Easy (Sigma-Aldrich) film was applied to minimize evaporation during 
measurements. OD measurements were conducted in 96-well plates containing 150 µl LB 
medium/well by the ELx808 plate reader (BioTek, USA). OD at 600 nms was measured over 5-minute 
intervals for a maximum of 16 h, and the plates were incubated at the medium shaking setting at 
37oC between measurements.   
 
Sequence parameters and statistical analysis  
All statistical analyses were performed using R (version 3.1.1). Sequence composition data were 
obtained using the native functions of Biopython (version 1.70)57. The mRNA-folding energy was 
calculated for 35 nt up- and downstream the start codon of each gene using the RNAfold web server 
(http://rna.tbi.univie.ac.at/). The non-parametric Mann-Whitney U test was used to compare sample 
means, and a χ2 test was used when frequencies were assessed. Spearman's rank correlations were 
performed to assess the strength of associations between two continuous variables. When the 
influence of multiple variables was assessed simultaneously, a generalized linear model was fitted to 
binary response variables (glm function in R), and a multiple linear regression was fitted (lm and 
anova functions in R) to continuous response data.  
Data availability  
The authors declare that all the relevant data are provided in this published article and its 
Supplementary Information files, or are available from the corresponding authors on request. 
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Supplementary data 
 
Supplementary Figure 1: 
(a) Rarefaction plots depicting the cumulative coverage of the included resistance gene databases by 
the included ARG clusters (b) Cumulative coverage of NCBI’s NT and Genomes sequence databases 
as a function of added clusters. The 200 included clusters are indicated by the blue dotted line. 
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Supplementary Figure 2: 
Cloning procedure. The vector backbone was amplified with restriction sites and digested by 
Xbal and AscI to allow ligation of the final library construct. The ordered genes were 
designed with primer binding sides (gB-FW and gB-RV) to allow amplification. 3 stop codons 
were inserted downstream each cloned gene to ensure proper translational termination and 
a 7nt barcode was incorporated for easy sequence validation. 
 
 
  
Supplementary material - manuscript V 
 
Supplementary Table 2 – MG1655/pZAT MICs:  
Antibiotic MIC (µg/ml) 
Amikacin 8 
Amoxicillin 8 
Aztreonam 0.1 
Cefuroxime 4 
Chloramphenicol 4 
Ciprofloxacin 0.0075 
Clindamycin 26.67 
Colistin 0.33 
D-cycloserine  80 
Erythromycin 16 
Fosfomycin 0.42 
Gentamicin  2 
Mecillinam 0.16 
Meropenem 0.12 
Nitrofurantoin 16 
Sulfamethoxazole 128 
Streptomycin 4 
Tetracycline 1 
Trimethoprim 0.25 
Vancomycin 128 
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Supplementary Figure 3   
Correlations of sequence parameters and resistance level.  
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Supplementary Table 3 - GLM:  
Sequential fitting of a logistic regression model with absolute functionality in E. coli as dependent 
variable. A model was fitted using the glm function in R. Each expanded model was assessed as a chi-
squared statistics of differences in deviance/error compared to the previous model (P-value added 
factor) and the null-model (P-value all). dGmRNA: N-terminal mRNA folding energy; GramClass: 
whether the a gene matches Gram-positives only, Gram-negatives only or Both, when blasted 
against RefSeq.    
Model components Deviance DF P-value  
added factor 
P-value  
all 
null model 263.58 199 NA NA 
GC 260.87 198 0.09 0.09 
GC+CAI 255.8 197 0.025 0.02 
GC+CAI+dGmRNA 254.96 196 0.36 0.034 
GC+CAI+dGmRNA+Mechanism  190.99 192 4.24E-13 4.42E-13 
GC+CAI+dGmRNA+Mechanism 
+DrugClass 
150.98 180 7.16E-05 2.66E-15 
GC+CAI+dGmRNA+Mechanism 
+DrugClass+GramClass 
146.56 177 0.21 6.11E-15 
 
Supplementary Figure 4  
Growth rate distribution of all functional genes tested.  
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Supplementary Figure 5  
The impact on the growth rate imposed by ARGs on E. coli stratified on resistance 
mechanism.  
 
Supplementary Figure 6  
Correlation between MIC and growth rates for the different mechanistic classes. Regulators 
were omitted due to the small sample size (n=1; see above). 
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Supplementary Figure 7   
A codon optimized dfrG gene variant was synthesized to test the influence of gene 
composition on growth rate in E. coli.   
 
Optimized gene sequence:  
”ATGAAAGTTTCTTTGATTGCTGCGATGGATAAAAACCGCGTGATCGGCAAAGAGAACGACATCCCGTGGCGCATCCCGAAAGACTGGGAGTACGTGAA
AAACACCACCAAAGGCCACCCGATCATCCTGGGCCGCAAAAACCTGGAGAGCATCGGCCGCGCGCTGCCGGACCGCCGCAACATCATCCTGACCCGCGA
CAAAGGCTTCACCTTCAACGGCTGCGAGATCGTGCACAGCATCGAGGACGTGTTCGAGCTGTGCAAGAACGAGGAGGAGATCTTCATCTTCGGCGGCGA
GCAGATCTACAACCTGTTCTTCCCGTACGTGGAGAAGATGTACATCACCAAAATCCACCACGAGTTCGAGGGCGACACCTTCTTCCCGGAGGTGAACTACG
AGGAGTGGAACGAGGTGTTCGCGCAGAAAGGCATCAAGAACGACAAAAACCCGTACAACTACTACTTCCACGTGTACGAGCGCAAGAACCTGCTGAGCT
GA” 
The first 10 codons were kept unchanged to avoid changes in mRNA folding from affecting 
expression. The growth rate was measured for the optimized (55% GC and 0.68 CAI) and the 
wild type (32% GC and 0.17 CAI) variant. No significant difference in growth was observed 
(Mann-Whitney U-test, P = 0.1). Error-bars show standard deviation of 16 biological 
replicates.  
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Supplementary Table 4 – MLR  
Sequential fitting of a multiple linear regression model to the change in growth rate imposed by 
functional resistance genes in E. coli. A model was fitted using the lm function in R. Each expanded 
model was assessed by the F-statistics of explained variance compared to the model without the 
added factor (P-value added factor) and the null-model (P-value all). dGmRNA: N-terminal mRNA 
folding energy; GramClass: whether the a gene matches Gram-positives only, Gram-negatives only 
or Both, when blasted against RefSeq.    
Model components Adj. R2 DF P-value 
added factor 
P-value all 
GC -0.002 124 0.4 0.4 
GC+CAI -0.002 123 0.3 0.4 
GC+CAI+dGmRNA -0.007 122 0.5 0.5 
GC+CAI+dGmRNA+GeneLength -0.01 121 0.58 0.6 
GC+CAI+dGmRNA+GeneLength 
+DrugClass 
0.16 111 3.00E-04 1.00E-03 
GC+CAI+dGmRNA+GeneLength+DrugClass 
+GramClass 
0.2 108 0.038 4.00E-04 
GC+CAI+dGmRNA+Mechanism+DrugClass 
+GramClass+Mechanism 
0.21 105 0.34 6.00E-04 
GC+CAI+dGmRNA+Mechanism+DrugClass 
+GramClass+Mechanism+MaxMIC 
0.2 104 0.59 0.001 
 
Supplementary Figure 8  
Correlation between relative GC-content and growth rate. 
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Supplementary Figure 9  
Correlation of growth rate with GC-content and 16s distance for cell-interacting genes. 
 
 
Supplementary Figure 10  
The impact on the growth rate of E. coli stratified on phylogenetic origin at the Gram-class 
affiliation. Gram-negative organisms (Neg); Gram-positive organisms (Pos); both Gram-
negative and Gram-positive organisms (Both); or none of currently sequenced genomes in 
RefSeq (Uncul). 
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Supplementary Table 5 – Native E. coli genes   
Due to their high abundance in resistance gene databases a number of native E. coli genes 
vaguely associated with antibiotic resistance were included in the synthetic gene selection. 
For the full list of gene information, see Supplementary data Table 1.  
Cluster GeneName Mechanism Drug class GC (%) CAI 
77 pmrC Reg Unk 49.5 0.315 
89 emrB Efflux Mul 56.2 0.279 
104 mdtP Efflux Mul 55.8 0.279 
108 phoQ Reg Mul 51.3 0.25 
121 mdtD Efflux Mul 55.5 0.271 
124 baeS Reg Unk 53.7 0.319 
136 hmrM Efflux Mul 53 0.331 
157 mdtA Efflux Unk 55.3 0.353 
164 mdtM Efflux Mul 53.8 0.266 
172 mdtG Efflux Mul 52.5 0.222 
184 MdtH Efflux Mul 55.3 0.294 
213 mdtL Efflux Mul 53.1 0.252 
216 EmrA Efflux Mul 53.4 0.386 
257 BasS/PmrB Reg Pol 54.2 0.256 
292 mdtN Efflux Mul 55.9 0.349 
326 arnC TargetMod Pol 49.8 0.3 
791 HNS Reg Unk 46.4 0.56 
228 AcrE Efflux Mul 52.1 0.32 
221 mdtA Efflux Unk 55.3 0.353 
135 cpxA Reg Ami 54.6 0.365 
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Supplementary Figure 11  
The effect of the average 16S distance on the growth reduction imposed by genes of 
different mechanistic categories. There was no significant effect of the different cell-
interacting categories (orange) in a multiple linear regression (ANOVA, P = 0.93). Regulators 
were excluded from the analysis because this mechanistic category only contained one 
functional gene (cpxA).    
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Supplementary Figure 12  
The effect of the average 16S distance on the growth reduction imposed by genes detected 
in different phylogenetic classes. Only taxonomical classes with more than two genes in 
each category were included. There was no significant effect of the phylogenetic class 
affiliation on the correlation of growth rate and average 16S distance (across affiliated 
genomes) in a multiple linear regression model including these factors (ANOVA, P = 0.23). 
 
 

